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Abstract

THE PHARMACIST SUPPLY IN THE UNITED STATES, 1994-2009:
A POPULATION ECOLOGY PERSPECTIVE
By Kevin Shawn Joseph Lett
A dissertation submitted in partial fulfillment of the requirements
for the degree of Doctor of Philosophy at Virginia Commonwealth University
Major Director: Director: Dr. Michael A. Pyles

The U.S. healthcare system is a complex segment of our society that is constantly
evolving with changes to various areas such as education, financing, safety, and health. There
continues to be a critical examination of how healthcare professionals are trained and utilized as
healthcare demands increase. One category of healthcare professionals that has evolved over
time to address societal needs is pharmacists. Pharmacists have kept their traditional function of
dispensing medications while expanding into multiple areas of expertise and training from
patient counseling and drug therapy, to being part of multidisciplinary teams treating acute care
patients.
According to the National Association of Boards of Pharmacy (NABP) in 2009 there
were approximately 265,000 licensed pharmacists in the U.S. (NABP, 2010). The Health
Resources and Services Administration (HRSA) reported the settings with the largest number of
positions are chain pharmacies (77,300), hospitals (49,200), and independent pharmacies
(36,200) (DHHS, 2008).

The ratio of pharmacists per 100,000 population is expected to increase from 68.9
pharmacists per 100,000 population to 76.7 per 100,000 between 1995 and 2020 (Gershon,
Cultice, & Knapp, 2000). This increase in the pharmacist to population ratio is consistent with a
growth rate of 13% during this time period of time.
Until 1998, the supply of pharmacists in the U.S. appeared to be in reasonable balance
with demand. Market forces gradually upset the delicate balance between the supply of
pharmacists and the demand for their services between 1998 and 2009. In particular, a
precipitous increase in the volume of prescription written and filled during this time period
contributed to upsetting this delicate balance between the supply of pharmacists and demand
(Cooksey, Walton, Stankewicz, & Knapp, 2003).
Researchers have noted a number of environmental factors affecting the pharmacist
supply in the U. S. This inquiry explores these factors within the context of the population
ecology theoretical framework. In addition to the volume of prescriptions, additional
environmental factors believed to have a discernible impact on the pharmacist supply include,
the number of physicians, size of the business industry and insurance coverage. Previous studies
on pharmacists supply have pointed to income, physician population, and population among
other variables that predict the demand for pharmacists (Walton, Cooksey, Knapp, Quist, &
Miller, 2004; Cherry, D.K., Woodwell, D.A., & Rechtsteiner 2007; Walton, Knapp, Miller, &
Schumock 2007). U. S. physicians wrote over 4 billion prescriptions in 2007 (Medical
Expenditure Panel Survey, 2008). Physicians are the primary healthcare providers that generate
prescriptions to be filled. Consequently, the number of physicians is believed to be a significant
environmental factor affecting the supply of pharmacists.

There were approximately 940,000 physicians in the U. S. in 2008. Projections call for
continuous growth of the number of physicians well into the future (Smart, 2010).

Another

important environmental factor potentially impacting the demand for pharmacists is the size of
the business industry. In 2006, the health plan offer rate for large or medium organizations (50 or
more employees) was 96.7% compared to 61.2% for small organizations (50 or less employees)
(Sommers & Crimmel, 2008; Crimmel & Sommers, 2008).
Insurance coverage has the potential to have a positive impact on the demand for
pharmacists because it provides the opportunity to obtain required prescriptions (Ranji, Wyn,
Salganicoff, & Yu, 2007; Weinick, Byron, & Bierman, 2005). The population ecology
theoretical framework has been used in the study of restaurants, newspapers, and physicians and
their interactions with their surrounding environments. The theoretical framework proved to be
beneficial in the exploration of the pharmacist supply vis-á-vis the environment. The primary
constructs in the population ecology theory are carrying capacity and density. Carrying capacity
consists of two sub-constructs: munificence and concentration. Density points to the current
pharmacists supply and its impact on the future pharmacist supply.
Numerous variables have been used in previous empirical studies of the pharmacist
supply. Among the indicators of munificence in previous studies in the extant literature on
pharmacist supply are total population, elderly population, hospitals, and median household
income. In the present inquiry, total population was found to be a statistically significant
environmental factor affecting the pharmacist supply. This was hypothesized that there is a
positive linear relationship between total population and the pharmacist supply.
The number of hospitals with pharmacies was also found to be a statistically significant
environmental factor affecting the pharmacist supply. Hospital pharmacies are important venues

wherein pharmacists can demonstrate their unique expertise and make discernible contributions
to desirable health care outcomes when pharmaceutical interventions are required. In light of
this empirical finding, it seems reasonable that a growth in hospital pharmacies corresponds with
an increased demand for pharmacists (Kaboli, Hoth, McClimon, & Schnipper, 2006).
Measures of the concentration dimension included the number of hospital beds per
100,000 population, employer volume and size and the number of insured. The only putative
indicator of concentration that was found to be statistically significant in this inquiry was the
number of employers with 20 or more employees. Previous pharmacist supply was found to be a
significant environmental factor affecting the pharmacist supply in the future. Thus, density is a
significant environmental factor affecting the pharmacist supply. Five of the 13 hypotheses
tested in this inquiry were accepted. These findings are consistent with related findings in the
extant literature on the pharmacist supply.
Empirical findings from this inquiry are believed to make significant contributions to the
literature on the pharmacist supply. The population ecology theoretical framework appears to be
a suitable tool for exploring environmental factors affecting the pharmacist supply.
Recommendations for future research are presented in the final chapter.

Chapter 1: Introduction

Background on Pharmacist Supply
The pharmacist supply continues to be one of great interest in a dynamic healthcare
environment faced with increasing demand to fill a high volume of prescriptions for
pharmaceuticals in addition to the infusion of multiple roles and responsibilities. Pharmacist
supply represents the third largest health professional group in the U.S. with approximately
265,000 active pharmacists in 2009 (NABP, 2010). The pharmacist supply has received
significant attention over the past two decades. In December 1999, the United States Congress
directed the Secretary of Health and Human Services to conduct a study on the potential shortage
of licensed pharmacists (Department of Health and Human Services [DHHS], 2000). The Health
Resources and Services Administration (HRSA) reported the settings with the largest number of
positions are chain pharmacies (77,300), hospitals (49,200), and independent pharmacies
(36,200) (DHHS, 2008).
Synopsis of Pharmacist Demand
While the pharmacist supply is increasing, there are multiple factors that can affect
pharmacist supply levels. One factor is the increased use of prescription medications.
From 1997 to 2004, the number of prescriptions purchased increased by approximately
one billion (Stagnitti, 2007). There is no projection for the number of drugs being prescribed or
dispensed subsiding in the near future.
1

Physicians are the primary healthcare professionals who write prescriptions filled by
pharmacists. An increase in prescription volume will lead to an increase in work volume and a
potential need for pharmacists. The number of physicians in the U.S. was approximately
940,000 in 2008 with projections for continuous growth well into the future (Smart, 2010). In
2005 there were approximately 963 million physician office visits in the U.S. and over 679
million of those visits resulted in medication being provided or prescribed by a physician
(Cherry, Woodwell, & Rechtsteiner, 2007). Undoubtedly, for an increase in office visits and
medications prescribed to patients to occur, there more than likely has been a gateway developed
to attain care. The increased access to healthcare through insurance coverage has created
this gateway.

In 1995 the over 65 population accounted for 24% of all physician office visits;

this percentage increased to 26% by 2005 (Cherry, Woodwell, & Rechtsteiner, 2007). The
implementation of Medicare Part D in 2006 allowed additional older Americans to receive
medication benefits. The Centers for Medicare & Medicaid Services (CMS) estimated in 2004
that 15 million of the 40 million Americans eligible for Medicare had no prescription drug
coverage (Reissman, 2004).
Implementation of Part D of Medicare could potentially help make 14 to 30 million
prescriptions available to persons who may not have been able to afford their prescription drugs
previously (Reissman, 2004). The ability for one to afford prescriptions is an important driving
force in the needed supply of pharmacists. As noted by Reed (2005), approximately 51% of
uninsured working adults surveyed did not purchase a prescription compared to 14% and 31.5%
of working adults who have private and public insurance, respectively.

2

In addition to Medicare Part D, the Patient Protection and Affordable Care Act is
estimated to give 32 million previously uninsured Americans insurance coverage (Stefanacci &
Spivack, 2010). This influx is projected to significantly increase prescription drug use (Matzke
& Ross, 2010). Thus, the demand for traditional pharmacist services will rise as these new
provisions take effect. The volume of prescriptions has the ability to increase substantially in
communities that can afford their medications. Communities have a strong desire to retain their
pharmacists because these individuals provide expert health advice, provide prescriptions, while
serving either formally or informally as health educators, thereby improving the community’s
public health (Manasse & Speedie, 2007).
In addition to an analysis of the insured and prescribers, there are the facilities in which
pharmacists provide their services. The increase in the number of pharmacy facilities may also
be an important predictor in reviewing the pharmacists supply. The number of pharmacy chain
drug stores has increased from approximately 51,000 in 1997 to approximately 56,000 in 2007
(NACDS, 2007). In conjunction with community pharmacies is the infrastructure for dispensing
and distributing prescription medications. These infrastructures consist of nearly 6,000 U.S,
hospitals, mail order pharmacies and foreign sources for obtaining prescription medications
(Manasse & Speedie, 2007).
Studies on Pharmacist Supply and Limitations
A number of studies have pointed to the importance of examining the pharmacist supply
and have done so utilizing varying timeframes and variables. Walton, Cooksey, Knapp, Quist,
and Miller (2004) have examined the impact of supply and demand factors on filled pharmacist
positions. They reported that after controlling for population, the number of filled pharmacy
3

positions was significantly correlated with prescriptions, hospital days, pharmacies, and residents
older than 65 years. Although not addressed in the Walton et al. (2004) study, Cherry et al.
(2007) reported that demand can be affected by the supply of physicians in a state.
A second study by Walton and his colleagues 2007 examined the relationship between
demographic and economic variables in their attempt to understand variations in the pharmacist
supply in America. Walton and his colleagues found that surrounding population size,
community income levels, and the number of healthcare facilities all play a role in the future size
of the pharmacist workforce. These results concurred with some of the evidence found in his
previous study in 2004.
Findings from extant studies on pharmacy supply in the literature, provides some insight
into the relationship among environmental factors that may impact the pharmacist supply in
America (Knapp, 1999; Manasse & Speedie, 2007; Burt 2002; Meissner et al., 2006; &
Sommers, 2004, Mott et al., 2006; & Knapp et al, 2005). An examination of pharmacist practice
environment allows researchers, policy makers and healthcare administrators an opportunity
ability to assess the demand for pharmacy services and address current local needs (American
Society of Health System Pharmacists [ASHP], 2007).
Conceptual Framework.
The theoretical framework for this inquiry is that of the population ecology. This
theoretical framework is conducive to an exploration of the pharmacist supply and considers the
environment. The population ecology theoretical framework has been utilized to study
restaurants, newspapers, and physicians and their interactions with their surrounding
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environment (Freeman & Hannan, 1983; Carroll, 1984; Jiang & Begun, 2002), and is based on
Darwin’s Theory of Evolution.
Darwin’s Theory of Evolution looked at growth and decline among species while
accounting for environmental factors (Darwin, 1859). Darwin dismissed any premise that a
population’s evolution could be attributed to a predetermined developmental trend (Bowler,
2009). Many theorists have concurred with Darwin’s assessment that environmental forces
produce and shape populations that occupy and flourish in a particular geographical setting.
The selection of the population ecology theory was based upon its emphasis on
organization-environment relationships (Hannan & Freeman, 1977). Population ecologists view
the environment as a resource, which aids in the continued viability of populations and
communities. This perspective recognizes much of the ongoing change within health services as
a function of necessity to better fit the environment (Hurley & Kaluzny, 1987). Using the
population ecology theoretical framework allows focus on two major mechanisms to evaluate the
growth and decline of the pharmacist supply: the environment’s carrying capacity and population
density.
The environment’s carrying capacity for the pharmacist population consists of
munificence, which refers to quantity of resources such as the physician population, pharmacy
facilities, and prescription volume; and concentration, which refers to the geographical
concentration of resources in specified vicinity such as hospital beds per 100,000 population,
pharmacies per 100,000 population, and number of insured. The second major mechanism for
evaluating the growth and decline of the pharmacist supply is population density. Population
density refers to the current pharmacists’ supply impact on the future growth of the pharmacist
5

supply. As the pharmacist supply increases it affects the carrying capacity for pharmacist
services of an area, which in turn may lead to a decrease in the growth rate of the future
pharmacists supply due the inability to support too many pharmacists. In this inquiry there will
be an investigation of the pharmacist supply and its interaction with the environment within the
context of the population ecology theoretical framework. This theoretical framework lends itself
to a longitudinal research design such as the one developed in this inquiry. Gaining an
understanding of the demographic changes that influence the pharmacist supply may help
identify ways to increase staff recruitment and retention, while addressing a host of additional
healthcare issues in the community.
Research Questions.
The conceptual framework for this inquiry will provide the ability to seek empirically
based answers to two broad research questions.
1. What are the environmental factors that influence the number of pharmacists in
the United States?
2. Does the past number of pharmacists impact the current and future number of
pharmacists?
Significance of the Study
This study will provide beneficial information about environmental dimensions of the
United States and its impact on the pharmacist supply change over time. Variables such as the
pharmacies, hospitals, physicians, prescriptions filled, insurance coverage, wealth, and
businesses all bring a different dynamic to this inquiry.
Physicians are primarily responsible for the volume of prescriptions written; therefore, it
is important to gauge their supply vis-à-vis the pharmacist supply. While having the medical
6

personnel available is important to prescribe medications, the ability to pay for the prescriptions
is equally as important. The ability to pay for ones medication through either personal wealth or
health insurance that is primarily provided by an employer/business aide in determining the
volume of prescriptions a pharmacy and pharmacists are tasked with filling.
Pharmacists fill prescriptions in numerous types of pharmacy work settings. Some
pharmacists may choose to work in a chain pharmacy or hospital based upon the ability to make
more money. In one survey hospital CEO’s describe their frustration and stress induced by their
continuing difficulty in filling pharmacist’s positions within their hospitals (AMN, 2009).
This inquiry provides the effects of environmental factors on the pharmacist supply and
will be useful for hospital administrators and pharmacy employers as they develop their strategic
plans for recruitment and retention of pharmacists. There have been numerous studies on the
pharmacist supply in relation to segments of the environment; however, there are limited studies
that reviewed the pharmacist supply on a yearly basis and none utilizing this length of time. This
study measured the change in the pharmacist supply over time, while accounting for a myriad of
environmental factors.
Summary of Findings
The pharmacist supply was measured overtime to attain an understanding of the
environments impact on its level of growth. There were 13 hypotheses tested with five of the
hypotheses results being statistically significant. The population and hospitals were the only two
variables found to be statistically significant while measuring munificence. Employers with 20
or more employees and the number of insured were also found to be statistically significant when
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measuring concentration. The last hypothesis on pharmacist supply displayed the ability to
consistently grow when accounting for the previous year growth in pharmacist supply.
The empirical evidence found in these hypotheses was corroborated by multiple studies and will
be discussed in more detail in the following chapters.
Implications
The population ecology theoretical framework proved to be useful in the study of the
pharmacist supply. There are several implications from this inquiry one would be on the insured
population which was proven to have a significant positive linear relationship with the
pharmacist supply. Couple this result with an increase in utilization and workload with the
introduction of the Healthcare Reform Act and you have a state of affairs that can considerably
impact the pharmacist supply. The inclusion of 32 million previously uninsured people receiving
insurance coverage could significantly change the pharmacist workforce landscape.
It is of the essence that healthcare players determine what the local market forces are that
impact their ability to determine their pharmacist manpower needs. Some of the questions that
can help determine and form their strategic goals/plans are: how many pharmacists are needed at
my hospital and will it improve the quality of care in the community? Is the number of
pharmacists in my community sufficient to address the number of insured and physicians in the
geographical area? Evaluating one’s environmental needs will help to ensure that a practical
plan is developed. This should help to guarantee that an appropriate number of pharmacists are
available to meet the current and changing demands of their surrounding environment.

8

Outline of the Remaining Chapters
Chapter 2 will provide an overview of the literature on the number of pharmacists in the
United States. Chapter 3 provides an overview of the theoretical framework for this inquiry as
well as the hypotheses to be tested. Chapter 4 presents the research design, variables and
statistical methods used to test the hypotheses presented in Chapter 3. Chapter 5 provides the
results of the analysis which include the descriptive statistics, and the repeated measures
regression analysis. Chapter 6 presents interpretations of each hypothesis, in addition to
implications for various entities. The chapter concludes with the limitations of the study and
suggestions for future research.

9

Chapter 2: Literature Review

In this chapter, a review of the literature regarding the role of pharmacists in the
healthcare system and factors affecting the supply and demand of pharmacists in the United
States are delineated. Factors that have changed in the healthcare arena that impact the dynamics
associated with the pharmacist supply and demand are discussed and a general statement of the
problem to be addressed in this study is presented.
Importance of Pharmacists for the United States Healthcare System
Pharmacists serve in varying roles in the US healthcare system. They distribute drugs
prescribed by physicians and other health practitioners and provide information to patients about
medications and their use. They interact with physicians, patients and the staff of healthcare
facilities. Pharmacists in the US dispense over 3.6 billion prescriptions per year (DHHS, 2008).
Pharmacists who practice in clinical settings such as hospitals, clinics, and nursing homes
are called clinical pharmacists. Other settings in which pharmacists practice include the
managed care industry and the pharmaceutical research industry. The American College of
Clinical Pharmacy (ACCP) defines clinical pharmacists as pharmacists that care for patients in
all healthcare settings (American College of Clinical Pharmacy [ACCP], 2008). The proportion
of U.S. pharmacists working in traditional community pharmacy practice settings (independent,
chain, mass merchandiser, and supermarket pharmacies) remained relatively stable between 2000
(55.4%) and 2004 (56.4%) (Beardy et al., 2004).
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Some other areas in which pharmacists’ skills are being used to improve the medication
use process include medication therapy management, pharmaceutical care, drug-use review,
drug-use management, disease management, and pharmacy benefit management (Schommer,
Sogol, and Brown, 2007). Outside of being directly involved with the discovery and testing of
new pharmaceutical agents, pharmacists may also work as medication sales representatives or
consultants for managed care organizations. Hospital pharmacists work in hospitals, and hospital
outpatient settings such as clinics, and nursing homes and they advise medical staff on the
selection of appropriate drugs and optimal dosing. Hospital pharmacists may also be involved in
activities related to monitoring drug levels for patients in the hospital, teaching, supervising
pharmacy interns and residents and conducting research. The proportion of pharmacists in
governmental and nongovernmental hospital settings remained stable between 2000 and 2004,
24.0% and 24.7%, respectively (Berardi et al., 2004). In 2001, U.S. hospitals reported nearly 2
billion drug orders for hospital in-patients (Knapp, 2002). This statistic is important in light of
the fact that 75% of the pharmacists surveyed reported entering over 90% of the medication
orders in hospitals and health systems through utilization of electronic order entry (Ringold,
Santell, & Schneider, 2000).
According to the National Association of Boards of Pharmacy (NABP) in 2009 there
were approximately 265,000 licensed pharmacists in the United States (NABP, 2010). The
Health Resources and Services Administration (HRSA) reported the settings with the largest
number of positions are chain pharmacies (77,300), hospitals (49,200), and independent
pharmacies (36,200) (DHHS, 2008). Pharmacists play a vital role in maintaining the quality of
system by providing their patients with valuable information on the safe and proper handling of
prescription and over-the-counter medications.
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Pharmacists are the primary source of scientifically valid information and advice on the
best use of medications. They are uniquely positioned within the healthcare system to deliver
objective, evidence-based therapeutic information and recommendations to assist their patients in
achieving optimal pharmacotherapeutic outcomes. This expertise entails offering
recommendations that include both traditional and nontraditional therapies and medications
(ACCP, 2008). Another vital function performed by pharmacists involves monitoring for
potential interactions of the medications being taken by a patient.
A study by Bond, Raehl, and Franke (1999) pointed to the importance of clinical
pharmacists in maintaining the quality of patient care in hospitals. This study utilized Medicare
Hospital Mortality Information Data and the National Clinical Pharmacy Services (NCPS)
database provided by the Centers for Medicare and Medicaid Services (CMS) (formerly the
Healthcare Financing Administration; (HCFA). In the aforementioned study the authors reported
that overall there were 44.15 fewer deaths per year, per hospital in hospitals that had pharmacistprovided drug information services compared to those that did not. Put another way, these
authors found that there were 10,463 fewer deaths per year in the 237 hospitals in which
pharmacists provided drug information services. This study clearly illustrates the vital role of
pharmacists in the U.S. healthcare system; especially in hospital settings. The consistent and
effective use of pharmacists in hospitals can reduce mortality in hospitals and contribute to
eliminating or reducing unnecessary medication incidents. Medication dispensing and
distribution practices affect safe medication administration (Pederson, Schneider, &
Scheckelhoff, 2009). Thus, pharmacists play a key role in safe medication use. MacLaren and
Bond (2009) found that mortality rates in patients with thromboembolic or infarction-related
events only and thromboembolic or infarction-related events with bleeding complications were
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higher by 37% and 31%, respectively, in ICUs without clinical pharmacy services when
compared to ICUs with clinical pharmacy services. The lengths of ICU stay were also longer in
ICUs without clinical pharmacy services.
MacLaren and Bond also reported a significant economic impact of not providing clinical
pharmacy services in ICUs. Based on their analysis, excess charges to Medicare ranged from
$63,175,725 to $215,397,354; depending on the presence of complications. These figures do not
include the additional realized drug charges, which also increase without pharmacist services
being present. Although their study was limited to a specific in-hospital setting, it was
concluded that care provided by intensive care pharmacists enhance clinical and economic
outcomes of critically ill patients. This was reaffirmed by additional studies measuring
effectiveness of pharmacists in intensive care settings. It may be plausible to speculate that the
addition of pharmacists to varying settings may help with the clinical and economic outcomes of
patients.
In a study of pharmacist review of medication orders in the Emergency Room (ER),
Brown et al. (2008) utilized retrospective chart review to investigate the frequency of medication
errors in an emergency department (ED) before and after an ED pharmacist was assigned to
check medication orders. They reported that the rate of errors was 66.6% higher when no
pharmacist was present to check medication orders in the ER. Following an in-depth review of
topics and study designs that involved pharmacists, Ellitt (2009) recommended that pharmacists
continue their successful interventions and multidisciplinary collaborations to ensure continuity
of care and optimal pharmacotherapeutic outcomes. Given the importance of pharmacists to the
healthcare system and to maintaining the health of the U.S. population, the availability of
pharmacists in adequate numbers is a crucial issue. Healthcare providers and professional
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organizations report signs of a moderate current shortage of pharmacists, as indicated by
persistent vacancy rates, difficulty recruiting and retaining pharmacists, growing dissatisfaction
among pharmacists due to working long hours, and rising costs to employ pharmacists (DHHS,
2008). Whether or not there is indeed a shortage of pharmacists is beyond the scope of this
inquiry. However, it is conceivable that environmental factors may play some role in the
distribution of pharmacists that could result in either a shortage or surplus. From the perspective
of the pharmacist supply, perceptions of key players may warrant some exploration within the
context of the population ecology framework.
Eighty six percent of hospital CEOs surveyed by AMN Healthcare, the nation’s largest
provider of clinical staffing, believe there is a shortage of pharmacists (AMN, 2009). Forty six
percent of the CEOs surveyed see this perceived pharmacist shortage as serious, while another
46% see the perceived shortage as moderate (AMN, 2009). To put these percentages in
perspective, only 30% of these hospital CEOs thought they had enough pharmacists at their
facility.
In light of perceptions that there is a shortage of pharmacists, it appears there is indeed a
need to understand the environmental factors that influence the pharmacist supply in the U.S. In
the next section, a summary of the Bureau of Health Professions model to evaluate the supply of
pharmacists in the US will be presented and its utility in understanding the factors that influence
the supply of pharmacists will be discussed.
Pharmacist Supply in the United States
The Bureau of Health Professions Model.
The Bureau of Health Professions (BHP) developed a model that is based on a year-byyear progression of cohorts of pharmacists (Gershon, Cultice, & Knapp, 2000). The pharmacist
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supply in any given year is the sum of the male and female pharmacists from 1-year age group
cohorts starting at age 24 and extending to age 75. The data for each of the base cohorts were
drawn from the 1989-1991 Pharmacist Manpower Project (PMP) (Gershon et al., 2000). The
final calculation of pharmacists for each year is based upon varying scenarios using the latest
available data on enrollment and graduate trends and assumptions about losses from the supply
pool. This calculation is a projection of the number of new entrants into the pharmacy industry
while subtracting both the number of base year pharmacists and new entrants who will die or
retire (Gershon et al., 2000). International Pharmacy Graduates (IPGs) were also accounted for
in BHP’s pharmacist supply model. A table depicting the Pharmacist Supply Model is presented
in Appendix A.
The growth rate of pharmacists during the 1980s and 1990s outpaced that of other
healthcare professions, such as nurses and physicians (Shih, 1999). The ratio of pharmacists per
100,000 population from 1995 to 2020 is expected to increase from 68.9 pharmacists per
100,000 population to 76.7 per 100,000 (Gershon et al., 2000). There is a predicted growth rate
of pharmacists of 13% between 1995 and 2020. Many observers have predicted that the
pharmacist supply will outpace the growth rate of the United States population during the same
period of time (Gershon et al., 2000).
Despite this appearance of growth in the pharmacist supply, there continues to be
concerns about a shortage of pharmacists needed in the United States. Until 1998 the supply of
pharmacists in the U.S. appeared to be in reasonable balance with demand. However, this
delicate balance vanished gradually due to market forces, particularly related to the increased use
of prescriptions dispensed (Cooksey, Walton, Stankewicz, & Knapp, 2003). In the pharmacy
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setting it is important to have the appropriate manpower to meet the needs of the population.
The proportion of pharmacists working with three or more technicians increased from 33% to
46% between 2000 and 2004 (Mott, 2005). Mott’s finding seems to point to a societal need for
increased pharmacy manpower. One might infer that the need for more pharmacy technicians is
closely tied to an increased volume of prescriptions that need to be filled. There may also be a
perception for a need for more pharmacists to provide administrative support for the delivery of
pharmaceutical care and general oversight for all aspects of pharmacy operations as an
increasing number of pharmacists find themselves supervising more pharmacy technicians on
their shifts.
The imbalance involving the demand for and supply of pharmacists is so severe in some
instances that pharmacies must close on certain days or shutdown all together due to lack of
pharmacists to staff their facilities (Buscher, 2005). Over the years, various observers have
attempted to identify and describe the factors that affect the pharmacist supply. Among such
attempts was the Aggregate Demand Index (ADI). In 2007, the National Association of Chain
Drug Stores (NACDS) reported over 3900 pharmacist vacancies (NACDS, 2007). A summary
of the NACDS surveys can be found in Appendices A, B & C. The development of the ADI
represents one-step toward understanding societal needs and pharmacist workforce dynamics.
The ADI was developed by the Pharmacy Manpower Project (PMP), whose purpose is to collect,
analyze and disseminate data on the supply of and demand for licensed pharmacists and
pharmacy services in the U.S. The PMP is an independent not-for-profit organization created in
the late 1980s when the demand for pharmacists exceeded the national supply. The PMP is
comprised of numerous organizations such as the Academy of Managed Care Pharmacy,
American Association of Colleges of Pharmacy, American Pharmaceutical Association,
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American Society of Consultant Pharmacists, American Society of Health-System Pharmacists,
and the Bureau of Health Professions (Knapp, 1999). The ADI is an ongoing, monthly survey by
members of the PMP who are directly responsible for hiring pharmacists. The members of the
PMP who are responsible for completing the questionnaire that generates the ADI do not receive
compensation and serve by invitation based on their organization’s direct role in hiring
pharmacists (Knapp & Livesey, 2002).
The monthly survey is delineated by state and average demand index scores and is
important to this study because the ADI addresses two broad areas of the pharmacy workforce.
First, the ADI questionnaire contains questions that can be used to determine if there is a
pharmacist shortage in a state. If there indeed is a shortage, the ADI allows observers to
determine the degree to which the shortage affects the citizens of the state. The ADI also permits
observers to determine if there is a national shortage of pharmacists and the degree to which a
national shortage affects the citizens of the United States as a whole. The second area of the
pharmacy workforce that the ADI addresses is pharmacy workforce shortage severity. The ADI
allows observers to describe the effect of a shortage by looking at pharmacy practice settings
(Knapp, Quist, Surrey, & Miller, 2005). There is a projected need for over 400,000 pharmacists
by the year 2020 according to estimates presented during a PMP conference in the early 2000s
(Knapp & Livesey, 2002).
It is imperative to understand not just fluctuations in the number of pharmacists, but the
antecedents to the supply so that it is determined how to appropriately adjust health manpower
resources to bring about a balance in demand and supply. The lack of pharmacists is not
relegated to one region. It seems there are issues across the entire country from the east coast to
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the west coast (Vandervoet, 2007). Some of the factors considered are demographics of the
population, health organization direction, and drug use trends.
No setting is immune to a deficiency in pharmacist manpower; even hospitals are also
having difficulty meeting adequate pharmacist staffing levels (Wisconsin Hospital Association,
2006). Lack of pharmacists can lead to individuals not being able to fill their medications in
their geographic vicinity, which can lead to patients having to travel to distant locations in order
to have their prescriptions filled. The lack of pharmacists also leads to increasing salaries and
sign-on bonuses to recruit pharmacists. In addition, geography can significantly affect the nature
of a pharmacist’s work. A pharmacist’s applicable skill may be dependent, to a certain degree,
on the availability of other health providers in or near that community (Manasse & Speedie,
2007). Communities have a strong desire to retain their pharmacists, because these individuals
provide expert health advice and fill prescriptions, while serving, either formally or informally,
as health educators, thereby improving the community’s public health (Manasse & Speedie,
2007).
An adequate supply of pharmacists is important for the efficiency and effectiveness of the
healthcare system. A shortage of pharmacists can affect other healthcare providers and the care
patients receive (Ricuitti, 2001). A shortage in pharmacists is believed to stem from a rapid
increase in demand and a limited ability to increase supply (Talley, 2001). An overworked labor
force due to potential shortages creates the possibility for increased incidences of medicationrelated errors, adding more stress to the pharmacist's already busy day. This correlates strongly
with the Institute of Medicine (IOM) report on medication errors.
The IOM pointed out that maintaining reasonable working hours, workloads and staffing
ratios, and avoiding distractions, are needed in order to keep errors to a minimum (IOM, 2000).
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Mott et al. (2002) considered work variables (e.g., work status, part-time work, secondary
employment, and full-time equivalents) in their examination of characteristics of actively
practicing pharmacists in the United States between 1990 and 2000. The findings of their study
have some significance in the present context because the trends they identified are among the
environmental factors that affect the pharmacist supply. Unlike previous studies, Mott examined
time series data instead of questionnaires involving opinions and perceptions. Mott’s approach is
consistent with this inquiry because it begins to fill in gaps in the literature where the pharmacist
supply is concerned. This inquiry is more explanatory in nature therefore much of the research
on the pharmacist supply has been descriptive in nature. Such research documents the balance or
imbalance between the pharmacist supply and demand but does not provide much insight
regarding the interaction of the factors that contribute to the situation. Explanatory research is
expected to generate empirical knowledge about factors that impact the pharmacist supply and
provide insights as to how such factors are interrelated.
Data for the Mott et al (2002) study were obtained from two national studies of the
pharmacist workforce conducted in 1990 and 2000. The study contained the final report of the
1990-1991 National Pharmacists' Compensation Survey by Schondelmeyer, Mason, Miller, and
Kibbe (1992). The survey focused on personal profile, current employment profile,
compensation profile, and fringe benefits in addition to other compensation of pharmacists and
attempted to explain how these all contributed to the size of the pharmacist workforce. The
second survey was the National Pharmacist Workforce Survey conducted by Pedersen, Doucette,
Gaither, Mott, and Schommer (2000). Insofar as the demand for pharmacists is concerned,
results from these studies suggest that the current pharmacist workforce has responded to an
increased demand for pharmacists by increasing the amount of work supplied to the pharmacist
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labor market, while limiting the number of pharmacists working outside the profession. The net
effect of such trends appears to be fewer pharmacists performing more tasks.
Factors Affecting the Supply of Pharmacists
Pharmacist Education and Training.
One factor affecting the supply of pharmacists is the extent of the training process. There
has been a lengthening of the training period for United States pharmacy students. In the past,
pharmacists were only required to obtain a Bachelor of Science degree in order to be eligible to
take the National Pharmacist Licensing Examination (NAPLEX). In 2003 the American Council
on Pharmaceutical Education (ACPE), which is responsible for the accreditation of professional
degree programs in pharmacy and providers of continuing pharmacy education, changed the
minimum requirement to practice pharmacy to persons who received the Pharm.D. as the entry
level degree from an ACPE accredited school of pharmacy. The new requirements also
restricted eligibility for accreditation to those schools offering the Pharm.D. as the entry level
degree (DHHS, 2000).
This change compelled schools with B.S. programs to develop curricula to meet the new
ACPE program standards. As a result of the new curriculum requirements, the scope of
pharmacy practice has been significantly broadened and has set the stage for inquiries such as
this one to explore factors affecting the pharmacist supply. A study conducted by Baran, Shaw,
and Crumlich (1998) found that Pharm.D. students were attracted to hospital pharmacy settings,
whereas more students in the B.S. program saw their future practice setting in a community
pharmacy. If this is true, there is the potential for a shortage of pharmacists in the community
setting, assuming that there are enough hospital positions to accommodate holders of the
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Pharm.D. degree seeking such positions. This has very important implications for the pharmacist
supply, at least insofar as site and scope of practice may be concerned.
Approximately 20% of pharmacy graduates seek additional postgraduate education in a
variety of fields (e.g., residencies and fellowships, master of business administration, doctor of
law, master of public health, doctor of philosophy) (Manasse & Speedie, 2007). A majority of
pharmacy school graduates seek one-year residency training positions in an attempt to increase
their opportunity for a position involving direct patient care.
While a residency is not required to practice pharmacy, some healthcare institutions make
this a requirement for employment; especially when it relates to certain clinical specialties
(American Society of Health-System Pharmacist, [ASHP], 2007; Kostick, 2006). Those desiring
academic or research roles in academia or the pharmaceutical industry often complete two to
three years of fellowship training in addition to a one- or two-year residency.
To compensate for the increased length of time to add pharmacists to the workforce,
some schools have increased their class size. Another measure taken by the profession is to open
new pharmacy schools. The increase in pharmacy schools that began in the 1990s and continue
currently accounts for a 35% increase in the pharmacist supply (Knapp & Cultice, 2007).
Between 2001 and 2009 alone 31 new pharmacy schools were established (American
Association of Colleges of Pharmacy, 2010). The rate of new schools may be an important
environmental factor affecting the pharmacist supply and should be accounted for in research on
the pharmacist supply in the U.S.
Age and Retirement.
It is also noteworthy that the median age of the pharmacy workforce is increasing. Mott
et al. (2005) reported that 44% of the practicing pharmacists surveyed in 2000 were 40 years of
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age or younger compared to 33% in 2004.While the percentage of younger pharmacists
decreased during this period, the percentage of practicing pharmacists over the age of 55
increased from 17% to 25% (Mott et al., 2005). This indicates that the supply of pharmacists
may decrease as the older pharmacists take retirement and there may not be enough younger,
trained pharmacists to take their place. If there is not a shortage, per se, age trends among
licensed pharmacists could portend a misdistribution of pharmacists. Both of these situations
may significantly affect the supply of pharmacists.
Patient Interaction.
Pharmacists are crucial in medication reconciliation and consultation with physicians and
patients. Pharmacists are vital to ensuring that quality pharmacy services are provided, while
transforming the practice of pharmacy to increase patient education on the proper use of
pharmaceuticals (Kong, 1995). In some instances a community pharmacy may be utilized as a
healthcare facility and may provide more services than what may be typically expected of or
available in a traditional community pharmacy. This is most likely to be the case in areas where
medical offices and clinics are in short supply. According to Knapp, Paavola, Maine, Sorofman,
and Politzer (1999), pharmacies may be a place where patients receive medical consultation and
education by pharmacists and other health professionals.
Pharmacist Practice Setting and Salary Forecasting.
As prescription volumes continue to increase so does the level of salaries being offered to
pharmacists by employers. A Drug Topics' 2010 salary survey drew 1,619 responses from
across the country, with respondents earning an average salary of $115,455 (Rajecki, 2010). A
previous survey by Drug Topics found that pharmacists working in health maintenance
organizations received the highest annual salary at $114,067; followed by pharmacists who
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practice at independent pharmacies ($109,618); mass-merchandisers ($109,466); chains
($107,885); hospitals ($107,168); supermarkets ($106,302); and mail order ($101,500) (Levy,
2008).
While pharmacist salaries continue to increase there are signs that increases are slowing.
One example is the amount of extra income pharmacists took home between 2002 and 2006.
Only 50% of the respondents received additional pay from sources such as bonuses and profitsharing, compared with 88% in the 2000 survey (Ukens, 2007).
Annual raises are also continuing to trend downwards for pharmacists. Ukens reported an
average raise of 3.8% in 2006, compared with 4.9% in 2004 and 7% in 2002. Rising salaries for
pharmacists have a positive impact on supply, however it has also led to pharmacies scaling back
on the number of hours they are open and scaling back on staff due to rising labor costs (DHHS,
2008).
Increase in the number of Women in Pharmacy.
One trend that is occurring quite rapidly is the number of females entering the profession.
Presently more females are applying to pharmacy school and receiving degrees than males. In
2006, 59.5% of applications to schools and colleges of pharmacy were submitted by women;
they also received 68.2% of the first professional pharmacy degrees conferred in that year and
60.8% of the post baccalaureate degrees conferred (Deyton et al., 2007). The percentage of
licensed female pharmacists increased significantly from 31% in 1990 to 43% and 46% in 2000
and 2004, respectively (Mott, Doucette, Gaither, Pedersen, & Schommer, 2002). This
information is presented in Figure 1.
According to Mott et al. (2005) approximately 30% of female pharmacists surveyed
between the ages of 31 and 60 worked part-time. Approximately 3% of male pharmacists
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Figure 1. Estimated Number of Pharmacists by Sex, 1995-2020.
From “How Many Pharmacists Are in Our Future? The Bureau of Health Professions
Projects Supply to 2020,” by Gershon et al., 2000, Journal of the American Pharmacists
Association, 40(6), p. 760.
between 23-40 years of age work part time compared to 23% of their female counterparts (Mott
et al., 2002). There may be many factors affecting this difference in the percentage of female
and male pharmacists working part-time. This difference is noteworthy because of its
implications for pharmacy manpower. Women are more likely to work part-time during the
childbearing years. This can further affect the pharmacist manpower needs of the environment.
The number of pharmacists may indeed be increasing. However, due to trends such as
the one described above there could still be a shortfall in the number of pharmacists available to
fill prescriptions due to more females working part-time.
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Summary of Environmental and Demographic Factors Affecting Pharmacist supply in the
Literature
There appears to be a consensus in the literature that a myriad of factors and interactions
among these factors affect the supply of pharmacists in the U.S. Among the factors that
previous studies have examined in relation to the number of pharmacists are rates of pharmacist
employment turnover, antecedents to pharmacist workforce decisions (e.g., reasons pharmacists
give for choosing part-time employment over full-time employment), pharmacist-to-population
ratio, rate of opening of new schools of pharmacy, age, practice venue (e.g., hospital or
institutional versus community), prescription volume and salary. Many observers believe that
even with growth in the number of pharmacists, strong factors of demand may confound the
adequacy of the supply of pharmacists. The net effects of supply trends may lead to a shortage
or misdistribution of pharmacists. Whether there is a shortage or surplus warrants a separate
inquiry that explores this phenomenon specifically. The focus of this inquiry is the impact of
environmental factors on the overall pharmacist supply.
The rapid growth in prescription volume, the increase in new drugs and its greater
complexities and the growth in the elderly population are additional factors that may have a
significant and remarkable impact on the supply of pharmacists (Gershon, Cultice, & Knapp,
2000).
Factors Affecting the Demand for Pharmacists
Physicians are primarily responsible for the volume of prescriptions written, so the
locations of their practices and the volume of prescriptions written play a crucial role in the
pharmacist supply. The number of prescriptions dispensed per year in the United States has
increased from approximately 1.9 billion to 2.9 billion between 1992 and 2004 (Stagnitti, 2007).
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The increase in the insured population is significant because it leads to a potential increased
workload for pharmacists striving to meet the prescription demand. The continuous
development of new drugs, many of which have high costs, will stimulate demand for more
pharmacists now and in the future. It is important to also note that managing drug interactions is
becoming more complex as a result of numerous drugs being used to treat multiple chronic
conditions. This problem is especially worrisome in hospital settings. Taken together these facts
certainly suggest that there will be an increased demand for pharmacists. Their expertise will be
sought by physicians and patients alike in all healthcare settings.
Physicians will be providing care to larger numbers of elderly persons in their practices in
the coming years. These patients often require multiple medications to manage their health
problems. Consequently, physicians write more prescriptions and patients are at greater risk for
drug interactions and medication misadventures. Under such circumstances it would appear
reasonable to expect that there will be a greater demand for pharmacists. Insofar as the elderly
and prescription volume are concerned, the passage of Medicare Part D is expected to have a
very remarkable. In addition to Medicare Part D is the passage of the 2010 Healthcare Reform
Act, both of which may have a positive impact on the demand for pharmacists.
Physicians and the Increased Volume of Prescriptions.
In light of their role as the primary source of prescriptions being written, any examination
of factors affecting the pharmacist supply should include some consideration of the physician
supply; as the forgoing discussion suggests. It is reasonable to assume that the likelihood of a
patient receiving a prescription as a result of a visit to their physician may increase as new
medications become available to treat more conditions.
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Access to prescription drugs is facilitated by an increased number of prescribers,
primarily physicians. The number of primary prescribers ((Medical Doctors (MDs) or Doctors
of Osteopathy (DOs)) per 1,000 population has increased steadily since 1985 (Kaiser Family
Foundation, 2000). The percentage of office visits with multiple drug orders increased from
45.3% in 1985 to 58.1% in 1999 (Burt, 2002).
In this study it was also shown that once the distribution of visits by patients’ age,
number of diagnoses, source of payment, and physician specialty are adjusted for, physicians
were 43% more likely to prescribe multiple drugs in 1999 than in 1985. The development of
better treatments involving pharmaceutical interventions will also lead to a greater dependence
on such drugs for maintaining a high quality of life (Burt, 2002). According to Mott et al. (2005)
61% of pharmacists working in chain settings (e.g., CVS, RiteAid, Eckerd) reported dispensing
over 200 prescriptions per day. Findings in the literature clearly suggest a direct, positive
correlation between prescription volume and the demand for pharmacists. As prescription
volume increases, so does the demand for pharmacists.
According to the National Ambulatory Medical Care Survey (NAMCS), in 1996 there
was an estimated 734.5 million visits made to physician offices in the United States (Woodwell,
1997). There were over 210 million more physician office visits in 2005 than in 1996 (Cherry,
Woodwell, & Rechtsteiner, 2007). Nearly two-thirds of the visits made to ambulatory
physicians’ offices in 1996 resulted in at least one medication being provided by or prescribed by
the physician; or about 469 million prescriptions (Woodwell, 1997). There were over 120
million physician visits in 1996 made by patients who had at least three medications provided by
or prescribed by a physician. This number has more than doubled by 2005 (Cherry et al., 2007).
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According to the Agency for Healthcare Research and Quality (AHRQ) Medical
Expenditure Panel Survey (MEPS), physicians wrote over 4 billion prescriptions in 2007 with
physicians being primarily responsible for the majority of the prescriptions written
(Medical Expenditure Panel Survey, 2008). Presently there are more than 750,000 physicians
practicing in the United States, with a physician supply projection of more than 900,000 by the
year 2020 (DHHS, 2006).
Prescriptions filled by chain drugstores alone increased by 7% between 2005 and 2007,
from 3.3 billion in 2005 to 3.52 billion in 2007 (NACDS, 2008). These figures suggest there
will be an increasing need for more pharmacists to dispense the rising number of prescriptions
being prescribed by physicians.
Employers and Pharmacist Workload.
The primary source of prescription drug coverage for most Americans (both nonMedicare and Medicare) is their employers. For retirees and the majority of persons age 65 and
over Medicare Part D is the primary source of coverage for prescription drugs. In 2008, 157
million Americans (60% of the nonelderly population) were covered by employer-based health
insurance (Kaiser Family Foundation, 2009). Approximately 99% of employees under employer
health plans have drug coverage (Kreling, Mott, Wiederholt, Lundy, & Levitt, 2000; Kaiser
Family Foundation, 2007).
Another important demographic factor potentially impacting the demand for pharmacists
is the size of the business industry. The more employees there are in an organization or industry
the greater the demand will be for benefits and services (Sommers, 2004). Among the 80.1
million employees who worked for large private sector employers in 2002, 97.8% were offered
employer-based health insurance and 62.7% of those employees enrolled in plans offered by
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their employers (Sommers, 2004). Organizations with large numbers of employees are more
likely to offer their employees health insurance (Stanton, 2004).
These facts are particularly salient in the context of this inquiry because employer
sponsored insurance enrollees are 4 times less likely to forego filling a prescription drug due to
cost as compared to the uninsured population, according to findings reported by Cunningham
(2002) from the community tracking study household survey. As a result, it would be expected
that the demand for pharmacists to be greater in such communities due to a larger volume of
prescriptions to be filled. In 2006 the health plan offer rate for large or medium organizations
(50 or more employees) was 96.7% compared to 61.2% for small organizations (50 or less
employees) (Sommers & Crimmel, 2008; Crimmel & Sommers, 2008). Reed & Hargraves
(2003) reported that the uninsured population was more than three times as likely as those with
private health coverage to have gone without at least one prescription in 2001 because of cost
concerns. Poisal and Chulis (2000) reported that Medicare beneficiaries with some type of
prescription drug coverage utilized an average of five more prescriptions per person than
beneficiaries that were uninsured.
It is plausible that if the proportion of persons covered by employer-sponsored plans
increases substantially in a region, there could be a disproportionately greater need for
pharmacists as a result of more persons then being covered by such plans. An analysis of such
trends might lead one at first glance to conclude that there is a sharp and sudden increase in
health conditions requiring prescription medications. However, it is more likely the case that the
increase may be due to more persons having their previously unmet prescription drug needs met
as a result of health insurance coverage that includes coverage for prescription drugs. In any
event there will presumably be a need for more pharmacists to handle the increase in prescription
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volume and to provide expert recommendations to manage all aspects of pharmacotherapeutic
interventions to ensure safety and efficiency.
Health Insurance and Paying for Prescriptions.
Americans obtain health insurance to help cover their expenditures related to the receipt
of healthcare. One aspect of receiving healthcare is the acquisition of prescription drugs and
pharmacotherapy services. In general, Americans purchase health insurance either individually,
paying out of their own pocket or through their employers as a benefit of employment.
In the latter instance the employer may provide coverage for their employees by fully
assuming the financial burden of providing it, or through some degree of cost sharing involving
employers and employees.
According to the United States Census Bureau (2006), in 2005 approximately 84% of the
United States population was insured through the government or private companies. The
majority of health plans provide coverage for prescription drugs, to varying degrees. According
to findings reported from the Health System Change (HSC) survey, approximately 12-13% of
American adults had problems filling a prescription between 2001 and 2003 (Reed, 2005).
Insurance coverage has the potential to have a positive impact on the demand for
Pharmacist’s because of its positive effect on the ability to obtain required prescriptions (Ranji,
Wyn, Salganicoff, & Yu, 2007; Weinick, Byron, & Bierman, 2005). The ability to pay for
prescriptions plays a vital role in the volume of prescriptions to be filled, which in turn plays a
role in the need for pharmacists. In order to employ and retain pharmacists there must be a
constant flow of patients in need of prescription medicines. Health insurance is usually the
primary source for paying for prescriptions. The growth of drug insurance coverage has
improved access to prescription drugs and the services of pharmacists. Ultimately, the growth of
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insurance for prescription medications is very likely to precipitate a greater demand for
pharmacists and the services that they provide (Knapp, 2002). Findings in the literature suggest
that having insurance is associated with a higher volume of prescriptions.
The implementation of Medicare Part D is one example of the effect of insurance for
prescription medications on the demand for pharmacists. It has been estimated that Medicare
Part D will allow 15 million elderly Americans with no prescription drug coverage to now obtain
coverage for prescription drugs. In turn, observers have projected that an additional 14 to 30
million prescriptions will be written and dispensed each month following the implementation of
Medicare Part D (Reissman, 2004).
While it is clear that being insured greatly affects one’s ability to obtain healthcare,
including prescription drugs, it is also clear that the lack of insurance nearly always leads to a
corresponding inability to obtain healthcare and prescription drugs. From a practical point of
view, it would seem reasonable that the percentage of the population that is uninsured may have
an impact on the pharmacist supply. In this case there may be a decreased demand for
pharmacists as the volume of prescriptions may be lower.
Reed and Hargraves (2003) reported that in 2001 the uninsured were more than three
times as likely as those with private health insurance to forgo at least one prescription because of
cost concerns. In a study involving data from the HSC Reed (2005) reported that, regardless of
insurance coverage, low-income adults (incomes 200% below the federal poverty level, or
$36,800 for a family of four in 2003) faced significant financial barriers to obtaining prescribed
drugs. As mentioned above, the percentage of uninsured persons in the population at a given
point in time is one environmental factor that could significantly reduce the demand for
pharmacists and, thus, affect the pharmacist supply.
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On March 23, 2010, President Barack Obama signed into law the Affordable Care Act.
The law puts into place comprehensive health insurance reforms that will help in lowering
healthcare costs, while guaranteeing more healthcare choices, and enhanced quality of healthcare
for all Americans (DHHS, 2010). The main selling point for the healthcare reform package put
forth by the Obama administration is that it offered healthcare benefits to some 32 million
uninsured Americans (Wechsler, 2010). Another major, positive step put forth by that legislation
was its promise to address the coverage gap or “donut hole” which affects one in four Medicare
Part D beneficiaries (Steffancci, 2010). The coverage gap, which occurs in the majority of
Medicare Part D prescription drug plans, involves beneficiaries paying the entire cost of their
prescription drugs, once they reach a certain limit. This limit is reached once a senior has spent
$2830 on prescription drugs in 2010. This limit lasts until catastrophic coverage kicks in (when a
Medicare beneficiary has spent $4550 out-of-pocket on medications) (Steffancci, 2010).
The Obama administration’s healthcare reform bill has developed a plan to start
gradually closing the donut hole with an anticipated full closure by 2020. As of 2011,
pharmaceutical manufacturers required to provide a 50% discount on brand-name prescriptions
in the Medicare Part D coverage gap. In 2013 federal subsidies for generic prescriptions will be
phased in while the out-of-pocket amount that qualifies an enrollee for catastrophic coverage
under Medicare Part D will gradually be reduced beginning in 2014 and continuing through 2019
until the donut hole is completely closed (Wechsler, 2010).
These changes to Medicare will augment drug usage by seniors. From changes in health
insurance parameters to quality assurance modifications, this legislation will alter the health-care
environment for providers in the US. Prescription drug coverage is included on the list of
essential benefits required to be offered by all insurance plans pursuant to mandates in this
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historic legislation. Decreasing copayments and other expenses associated with prescription
medication use will expand pharmaceutical benefits to patients in need, and conceivably, lead to
a greater need for pharmacists.
The healthcare reform initiated in 2010 has the potential to provide tens of millions of
Americans with access to healthcare coverage and allow others to retain coverage. The
researcher further notes that the laws that constitute healthcare reform seem to have a potential
two-fold impact on the pharmacist supply. First, there is a new requirement that premium
subsidies be provided for individuals to purchase health insurance. As previously discussed, as
access to insurance increases the volume of prescriptions written and subsequently dispensed
also increases, directly increasing the demand for pharmacists and the services they provide.
Secondly, new laws that have been enacted as a part of healthcare reform require that tax credits
be given to small employers as an inducement for them to offer health insurance to their
employees (Matzke, 2010). Matzke further notes that a swell in the number of insured
individuals are expected to significantly increase prescription drug use and lead to an expanded
role for pharmacists in the U.S. healthcare system through medication therapy management
(MTM) programs (Matzke, 2010). It is difficult to accurately project exactly how the pharmacist
supply will be impacted by the healthcare reform begun in 2010. The purpose here is to just give
insight into future changes in the environment that may affect the pharmacist supply in the
future.
Increasing Complexity of Medications and Pharmaceutical Treatment.
The increase in the number of medications developed to treat varying medical conditions
has increased the need for pharmacists to help manage drug utilization. Additionally, there has
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been the introduction of pharmaceuticals to treat diseases for which drug therapy previously was
not available or had limited efficacy (Mott & Kreling, 1994).
The increasing acuity of hospitalized patients receiving complex medication regimens, in
conjunction with the national focus on medication safety, and the increasing number of drug
safety warnings issued by the Food and Drug Administration that focus on medications, strongly
support the need to identify and describe factors affecting the pharmacist supply (Shane&
Gouveia, 2009). Pharmacists are an integral part of the healthcare team in the hospital and other
healthcare settings and they are very involved in the management of a variety of illnesses,
especially those requiring complex drug therapies such as chemotherapy or treatment for lifethreatening infections.
Pharmacists are best poised to oversee the entire drug distribution system including
prescribing, dispensing, and administration and safety of drugs. Such oversight by pharmacists
clearly describes the important role they play in improving medication safety (Guchelaar, Colen,
Kalmeijer, Hudson, & Teepe-Twiss, 2005). Geography can significantly affect the nature of a
pharmacist’s work. A pharmacists' applicable skill may be dependent, to a certain degree, on the
availability of other health providers in or near that community (Manasse & Speedie, 2007).
Communities have a strong desire to retain their pharmacists because they provide expert health
advice, fill prescriptions and serve as formal or informal health educators (Manasse & Speedie,
2007).
Growth in the Older Population and Those with Chronic Diseases.
The graying of America also seems to be having an impact on the number of
prescriptions written. As Americans live longer, and as the population of persons 65 years of age
and over increases, the volume of prescriptions being filled per year continues to grow. There is
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expected to be an increase in the number of prescriptions written by physicians treating the
elderly as the baby boom population enters late life. This is because the over 65 segment of the
population consumes a disproportionately higher volume of prescription medicines than the rest
of the population (ASHP, 2001).
Older patients generally have more chronic illness than younger individuals, which
usually leads to more complicated medication treatment plans. Eighty-five percent of Americans
65 years of age and older have at least one chronic disease that is primarily managed with a
prescription drug (ASHP, 2001). This trend suggests that there will be an increase in the volume
of prescriptions to be filled and dispensed. Concomitant with any increase in prescription
volume will be the need for more pharmacists (Deyton et al., 2007).
To put the volume of prescriptions in perspective, there were approximately 1.9 billion
patient prescriptions filled in 1997, versus 2.9 billion in 2004 (Stagnitti, 2007). During the
period 1997 to 2004 there was a 40% increase in the average number of prescriptions filled per
person per year for persons over the age of 65. In 1997 persons over the age of 65 averaged
21.9 prescriptions per year compared to 30.8 prescriptions per year in 2004 (Stagnitti, 2007).
These figures are more than twice those for persons under 65 years of age, who averaged 8.8 and
12.6 prescriptions per year, respectively, during the same period of time.
It is estimated that 77 % of the over 65 population surveyed regularly use three or more
prescription medications (ASHP, 2001). The over 65 population comprises approximately 13%
of the total U.S. population, or just over 40 million people (U.S. Census Bureau, 2008). This
segment of the population is projected to grow significantly over the next few decades,
especially the 85 and over segment of those over 65 years of age. Current projections estimate
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that the over 65 population will account for 18% of the U.S. population in 2020 and 22% in 2030
(U.S. Census Bureau, 2008).
The Medicare Prescription Drug Improvement and Modernization Act (MMA) were
signed into law in 2003 and went into effect on January 1, 2006 (Gore & Seeds, 2004). The
MMA’s goal was to provide an estimated 7 to 15 million older Americans who had no
prescription drug coverage with such coverage with the addition of Medicare Part D. Medicare
Part D is aimed primarily at helping these individuals by providing them with assistance in
paying for the prescription drugs they need. As a result of the MMA, all Medicare beneficiaries
are able to enroll in a prescription drug plan. It is estimated that as many as 14 to 30 million
additional prescriptions may be written and dispensed each month by retail pharmacies as a
result of MMA (Reissman, 2004). Increased pharmacist manpower will likely be needed to
address the increasing elderly population and its large and varying consumption of medications.
Central Fill Pharmacies.
The decade following 2008 was marked by an emerging trend within the
pharmacy profession that could conceivably impact the future of the profession in coming
decades. The time period for this inquiry covers the 16 years between 1994 and 2009.
This emerging trend is believed to have occurred toward the end of this time period and will not
be examined in this inquiry. However, the trend warrants being mentioned here because of its
theoretical importance in examining environmental factors affecting the pharmacist supply.
At the core of this trend is the increasing use of central fill operations to accommodate
increased demand for pharmacist services caused by an increasing volume of prescriptions to be
filled. Key players in the profession appear to be developing these central-fill pharmacies to act
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as mass-dispensing centers for retail pharmacies to meet the growing demand for pharmacist
services at the retail level.
These centers are allowed to receive non-controlled and controlled substance
prescriptions from retail pharmacies as long as they subsequently dispense the prepared
prescription to the same originating retail pharmacy (Anderson & Crawford, 2010).
Central-fill pharmacies are not allowed to take prescriptions directly from a patient or
practitioner and they are not allowed to dispense prescriptions directly to a patient or
practitioner.
While a closer examination of this emerging trend is beyond the scope of this
inquiry, it would be remiss to not mention it because it may be a noteworthy environmental
factor affecting the supply of pharmacists in the future. One major benefit of central-fill
pharmacies is that they enable busy retail pharmacies to send their entire volume of prescriptions
(especially refills) to a central location for processing. In terms of our theoretical framework,
these central fill pharmacies are likely to have an appreciable effect on two of the constructs in
the population ecology framework: density and concentration. Central fill pharmacies may very
well alter the distribution of pharmacists and, thereby, significantly impact pharmacist supply.
Having the option of sending prescriptions to another location to be filled frees staff in
local retail pharmacies to concentrate on dispensing acute care prescriptions and to perform other
essential duties such as patient counseling and medication therapy management (MTM) (Chain
Drug Review, 2010). Future studies of the pharmacist supply using the population ecology
theoretical framework should include an examination of this trend toward central fill pharmacies
to shed more empirical light on its impact.
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Studies on the Pharmacist Supply
This section summarizes studies that have examined environmental factors impacting the
pharmacist supply in the United States. Practice setting can affect the extent to which
pharmacists can serve as active members of collaborative healthcare teams in the community
(Schommer, Reshmi, Cline, & Hadsall, 2006). It seems very likely that the pharmacist supply
may be significantly affected by the realization of these goals by future pharmacists.
Walton et al. (2004) examined supply and demand factors across states and analyzed
differences in relation to pharmacy labor using data from the Bureau of Labor Statistics (BLS).
BLS estimates of the number of filled pharmacist positions were used to generate state-level data
regarding the size of the pharmacist labor market. BLS estimates rely on industry surveys that
require the selected industry to disclose the number of filled positions they have for each
occupation on the list.
Based on their analysis of BLS data, Walton et al. (2004) stated that the pharmacist
supply can be explained in terms of four variables: 1) wages earned by pharmacists in a state; 2)
the number of new graduates; 3) the number of existing pharmacists; and 4) work preferences.
Demand was defined as the number of pharmacist positions available at a given wage in each
state.
These investigators also determined that the demand for pharmacists at the market level
is positively related to the number of community pharmacy prescriptions and population. They
reported that after controlling for population, the number of filled pharmacy positions was
significantly correlated with prescriptions, hospital days, pharmacies, and residents older than 65
years. Although not addressed in the Walton et al. (2004) study, Cherry et al. (2007) reported
that demand can be affected by the supply of physicians in a state.
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In another study, Walton, Knapp, Miller, and Schumock (2007) examined the
relationship between demographic and economic variables in their attempt to understand
variations in the pharmacist supply in America. Walton and his colleagues found that
surrounding population size, community income levels, and the number of healthcare facilities
all play a role in the future size of the pharmacist workforce.
Summary of Extant Studies on the Number of Pharmacists
There have been numerous studies on the factors that impact the pharmacist supply in
America. Some of the key variables that have been common to a majority of the studies on the
number of pharmacists in the literature are patient population, practice setting, practice location,
salary, utilization of skills, benefits, pharmacy student enrollment, managed care penetration and
insurance coverage, work hours, practitioner gender, prescription volume, demand for clinical
pharmacy services, number of pharmacies in a community, number of physician visits, size of
population over 65 years of age, per 100,000 population income, number of pharmacist
vacancies in a community, number of physicians, size and number of employers, implementation
of healthcare reform and passage of new laws.
In broad terms, these factors fall into one of three domains that have emerged from
previous research on the pharmacist supply: (1) Demographic, (2) Ecological and (3)
Institutional/Legal. A summary of studies in these domains is presented in Table 1 below.
Findings from extant studies on pharmacist supply in the literature, when taken as a group,
provides some insight into the interrelationships among factors that may determine the
pharmacist supply in America (Knapp, 1999; Manasse & Speedie, 2007; Burt 2002; Meissner et
al., 2006; & Sommers, 2004). The changing demographics of the pharmacy profession may
require innovative approaches to recruitment, retention, and training of faculty and clinical
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specialists to meet current and future needs of a population that includes a growing number of
persons with chronic illnesses and increasingly more complex pharmacotherapeutic regimens
(Patry & Eiland, 2007).
While healthcare facilities try to find a way to meet their demands, retail pharmacies also
must turn to the same pool of pharmacists to meet their demand as well. These facts point to the
dire need for more empirical evidence about the factors that impact the pharmacist supply.
Managing the balance between the demand for pharmacists and the supply of pharmacists will
continue to be of paramount concern to the profession over the next several decades. In light of
limited, dwindling resources, there must be ways found to maximize our resources to avoid
critical imbalances between supply and demand for pharmacists. Several researchers have
suggested a shortage of pharmacists.
Assessing the environment is a critical prerequisite for adequate workforce planning to
address the challenges in maintaining a suitable number of pharmacists. Among the variables to
be considered are increasing work-force demands, patient safety, resource constraints, and health
work-force policy reforms (Wuliji, 2009). Understanding the environmental dynamics that help
determine pharmacists supply and distribution throughout the United States may help
communities, hospital administrators, and other pertinent personnel in determining the
appropriate number of pharmacists to meet population demands. In this chapter the role and
importance of pharmacists in the U.S. healthcare system have been reviewed. There was an
exploration of factors that affect supply and demand and there was a discussion of the dynamic
nature of the relationship between the two. Changes in the organization of healthcare services,
including pharmacy services, changes in the demographics of the population and changes in the
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financing of healthcare will impact supply and demand where pharmacists are concerned. Table
1 provides a summary of studies that have been conducted on pharmacist supply/manpower.
Table 1. Summary of Research Domains on the pharmacist supply found in the Literature.
Key Variables

Point of Interest

Reference

Salary, utilization of
skills, and benefits

Assessing the factors that impact pharmacy
graduates’ practice location preference

Besier & Jang, 1992

Student Program
Enrollment Status,
Pharmacy Practice
Setting

Practice Location Preferences for B.S. and
PhamD. Students

Baran & Cumlich, 1998

Pharmacists Manpower,
Managed Care
Penetration

The impact of managed care on pharmacy
Knapp, 1999
practices and the ability to retain roles that are
useful to the system and satisfying to pharmacists
in a changing healthcare system. Pharmacists
participation in population-based patient
management programs, adaptation to new
relationships with other providers.

Pharmacist population
size, Pharmacy School
Enrollment

Investigation of the existence of a pharmacist
shortage in the United States for the years 1987
to 1991. Utilization of earnings data for
pharmacists at a regional and state level to
determine which areas of the U.S. or which
individual states are most in need of more
pharmacists by practice settings to determine
supply levels.

Mott & Kreling 1994

Aging Pharmacist
Population, Increased
Hours worked and
Increased female
pharmacist population

The U.S. Department of Health and Human
Services, Health Resources and Services
Administration's (HRSA's) 2008 report on the
pharmacist workforce documented the current
and growing shortfall of pharmacists.

Department of Health and
Human Services, 2000 &
2008

Pharmacist gender
makeup, Pharmacist
supply, Patient
Population Data

To describe a Bureau of Health Professions
model for estimating active pharmacists in the
United States and its findings

Gershon, Cultice, & Knapp,
2000
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Table 1. Summary of Research Domains on the Pharmacist Supply Found in the Literature
(Continued)
Key Variables
Demand for prescriptions or clinical
services, patient population.

Number of community/outpatient
prescriptions dispensed
Number of active community and
outpatient pharmacy licenses,
Number of active pharmacy licenses,
hospital setting , Per capita income ,
Age > 65 years
Number of filled pharmacist
positions in the state , Number of
pharmacy technician and pharmacy
aide positions, Pharmacist wages
Prescription Growth, Growth of
Pharmacies, Pharmacy Vacancies
Number of Drugs Prescribed and
Office Visits, Patient Population
Institutional/Legal component
Key Variables
Trends of Hospital and Healthcare
System pharmacy’s, Recruiting and
Retaining Staff
Pharmacy Practice Expansion,
Improvements in Medicare and
Medicaid
Work status, part-time work,
secondary
employment, full-time equivalents
Legislation, medication utilization,
and mortality

Point of Interest
To estimate the impact that the
new Medicare drug benefit
program will have on pharmacy
workforce demand.
Examine the impact of supply and
demand factors on filled positions
for pharmacists and pharmacist
extenders (pharmacist technicians
and aides) and assess differences
across states through analysis of
state-level pharmacist
labor market data

Reference
Meissner, Harrison, Carter, &
Borrego, 2006

Manpower issues for all pharmacy
managers and the demand of
prescription volume
A report that describes ambulatory
care visits made to physician
offices in the U.S.

Knapp, 2001

Point of Interest
Assessment of Pharmacy’s
changing demographic

Reference
Deyton et al., 2007

Impact of Healthcare Reform on
Pharmacy Practices

Matzke & Ross, 2010

Examination of trends in work
practices of pharmacists from 1990
to 2000.
Pharmacists, Pharmaceuticals, and
Policy Issues that are Shaping the
Work Force in Pharmacy

Mott et al., 2002

Walton, Cooksey, Knapp,
Quist,& Miller, 2004

Cherry, Woodwell, &
Rechtsteiner, 2007

Manasse & Speedie, 2007

Understanding the environmental dynamics that help determine pharmacists supply and
distribution throughout the United States may help communities, hospital administrators, and
other pertinent personnel in determining the appropriate number of pharmacists to meet
population demands.
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In this chapter the role and importance of pharmacists in the U.S. healthcare system have
been reviewed. There was an exploration of factors that affect supply and demand and there was
a discussion of the dynamic nature of the relationship between the two. Changes in the
organization of healthcare services, including pharmacy services, changes in the demographics
of the population and changes in the financing of healthcare will impact supply and demand
where pharmacists are concerned.
Previous research in this area has presented a nascent understanding of the confluence of
myriad factors that may significantly impact the pharmacist supply, but there are gaps in our
understanding of the context in which these factors operate and the interactions among them. An
understanding of these factors will be useful to closing the gap that currently exists in our
knowledge of the pharmacist supply and the interaction among the factors affecting it. Within
the context of this inquiry, an understanding of the pharmacist supply and the factors affecting it
can only come about as a result of an empirically based, purposeful examination using a rigid
theoretical framework. It was proposed that the population ecology framework is suitable for the
task at hand. There will be more in depth discussion of the population ecology framework in the
next chapter.
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Chapter 3: Theoretical Framework

The population ecology theoretical framework will be used to guide this inquiry of
factors affecting the pharmacist supply in the United States. The population ecology theory is an
adaptation of Darwin’s theory of evolution and climactic change and consists of four main
constructs: population, natural selection, niche and carrying capacity. In this chapter a there will
be a description of the population ecology theoretical framework and statement of the hypotheses
that will be tested in this inquiry.
The Impact of Darwin’s Theory of Evolution on the Development of Population Ecology
Darwin’s theory of evolution looks at growth and decline among species and accounts for
growth and decline by considering the impact of environmental factors. The species that can
adapt to an environment continue to thrive, and those unable to do so disappear over time. To
illustrate the central premise of his theory Darwin thought that it might be helpful to consider a
country undergoing some physical change, for instance, of climate.
A portion of the country’s inhabitants would adapt to change and survive. The
inhabitants that do not are likely to become extinct (Darwin, 1859). Darwin also noted that a
numerical proportion of some of the inhabitants, independently of the climate change itself,
would seriously affect the survival of many others. Darwin’s theory of evolution by natural
selection was based on the premise that species change and adapt to their environment with the
fittest surviving and giving way to new species.
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Darwin’s observations have been the focus of studies in biology and various other
scientific disciplines (Adami, Ofria, & Collier, 2000; Gavrilets & Losos, 2009; Schluter, 2009).
Darwin’s thoughts regarding variation in a population are focused on understanding the process
of evolution (Bowler, 2009). He believed that variation in a population was not the result of
some predetermined developmental trend. On the contrary, population variation was caused by
something other than random variation. It was later determined Darwin was actually talking
about genetic mutations, which are not aimed in any one direction (Bowler, 2009). Darwin
rejected the notion that evolution occurred over time as a result of some predetermined
developmental trend. Rather, he stated, evolution is the result of a naturally occurring sequence
of events in which environmental forces contribute to the adaptation of a species over others. He
called this sequence “natural selection.”
Over time it became the consensus of organization theorists that the environment could
influence the survival of individual organizations and that there are environmental forces that
produce and shape populations of organizational forms (Mckelvey & Aldrich, 1983). Just as
biological evolution of species is central to Darwin’s theory of natural selection, organization
theorists have suggested that processes within organizational environments are essential to the
emergence of organizational forms and to the defining attributes of populations of organizations.
These processes are variation, selection and retention (Hansenfeld, 1992).
Population Ecology Theory: Constructs
Population.
The population ecology theoretical framework enables researchers to understand changes
in organizational forms based upon environmental factors and their impact on outcomes such as
the financial and demographic disposition of organizational environments. Among the typical
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questions that organization theorists attempt to answer within the context of the population
ecology perspective are “Why are there so many organizations?” and “What causes organizations
to prosper or reduce?” The differences among organizations’ characteristics, environmental
characteristics, and the probabilities of entry and exit have been the dominant empirical concern
of population ecologists (Alexander & Amburgey, 1987).
The population ecology theory shifts the level of analysis from a single organization to a
population of organizations. In this inquiry the pharmacist supply will be referred to as an
organization. This approach has previously been utilized to understand factors affecting the physician
supply in the U.S. (Jiang and Begun, 2002). Treating the pharmacist supply as an organization
allows the ability to explore the factors affecting it within the population ecology framework.
Organization theorists who employ the population ecology framework to describe how
organizational forms emerge have made certain assumptions. Perhaps foremost among their
assumptions is that populations of organizations can be defined in terms of Darwin’s natural
selection thesis (Amburgey & Rao, 1996).
Along the same lines as Darwin’s concept of natural selection, organization theorists
have pointed out that a longitudinal analysis is required to assess distributional relationships
among organizational forms. Such analyses enable researchers to account for the effect of time
on the emergence of organizational forms. The longer the period of time for which historical
data are available, the more accurate the ecological picture (Alexander & Amburgey, 1987).
By extension of their logic for using longitudinal studies as the correct methodological
approach to studying organizational forms and their emergence, organization theorists reject
studies that employ cross-sectional data, or that use shorter time periods. Specifically, these
latter two approaches are unable to adequately account for rare or uncommon occurrences, and
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thus, may lead the researcher to misinterpretations and to reaching incorrect conclusions. For
these reasons, longitudinal studies are preferred among organization theorists. In light of this
rationale, this inquiry seeks to explore and delineate the impact of environment on the
pharmacist supply in the U.S. The fundamental premise here is that, as an organizational form,
the pharmacist supply is actually the result of a process of natural selection in which the
pharmacist supply is determined by environmental forces. In this regard, it is a premise of this
inquiry that the collective characteristics of pharmacists and trends within the profession of
pharmacy fit within the population construct of the population ecology framework.
Natural Selection.
Natural selection is the second construct in the population ecology theory. It is
comprised of three components or stages: variation, selection and retention. Variation involves
any kind of change or deviation in form, condition, appearance, or extent from a former or usual
state or from an assumed standard; whether intentional or unintentional (McKelvey & Adrich,
1983). Variation in health manpower may involve formal recognition of new specialties or the
emergence (or reemergence) of different forms for providing healthcare such as the use of
physician assistants, nurse practitioners and pharmacy technicians (Rundall & McClain, 1982).
Jiang and Begun (2002) declare that variation is a precondition for selection. Theirs is a
sociological perspective of population ecology. Selection is the apparent predisposition of an
organizational form for the environment in which it exists. In other words, the selection of an
organizational form for its environment refers to its suitability for its environment as a result of
prior variation.
Hannan and Freeman (1977) believe that very few organizations are able to change their
structures quickly when faced with dramatic changes in. their environment. Organizations that
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are able to do so are selected over time and exhibit the fluidity that is required for them to adapt
to a rapidly changing and sometimes complex environment. Once selected for their
environment, organizations demonstrate stability and the ability to survive.
Hannan and Freeman further assert that organizational adaptation can best be understood
in terms of being selected for multiple places (environments) as a result of natural selection
versus being specifically and uniquely selected for a single environment. The difference
between these two organizations or organizational forms is their properties. The properties of
organizational forms are believed to be essential to an organization being selected for one or
more environments. Hannan and Freeman see selection as an adaptive process. Looking at
variation in the pharmacy workforce over time, one can see the various settings in which
pharmacists now have increased presence, such as managed care organizations, wholesale
industries and long-term care. This type of variation leads one to conclude that the pharmacist
supply is suitable and likely to remain potent in the very volatile U.S. healthcare environment.
In this inquiry it is proposed to view the pharmacist supply as an organization poised to
take its place within the larger healthcare system. The increasing specialization within the
profession is an organizational form that predisposes it to survival in the volatile healthcare
domain. As the organization’s constituents (individual pharmacists) choose to become
specialists, this collective action results in a new organizational form that is more suitable for the
environment in which it operates. It is contended in this inquiry that the rate at which the
organization changes is equal to the rate at which specialization within the profession is
occurring.
In this vein, pharmacists selected for their environment will survive and thrive. Although
the decision making process that leads pharmacists to practice in one environment versus another
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is beyond the scope of the present inquiry, it should be noted that the ultimate choice a
pharmacist makes regarding practice venue may be a result of a number of factors including the
healthcare workforce (number of other healthcare providers), socio-economics (insured
population, employers based in vicinity), type of patients (elderly, young adults) and facilities
(pharmacies, hospitals). All of these are important for survival or retention possibilities in a
particular environment.
Niche.
The third construct in population ecology theory is niche. One of the important aspects of
the environment with which a species must be concerned is other species. Each species needs a
particular set of resources in order to survive and reproduce. This set of resources is their niche
(Langston, 1987). When viewed as an organization, and in order to survive, pharmacists require
a patient population, prescribers, a volume of prescriptions to be filled and an insured population.
If one or more of these is missing, it is unlikely that the organization (pharmacists) will find its
niche, and consequently would not be selected for that environment.
The extent to which two species will compete with each other is determined by two
factors: their degree of niche overlap and the amount of resources available in the local
environment (Langston, 1987). Niche overlap occurs when two species in the local environment
require the same resources for survival and reproduction. When two or more species need the
same amount or nearly the same amount of resources from their shared environment the
competition between them will be intense. If one species manages to obtain the amount of
resources they need they are more likely to be selected for the environment and will be able to
survive. If neither of the species is able to achieve their niche, they may both disappear from the
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environment, unless they both undergo transformations that result in them becoming a single
organization and as such are able to get the resources needed for survival.
In the present case it disputed that niche finding will not likely result in the disappearance
of pharmacists. Rather, in organizational terms, it will affect the total population of pharmacists
(number) and yield an organization that is suited for survival in the tumultuous healthcare
environment. In the worst case scenario the size of the organization would diminish to the point
that other health professions may perform functions that previously had been exclusively
performed by pharmacists. This inquiry seeks to explore the dynamics of environmental factors
that may affect the pharmacist supply over time and seeks to fill gaps in our knowledge
regarding the pharmacist supply within the population ecology theoretical framework.
In this inquiry niche will be discussed within the context of the population ecology
theory, but it will not be explored separately. Although niche overlap may be a significant
factor in the pharmacist supply in the U.S. (e.g. mail order pharmacists vs. retail pharmacists),
the data used in this inquiry are not sufficient to test this potential competitive relationship.
Carrying Capacity.
The fourth and final construct of the population ecology theory is carrying capacity.
Carrying capacity is the population size that an area can support (Wholey & Sanchez, 1991). For
example, the equilibrium number of organizations that can be supported in a specified area may
depend on a community’s size, wealth, and other demographic factors (Wholey & Sanchez,
1991). Hence, as an environment changes over time so does its carrying capacity.
The overall perspective of the population ecology theory is that the abundance or rarity of
organizations and organizational forms may be discerned in terms of environmental surroundings
(Namboodiri, 1994). Namboodiri contends that environmental conditions affect the rate of
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creation and extinction of organizations. The rate at which organizations change and the
interactions that occurs within and among organizational populations constitutes the
environmental surroundings. An analysis of populations possessing a unique character or
attribute and of their environment is an extremely useful exercise for administrators and various
decision makers because it facilitates strategic planning for the future.
Several studies in various industries have utilized the population ecology theory.
Freeman and Hannan (1983) used it to study restaurants, Carroll (1984) used it to study the
newspaper industry and Jiang and Begun (2002) used it in a study of the physician population.
Nielsen and Hannan (1977) and Carroll (1981) also utilized the population ecology perspective
to study economic resources affecting the growth of education organizations. The theory has
been beneficial in research targeting the healthcare industry; particularly research looking at
physician practice location and the environmental circumstances that help guide it.
The use of the population ecology theoretical framework in this inquiry is expected to fill
in some of the gaps in our knowledge concerning the pharmacist supply. This inquiry will also
provide a basis from which pharmacist leaders may be able to more effectively and optimally
utilize environmental resources to ensure that sufficient numbers of pharmacists are available at
all times to meet societal needs. Based on findings from this inquiry and previous inquiries,
population ecology researchers may be able to develop and test more detailed models that
address the pharmacist supply. The population ecology theory is considered one of the most
abstract and broad perspectives on organizations. Although not necessarily rich in detail, it
provides a critical basis for cumulative research (Bacharach, 1989).
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Applying Population Ecology Theory to the Pharmacist Supply
The majority of the studies on the pharmacist supply in the United States have used time
periods encompassing ten years or less. Two studies Mott et al. (2002) and Walton et al. (2004)
applied a three year and ten year time frame, respectively, in their studies of the number of
pharmacists. The final determination of the appropriate length of time for a study depends on the
research question, circumstances, and variables involved. Variables that will be of importance
for this inquiry include income, population composition and size of the insured population.
Within the context of the population ecology theoretical framework, these variables describe the
socio-demographic component of the environment. In this instance, these variables, among
others, describe the socio-demographic component of the environment in which pharmacists ply
their trade. Identifying and understanding the important variables and factors affecting the
number of pharmacists in the U.S. may be extremely important in light of current and past
discussions about reforming the U.S. healthcare system. Fryer, Green, Dovey, Yawn, Phillips,
and Lanier (2003) suggest that income, population composition, size of the insured population
and having a consistent source of care are important and helpful for conceptualizing system
redesign in order to address healthcare disparities.
Population ecologists perceive the environment as a broad illustration of the resource
pool from which organizations obtain their sustenance, thereby aiding in the organization
selection process (Hurley & Kaluzny, 1987). Accordingly, this perspective recognizes that much
of the ongoing change within the health services arena may be a function of necessity to achieve
a better fit between resources and the environment (Hurley & Kaluzny, 1987). One example
may be the growth of medical group practices and medical plans to better accommodate their
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population base. One area of research for many population ecologists is organizational
mortality.
Researchers in this area have asserted that failures of organizations are due to causes
external to them (Carroll, 1985). Along similar lines, variation in the pharmacist supply is
believed to be a result of factors extrinsic to the profession of pharmacy. Using the population
ecology framework, and consistent with the approach of population ecologists, the pharmacist
supply may be seen in the same light as organizations. Consequently, the pharmacist supply is a
result of the operation of environmental forces as well as certain preferences and characteristics
of individuals who choose pharmacy as a profession. At various times the supply of pharmacists
is inadequate and at other times it is adequate—in the former case not meeting the needs of the
population and in the latter case meeting the needs of the population. Another popular focus of
research by organization theorists is organizational transformation. Organizational
transformation is a critical issue in health services delivery and can be examined using the
ecological perspective.
The process of change in the healthcare arena can perhaps be more accurately and clearly
understood when researchers use the population ecology theoretical framework to provide
insights into the process of change (Hurley & Kaluzny, 1987). The study of organizational
transformation usually includes three fundamental issues—rates of organizational founding,
disbanding and change in a given population. Organizational founding is best explained in terms
of two important concepts: density dependence and population dynamics.
An increase in organization volume (number of organizations in a particular geographical
area) signals an increase in founding. At the same time, a larger number of organizations
typically lead to more competition in the local environment and that results in disbanding.
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Disbanding occurs when the environment cannot support the organization. For example, in the
context of this inquiry, if the needs and expectations of the patient and provider populations do
not create a demand for pharmacists and the tasks that they perform, the number of pharmacists
will diminish.
The patient population here is synonymous with organizations that offer similar products.
Insofar as the pharmacist supply is concerned, understanding founding (influx of pharmacists)
and disbanding (decrease of licensed pharmacists available to provide services in the
marketplace) are critical to recognizing and describing the cyclical patterns of rapid expansion
and contraction that shape the pharmacist supply. Hasenfeld (1992) suggests that this is true
across the board in the human services field.
The provider population also figures very prominently in this context, especially those
providers whose usual breadth and scope of practice includes writing prescriptions for the
medications that their patients require. One important observation here is that interdependence
among organizations may increase the rate of founding and disbanding among organizations
operating in the same environment.
By way of example, it is suggested here that both patients and providers depend heavily on
reimbursements from insurance companies and other third parties to the healthcare transaction for the
services provided and received in the healthcare marketplace. The availability or lack of availability
of reimbursement will certainly affect the patients (causing limited access to care and their inability
to obtain needed treatment) and their providers (causing them to restrict their practices or to cease to
provide care to a segment of the population). These scenarios may be tied to the coming and going
of employers in the area (because they typically are the entities that make insurance coverage
available to their employees and they determine the extent and duration of coverage when it is
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provided). Therefore, as mentioned previously, an exploration of the pharmacist supply using the
population ecology framework must include variables such as the number of insured persons, the
number of employers, and the number of healthcare providers with prescribing authority.
Utilizing the population ecology framework to describe factors that impact the physician
supply in America, Jiang and Begun (2002) noted that processes of change should be examined
at the population level, rather than at the individual level. One implication of their work for
explaining the supply of pharmacists is that the pharmacist supply is better understood by
looking at macro trends among pharmacists and interactions with their environments as opposed
to looking at the decisions, practices and environments of individual pharmacists.
It has been stated that a population is an aggregate of individuals that have a common
dependence on the material and social environment (Freeman & Hannan, 1989). Examples
of the material and social environment include facilities, prescriptions, physicians, and the
patient population, where the pharmacist supply is concerned. These variables tend to fluctuate
in an environment and are expected to have an impact on the number of practicing pharmacists
(i.e., the pharmacist supply).
Consistent with Darwin’s point of view, changes in the environment are expected to have
similar effects on members (organizations) of a population. When this concept is applied to the
health workforce, such as physicians who are generalists, or other health professionals such as
nurses and pharmacists, these healthcare workers can be viewed collectively as a population.
Hasenfeld (1992) states that there are two very important theoretical constructs that must be
examined in research involving organizations and their environments: 1) openness of the organization toward its environment and 2) the degree to which the organization can control its own
destiny. Organizations best positioned to take advantage of new environmental conditions will
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survive and reproduce through social, cultural, and institutional transmissions of beliefs and
values, (Alexander & Amburgey, 1987).
Other observers have stated that the population ecology theoretical framework provides a
useful perspective for examining the relationship between organizational transformation and
organizational performance over time (Wischnevsky & Damanpour, 2006). The logic is that
organizations that change at their core confront problems that are prevalent in new organizations.
Hannan and Freeman (1984) believe that organizations are unable to change at the same pace as
the environment due to structural inertia. Structural inertia is an organization’s limited ability to
adapt to its environment (Hannan & Freeman, 1977). In Hannan’s and Freeman’s view the
faster and easier organizations adapt to their environments the more quickly they will achieve
stability; thus ensuring their long-term survival. A summary of the studies that have been
utilized in the development and study of the population ecology theory are provided in Table 2.
The following section the hypotheses that will be tested in this inquiry are presented.
These hypotheses have been developed to provide the empirical foundation upon which this
inquiry into the pharmacist supply in America is based and they are consistent with the
population ecology theoretical framework that has been discussed in this chapter.
Hypotheses
Hypotheses H1 – H7 address the environmental dimension of munificence. Hypotheses
H8 H12 address the environmental dimension of concentration and the final hypothesis (H13)
addresses density-dependence. The data that will be used to test these hypotheses are described
in the next chapter.
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Table 2. Studies on the Creation and the Development of the Population Ecology

Key Points of Interest

Title

Reference

Species, environment, resources

Determining the survivability of
species in relation to their
environment
The Dynamics of Change in the
American Hospital Industry:
Transformation or Selection?

Darwin, 1859

Political Economy, Marxist Theory, Population Ecology
Theory

Theoretical Approaches to Human
Services Organization.

Hansenfeld, 1992

Key issues facing ecological research

Organizational Ecology: Past,
Present, and Future Directions

Amburgey & Rao, 1996

Review of the population perspective with an outline for
developing a classification of organizational forms.
Suggestions on how to improve the application of
organizational research.
A conceptual framework on physician distribution and
forecasting regional physician supply. The study addresses
an environmental selection model in which populations of
physicians are viewed as the unit of analysis.

Populations, Natural Selection, and
Applied Organizational Science

McKelvey & Aldrich, 1983

Environmental Selection and
Physician Supply

Rundall & McClain, 1982

Dynamics of change in local
physician supply: an ecological
perspective

Jiang & Begun, 2002

The Population Ecology of
Organizations

Hannan & Freeman, 1977

An overview of human ecology is presented, with an
ecological perspective on demography of households.

The Human Ecological Approach to
the Study of Population Dynamics

Namboodiri, 1994

A model is developed to study environmental variability on
populations of organizations is studied, specifically specialist
and generalist organizations. This model predicts that death
and growth rates of generalists and specialists in relation to
environmental variation

Niche Width and the Dynamics of
Organizational Populations

Freeman & Hannan, 1983

Determination of changes in the U.S. hospital industry
through the application of population ecology theory. The
process of ecological selection rather than the transformation
of individual organizations.

This study explores the physician supply based on
population ecology theory, the framework attempts to
explain the growth of a particular physician population by
four mechanisms
A population ecology perspective is assessed for its utility on
organization to environment relations instead of the
conventional adaptation perspective. There is a discussion on
models that have attempted to discuss the organizational
environment.

Educational organizations are assessed utilizing population
ecology. It was found that the educational organizations and
characteristics were dependent on the national environment
abundance of resources.
A study of national systems of education and how they
expand organizationally at varying speeds in different
countries and time periods. The results suggest that
organizational expansion in large, geographically
decentralized systems follows a process dependent upon the
limits of the environmental resources.

Alexander & Amburgey, 1987

Nielsen & Hannan,1977
The Expansion of National
Educational Systems: Tests of a
Population Ecology Model
Dynamics of Organizational
Expansion in National Systems of
Education
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Carroll, 1981

Munificence.
This scenario correlates with carrying capacity. Environmental resources important to
the pharmacist supply include total resident population, number of physicians, number of
pharmacies and hospitals and the financial viability of communities (e.g., median household
income of residents). One would expect that as the resident population increases so does the
patient population.
H1 There is a linear, positive relationship between a change in the size of the population
and a change in the pharmacist supply over time.
While the size of the population may be important in determining pharmacist supply, the
size of certain segments of the population may have a disproportionate effect on the need for
pharmacists. Older residents utilize a disproportionate share of pharmacist manpower because
they are more likely than their younger population counterparts to have chronic conditions that
require pharmaceutical interventions (Kaiser Family Foundation, 2011). Older residents utilize a
disproportionately higher number of prescribed medications than younger residents.
Hence, more pharmacists may be required in a community with a large proportion of older
residents than in a similar community with the same proportion of young residents. The elderly
consistently account for a majority of the prescriptions filled in many communities across the
U.S.
H2 There is a positive, linear relationship between a change in the size of the elderly
population and a change in the pharmacist supply over time.
Beginning in 2001 schools of pharmacy in the United States was required to have a
curriculum leading to the Pharm.D. degree as the entry level degree for the profession. In
addition, the profession experienced increased specialization among its practitioners. From a
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population ecology point of view, the survival of the profession would be dependent on the
extent to which the environment in which pharmacists practice can accommodate more highly
trained entry-level pharmacists and greater specialization among them. In particular, the
profession must work to ensure that pharmacists are given the opportunity to use their skills on
the job (Cox & Fitzpatrick, 1999).
There appears to be a disparity of opportunity to do so between community-based and
institutional settings. Hospital-based pharmacists are more likely to have an opportunity to
utilize their skills to the fullest extent possible compared to their community-based counterparts.
In hospital and other institutional settings pharmacists are often members of medical teams
providing a wide array of duties such as drug therapy and other clinical services for
institutionalized patients.
H3 There is a positive, linear relationship between the number of hospitals with
pharmacies and the pharmacist supply over time.
Pharmacists practice in a variety of environments including managed care organizations,
academia, and industry. However, the majority of pharmacists work in pharmacies located either
in a community (retail) setting or a hospital. Regardless of the setting, pharmacists perform a
number of tasks essential to desirable, high quality patient care outcomes. Among these tasks
are accuracy of order fulfillment, review of prescriptions for drug interactions and errors in drug
selection and dosage, assistance with the selection of medications consistent with the ability of
patients to pay for them, problem solving related to payment/reimbursement for filled
prescriptions and answering patients' and other healthcare providers' general questions. Despite
these facts, all too often, there is too little contact between pharmacists and patients.
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The need for pharmacists may be greater in certain community/retail settings than in
hospital or institutional settings. A number of previous studies have provided empirical evidence
regarding the consequences of an insufficient number of pharmacists in the face of increasing
demand (Mott, Doucette, Gaither, Pedersen, Kreling, & Schommer, 2006; & Knapp, et al. 2005).
Some pharmacies have shortened their business hours, decreasing their accessibility to patients,
while others (especially in rural communities) have closed because a replacement could not be
found for a retiring pharmacist (Manasse & Speedie, 2007).
H4 There is a positive, linear relationship between the number of pharmacies and the
pharmacist supply over time.
Another important factor pertaining to munificence where the pharmacist supply is concerned is
the volume of prescriptions filled. The writing of a prescription is one of the most common, and
important, therapeutic interactions between physicians and their patients. About three billion
prescriptions were dispensed in 2001 by more than 136,000 full-time equivalent (FTE)
pharmacists.
According to Pal (2002) those three billion prescriptions amounted to approximately
30,000 prescriptions /pharmacist/year. Based upon current trends and annual growth rates it is
estimated that approximately 7.2 billion prescriptions will be written to be filled in 2020; or
about 90,000 prescriptions/pharmacist/year (Pal, 2002). This projection appears to be reasonable
and tenable in light of the fact that approximately 4 billion prescriptions were dispensed in 2010
(Kaiser Family Foundation, 2011). Pal estimates that an additional 80,000 to 100,000 FTE
pharmacists will be needed by 2020 to meet such a great prescription demand.
H5 There is a positive, linear relationship between the number of prescriptions filled and
the pharmacist supply over time.
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According to one national survey, physicians wrote over 4 billion prescriptions in 2007.
Physicians are responsible for the majority of the prescriptions written in the U.S.(Medical
Expenditure Panel Survey, 2008). To keep this in perspective, there were approximately 1.5
billion physician office visits in 2008, with approximately 20% of those visits resulting in
patients leaving with at least one prescription (Medical Expenditure Panel Survey, 2010). Studies
have revealed that there has been a consistent increase in both the physician and pharmacist
workforce populations in recent years (Shih, 1999; DHHS, 2006; DHHS, 2008). Empirical
findings reported by these studies seem to support the notion that the pharmacist supply increases
to match the demand for more prescriptions to be filled by an increasing number of physicians.
H6 There is a positive, linear relationship between the size of the physician supply and
the pharmacist supply over time.
The affluence in an environment gives rise to the ability to afford healthcare.
Communities that are relatively wealthy are better able to afford healthcare compared to
communities that are not doing as well financially. A healthcare quality survey was conducted by
Weinwick, Byron, and Bierman (2005) to collect detailed information about experiences with
healthcare from a nationally representative sample of 6,722 adults ages 18 and older living in the
continental United States. Approximately 16.9% of those included in the survey said they had
postponed care, not filled prescriptions, used alternative care, or engaged in other noncompliant
behavior as a result the exorbitant cost of healthcare and their inability to afford it. This statistic
lends itself to the notion that people with higher levels of income tend to purchase more
healthcare, all other factors being equal (Sing, Miller, & Banthin, 2008).
H7 There is a positive, linear relationship between the wealth of a community and the
pharmacist supply over time.
61

Concentration.
Concentration describes the level to which resources are distributed. In the healthcare
arena the organizations and entities that impact the distribution of resources include pharmacies,
hospitals, physicians, and employers. In the case of hospitals, the distributions of these facilities
affect pharmacists’ options regarding where they are going to work. Hospitals that are involved
in mergers may be participating in consolidation across markets that have no customer overlap
(Ho & Hamilton, 2000). Increasing mergers of hospitals in an area may lead to improvements in
services such as pharmaceutical services (Brooks & Jones, 1997). Hospitals in more competitive
markets have a greater probability of mergers and acquisitions, but not closures; which increases
market power (Ho & Hamilton, 2000).
Based upon a study by Dasatani & Siganga (2003) the greatest effects that mergers and
strategic alliances were expected to have on pharmacists’ duties and responsibilities is an
increase in clinical duties, administrative duties, and an increase in patient-monitoring duties.
Pharmacy directors also indicated that there would be increases in inpatient and outpatient drug
distribution duties (Dasatani & Siganga, 2003).
Hospitals with a strong market share have the ability to promote the provision of tertiary
care services, this leads to an increase in occupied beds in a facility. This in turn increases the
demand for pharmacists who are integral in drug therapy for patients. The importance of clinical
pharmacists to hospitals cannot be understated; their roles have increased with emphasis on
collaborative care and patient interaction (Kaboli, Hoth McClimon, & Schnipper, 2006). The
ASHP conducted a national survey, which ended in 2000 on pharmacy practices in hospitals.
The number of pharmacists involved in monitoring increased to 84% of hospitals in the
2008 survey with larger bedded hospitals employing a greater number of pharmacists (Pederson,
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Schneider, & Scheckelhoff, 2009). This number increased to over 93% of the hospitals surveyed
with 200 beds or more reported having their clinical pharmacists actively involved in monitoring
patients (Pedersen, Schneider, & Scheckelhoff, 2012). The hypothesis proposed applies to
hospital beds and its impact on the pharmacist supply.
H8 There is a positive, linear relationship between hospital beds per 100,000 population
and the pharmacist supply over time.
Some regions of the country may have higher volumes of pharmacies based upon the demand of
their population. States with large elderly populations may have more pharmacies and may have
a larger volume of prescriptions filled annually than states with smaller elderly populations.
Chain pharmacies employ nearly 118,000 full-time equivalent (FTE) pharmacists
(NACDS, 2011). More community pharmacies in a state may provide more potential work
opportunities for pharmacists and more desirable benefits such as flexible schedules, upward
mobility and l higher salaries. Marketplace factors have a greater impact on the number of
community pharmacies than geography (Christensen & Farris, 2006). There are approximately
55,400 community pharmacies in the U.S., More than 50% are members of chains and the
remainders are independently owned. Chain pharmacies fall into the following categories:
traditional chains (e.g. CVS), mass merchandisers (e.g. Walmart), and supermarket pharmacies
(e.g. Safeway) (Christensen & Farris, 2006). Chain pharmacies operate approximately 39,000
pharmacies and fill nearly 2.6 billion prescriptions annually, which are more than 72% of annual
prescriptions in the United States (NACDS, 2011). The majority of currently employed
pharmacists work for community pharmacies.
H9 There is a positive linear relationship between the number of pharmacies per 100,000
people and the pharmacist supply over time.
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The numbers of physicians practicing in states across the U.S. vary as a result of many
factors. These factors include practice environments and preferences for their personal lives.
Insofar as practice environments are concerned, factors affecting a physician’s decision to
establish a practice in a certain location include specialty, academic and healthcare resources and
patient population. Outside of the office physicians desire good neighborhoods for their families,
good schools and a wide selection of leisure activities. According to one study utilizing
economic theory, physicians locate both in previously underserved smaller communities, as well
as in locations where their colleagues are already practicing in an attempt to balance their patient
loads (Rosenthal, Zaslavsky, and Newhouse, 2005). Physicians are primarily responsible for
almost all of the prescriptions that are written in the United States.
According to a study by Cherry et al. (2007) physicians wrote two billion prescriptions
during office visits in 2005. Physicians also write prescriptions in hospitals, long-term care
facilities and governmental agencies. When physicians are part of a larger physician network
they tend to be more concentrated geographically. The vicinity in which physicians practice
lends itself to the potential for a certain volume of prescriptions being generated, thereby leading
to a specified need of pharmacists to meet the rising demands.
H10 There is a positive linear relationship between the number of office based physicians
per 100,000 population and the pharmacist supply over time.
Employers are a principal source of healthcare benefits for the general population.
Recent estimates from the United States Chamber of Commerce suggest that United States
companies spend approximately $0.11 of every payroll dollar on healthcare benefits (Abraham,
Feldman, Carlin, Christianson, & Davis, 2005). Employers play a key role as purchasers and
administrators of health insurance for the working-age population in the United States. In 2003,
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approximately 174 million Americans (60.4% of the U.S. population) obtained their health
insurance through an employer (Denavas-Walt, Proctor, & Mills, 2004).
Nearly 60% of people with employer-sponsored health insurance coverage obtain it
through a very large employer (500 or more employees). Slightly more than one in four persons
with employer-sponsored health insurance coverage obtained it through a small employer (fewer
than 100 employees) (State Health Access Data Assistance Center [SHADAC], 2011). With this
in mind it can be surmised that employers wield a considerable amount of buying power in the
healthcare arena, and consequently, may substantially impact the pharmacist supply.
H11a

There is a positive linear relationship between the number of employers and
the pharmacist supply over time.

H11b1 There is a positive linear relationship between employer size (19 or less employees)
and the pharmacist supply over time.
H11b2 There is a positive linear relationship between employer size (20 or more
employees) and the pharmacist supply over time.
In the past decade, prescription drug utilization and spending in the United States has
increased dramatically (Reed, 2005). One study of Medicare beneficiaries reported that drug
coverage was associated with a 9.6% increase in the probability of any prescription use (Huh,
Rice, and Ettner, 2008). One review of studies examining the implementation of Medicare Part
D found that there has been a 6% to 13% increase in reported drug use since its implementation
(Geib, 2007). Ostensibly, increased utilization of medication benefits leads to an increased
prescription workload for pharmacists, which may exceed the capacity of the pharmacist supply
(Geib, 2007). In addition to the increased number of Medicare beneficiaries obtaining
prescription access through Medicare Part D; by 2014 approximately 32 million Americans who
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are currently uninsured will gain access to healthcare benefits including coverage for prescription
drugs through some form of insurance (Vivian, 2010).
Provisions of the Affordable Care Act of 2010 are expected to play a very significant
role in the increase of the number of insured Americans by 2014. The most prominent outcome
of a larger percentage of persons having coverage for prescription drugs is likely to be an
increased volume of prescriptions being written, which will increase demand for more
pharmacists and pharmacy personnel (Vivian, 2010).
H12

There is a positive linear relationship between the number of insured and
the pharmacist supply over time.
Density Dependence.
Complete data on interactions between organizations in a community are generally not

available. Ecologists have therefore relied on the indirect evidence provided by the estimated
effects of population density (the number of organizations in a population) on vital rates
(founding and mortality) (Staber, 1992). Population ecologists study competition and symbiotic
relationships and their outcomes in an attempt to discover and describe density dependence.
According to Hannan & Freeman (1977) the rate at which units are added to populations
of organizations depends on how much of the fixed capacity has already been exhausted. The
greater the unexhausted capacity in an environment, the faster should be the rate of growth of
populations of organizations. There are two distinctive ecological considerations: the capacity of
the environment to support forms of organization and the rate at which the populations grow (or
decline) when the environmental support changes. This lends itself to the understanding that
competition grows with density at an increasing rate. The pharmacist supply is believed to also
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be susceptible to environmental competition. If there is an oversaturation of pharmacists at any
given point this may impede the future growth of the pharmacist supply.
Organizational forms presumably fail to flourish in certain environmental circumstances
because other forms successfully compete with them for essential resources. As long as the
resources which sustain organizations are finite and populations have unlimited capacity to
expand, competition must ensue (Hannan & Freeman, 1977). With this notion of potential finite
resources, it is imperative to assess the pharmacist supply while accounting for density. Staber
(1992) asserts that a current population’s growth rate must be taken into account in order to
clearly understand how density dependence may alter this population’s growth rate as density
changes; otherwise the population projections may be deceptive. The Population Ecological
Framework and hypotheses for this inquiry are listed in Figure 2 and Table 3, respectively.
H13

Is there a change in the total number of pharmacist’s overtime.
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Munificence
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Growth of
pharmacist
population

Environment’s
Carrying
Capacity

Resident Population, H1
Elderly Population
H2
Hospital Facilities
H3
Pharmacy Facilities H4
Prescription Volume H5
Physician Population H6
Median Household Income H7

Concentration

Community Wealth

Density H13

H7

Hospital Beds Per 100,000 population H8
Pharmacies Per 100,000 population
H9
Office Based Physicians
Per 100,000 population
H10
Employer Volume
H11A
Employer Size
H11B1,H11B2
Number of Insured
H12

Figure 2. Pharmacist Supply and the Ecological Spectrum of the Hypotheses

Table 3. Hypotheses

H1

There is a positive linear relationship between a change in the size of the and a
change in the pharmacist supply over time.

H2

There is a positive, linear relationship between a change in the size of the elderly
population and a change in the pharmacist supply over time.

H3

There is a positive, linear relationship between the number of hospitals with
pharmacies and the pharmacist supply over time.

H4

There is a positive, linear relationship between the number of pharmacies and the
pharmacist supply over time.

H5

There is a positive, linear relationship between the number of prescriptions filled
and the pharmacist supply over time.

H6

There is a positive, linear relationship between the size of the physician
population and the pharmacist supply over time.

H7

There is a positive, linear relationship between the median household income and
the pharmacist supply over time.

H8

There is a positive, linear relationship between hospital beds per 100,000
population and the pharmacist supply over time.

H9

There is a positive linear relationship between the number of pharmacies per
100,000 people and the pharmacist supply over time.

H10

There is a positive linear relationship between the number of office based
physicians per 100,000 population and the pharmacist supply over time.

H11a

There is a positive linear relationship between the number of employers and the
pharmacist supply over time.

H11b1

There is a positive linear relationship between employer size (19 or less
employees) and the pharmacist supply over time.

H11b2

There is a positive linear relationship between employer size (20 or more
employees) and the pharmacist supply over time.

H12

There is a positive linear relationship between the number of insured and
pharmacist supply over time.

H13

Is there a change in the pharmacist supply overtime.
69

Chapter 4: Methodology

This inquiry examines the impact of environmental factors on the pharmacist work force
in the United States. A review of the relevant, extant literature was presented in chapter two.
The theoretical framework for this inquiry was presented in chapter three. In this chapter an
overview of the study design, the data and the procedures and techniques for analyzing the data
are presented.
Study Design
A non-experimental cohort design will be used to examine the effects of changing
environmental conditions on the pharmacist supply. This study design is appropriate for
studying a subset of a population over time (Polit & Beck, 2004). The time frame for this
inquiry covers the 16 years between 1994 and 2009. During this period there was a significant
and noteworthy shift in the accreditation process for U.S. schools of pharmacy. All schools of
pharmacy were required to make the transition from the B.S. degree as the entry level
professional degree to the Pharm.D. degree as the entry level degree for the profession. This
change and the widespread implementation of the standardized curriculum leading to the
Pharm.D. degree is beyond the scope of this inquiry.
However, the mandatory transition from the B.S. to the Pharm.D. degree is an important
environmental factor that is believed to have significant, discernible impact on the pharmacist
supply during the time frame for this inquiry and should be examined in a separate inquiry.
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Determining an appropriate length of time to examine the pharmacist supply is a
challenge. Findings from a majority of previous studies addressing the issue of the pharmacist
supply were based on a time frame of fewer than 10 years (Gershon, Cultice, & Knapp, 2000;
Walton, Cooksey, Knapp, Quist,& Miller, 2004). This inquiry will be utilizing a timeframe from
1994 – 2009, with some variables being tested on a slightly shorter timeframe based on data not
being available for the entire timeframe. A table depicting all variables and timeframe available
is presented later in this chapter.
Lotka-Volterra Model
A good proportion of the previous research on the population ecology of organizations
has relied on models of multiple populations. Such models capture population growth and
decline. Most frequently, these models are multivariate extensions of the logistic model
commonly referred to as the Lotka Volterra (LV) model (Carroll, 1985). The LV model,
developed by American physical chemist Alfred Lotka and Italian mathematician Vito Volterra,
attempts to describe the dynamics of biological systems in which two species interact.
The use of LV equations was initially advocated by Hannan & Freeman (1977) for use in
studies involving populations of organizations. Since their use by Hannan and Freeman, these
models have been used in additional studies involving various professions and professional
organizations (Carroll, 1981; Wholey & Brittain, 1986).
The LV equation has become the basis of modern-day population ecology, although some
consider it to be of limited practical utility for complex organizations. Today, LV equations are
regarded for their instructive value, rather than their applied utility (Dorschner, Fox, Keener, &
Eikenbary, 1987). The LV equation will provide the methodological and conceptual framework
for this inquiry. The change in size of the pharmacist supply between 1994 and 2009 will be
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examined using the LV equation. The LV equation will be particularly useful for exploring the
two population ecology dimensions as they relate to the pharmacist supply: munificence and
concentration. The adaptation of the LV equation for this inquiry is represented by the following
equation.

dNi
dt

Ki Ni
riNi

J

ij

Ni

j i

Ki

Ni= number of organizations in population i, Ki = environmental carrying capacity for
population i, ri= growth response parameter for population i (i.e. the speed with which the
population grows in the absence of competition),

ij=

the interdependence coefficient, which is

the effect of population j on i (Jiang and Begun, 2002). This specification describes the growth
rate of an organization or population. The growth is influenced by population size relative to
the environmental carrying capacity for the population (Baum & Singh, 1994).
Model Specification
Munificence (M) and Concentration (C) are two environmental factors that help
determine the pharmacist carrying capacity. The munificence dimension will be measured using
the following variables: patient population, hospital facilities, pharmacy facilities, prescription
volume, physician population, and community wealth. The concentration dimension will be
measured using hospital beds per 100,000 population, pharmacies per 100,000 population, office
based physicians per 100,000 population, employer volume, employer size, and number of
insured. Munificence and concentration vary with time and cannot be observed directly.
However, these dimensions are useful for determining and specifying resource availability. The
following model and formulas will be utilized to explore the pharmacist supply over time.
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Pjk = ß0 + ß1j* yearj+ ß2+

k+

jk

Pjk = ß0 + ß1j*yearj+ ß2 Pop+

Where j= 1994-2009

k+

Pjk = ß0 + ß1j*yearj+ ß2 Pop 65+ +
population
Pjk = ß0 + ß1j*yearj+ ß2 Hosp+

Where Pop = Total population

jk

k+

k+

Where Pop 65+= Total number over 65 in the

jk

Where Hosp = Total number of hospitals

jk

Pjk = ß0 + ß1j*yearj+ ß2 PharmF+

k+

Where PharmF = Total number of pharmacies

jk

Pjk = ß0 + ß1j*yearj+ ß2 Rx+

k+

jk

Where Rx = Total number of prescriptions filled

Pjk = ß0 + ß1j*yearj+ ß2 Dr +

k+

jk

Where Dr = Total number of physicians

Pjk = ß0 + ß1j*yearj+ ß2 MHI +

k+

Pjk = ß0 + ß1j*yearj+ ß2 HospC+
population

k+

Pjk = ß0 + ß1j*yearj+ ß2 PharmFC+
100,000 population

Where MHI = Median Household Income

jk

jk

k+

Where HospC = Number of hospitals per 100,000

jk

Where PharmFC = Number of pharmacies per

Pjk = ß0 + ß1j*yearj+ ß2 OBDR +
per 100,000 population

k+

jk

Where OBDR = Number of office based physicians

Pjk = ß0 + ß1j*yearj+ ß2 EmpV +

k+

jk

Where EmpV = Total number of employers

Pjk = ß0 + ß1j*yearj+ ß2 EmpS1+
(0-19 employees)

k+

jk

Where EmpS1 = Total number of employers by size

Pjk = ß0 + ß1j*yearj+ ß2 EmpS2+
(20+ employees)

k+

jk

Where EmpS2 = Total number of employers by size

jk

Where Ins = Total Number of Insured

Pjk = ß0 + ß1j*yearj+ ß2 Ins+

k+

Pjk represents the pharmacist supply as it interacts with the environment. The parameter
ß0i is the intercept term; it is a baseline estimate according to the model. The parameter ß1j
represents the relationship between year and the pharmacist supply. ß2j is the relationship
between the pharmacist supply and the current variable.
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k represents

random effects in the

model. E represents the error term within the model. This is a mixed effects model and it takes
into account both fixed and random effects.
Data
For the purposes of this inquiry, the pharmacist supply will be the unit of analysis. The
pharmacist supply is defined as the total number of licensed pharmacists at a point in time. Data
for this inquiry come from a number of sources and are supplied on a state by state basis. In
order to effectively assess the environment’s impact on the pharmacist supply, data will be
drawn from several sources. The first source is the National Association of Boards of
Pharmacy (NABP). Founded in 1904 the NABP is a professional organization that supports the
state boards of pharmacy in protecting public health.
The NABP’s member boards of pharmacy are grouped into eight districts that include all
50 United States, the District of Columbia, Guam, Puerto Rico, the Virgin Islands, eight
Canadian provinces, and New Zealand. The Association is governed by its Executive
Committee, whose officers and members are elected at an annual conference. The data that are
compiled by the NABP are produced by the Survey of Pharmacy Law Census. The survey
describes and summarizes how the state boards of pharmacy are organized, how they function,
and their requirements for licensure.
There are limited options for obtaining pharmacist and pharmacy data. The NABP is
perhaps the most suitable source for such data. The NABP receives its data from each state’s
board of pharmacy. When pharmacists and pharmacies apply for licensure to their state’s board
of pharmacy, certain information is collected and added to a database. The NABP collects the
databases from each state and assembles a master database of pharmacist and pharmacy data that
may then be used in research such as this inquiry.
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One limitation of using NABP data is that practice location is determined from
professional mailing addresses. However, the state of residence may not necessarily indicate the
state in which a pharmacist practices. A licensed pharmacist may work in a state that borders
his/her state of residence. At this juncture, the NABP provides the most comprehensive data
available on the pharmacist supply and pharmacy demographics.
The Area Resource Files (ARFs) are the second source of data for this inquiry.
Quality Resource Systems, Inc. (QRS) maintains the ARF System under contract from the
Health Resources and Services Administration of the U.S. Dept of Health and Human Services
and has maintained and expanded the database for the past fifteen years.
The database contains data from many sources including the American Hospital
Association, the American Medical Association, the Centers for Medicare and Medicaid
Services, the National Center for Health Statistics, and the Census. The database is an annuallyupdated file with over 6,000 variables of interest that pertain to health facilities, health
professions, measures of resource scarcity and socioeconomic and environmental characteristics.
ARF data used in this inquiry include number of hospital facilities and number of
licensed physicians. The AMA data on physician workforce in the ARF contains data on all
doctors in the United States who have completed or are completing requirements to practice
medicine. This number includes graduates of foreign medical schools who reside in the United
States as well as doctors of osteopathy who have met the educational and credentialing
requirements necessary for licensure. The one main limitation, as with the NABP data, is that a
physician’s state of residence may not necessarily indicate the state in which he or she practices
medicine. The AHA is the national organization that represents and serves all types of hospitals
and is comprised of nearly 5,000 member hospitals. The AHA database contains
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hospital-specific data obtained annually through a survey of hospitals in the United States.
Hospital specific ARF data include an analysis of trends and data on personnel, resource
utilization, budgets, and bed size.
The third data source for this inquiry is the National Association of Chain Drug Stores,
which represents traditional drug stores, supermarkets, and mass merchants with pharmacies
from regional chains with four stores and national companies. The chains operate 39,000
pharmacies, and employ approximately 118,000 full-time pharmacists, and fill nearly 2.6 billion
prescriptions annually, which are more than 72% of annual prescriptions in the United States
(NACDS, 2011).
The prescription data utilized by NACDS is compiled by Wolters Kluwer Health, which
is an organization that has been around for over 170 years and provides important information to
global and national pharmacy professionals and the pharmaceutical industry. Wolters Kluwer
Health obtains electronic drug data and clinical information from more than 20,000 pharmacies,
2,000 hospitals, and numerous health insurers and physicians' offices. Prescription fill data used
in this inquiry will come from the NACDS database.
The fourth data source for this inquiry is provided by the U.S Department of Commerce
which promotes job creation, economic growth, and sustainable development and improved
standards of living for all Americans by working in partnership with businesses, universities,
communities and our nation’s workers. The U.S Department of Commerce collects information
on employers throughout the United States based upon County Business Patterns. The
department compiles data from an annual report that contains data on budgetary projections,
market potential and sales quotas over time. Businesses utilize the data for analyzing market
potential, measuring the effectiveness of sales and advertising programs, setting sales quotas, and
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developing budgets. The data on the number and size of employers per state will be obtained
from the U.S Department of Commerce and utilized in this study.
The fifth and final data source that will be utilized is provided by the U.S. Census
Bureau. The Census Bureau is an agency within the U.S. Dept of Commerce and is the premier
source of quality data about the nation's population and economy. The Census Bureau collects a
variety of data about the U.S. population and various subpopulations. The census also collects
and analyzes data pertaining to median household income and insurance status.
Sampling
Unless otherwise noted, the data used in this inquiry are derived from the entire
population or sub-population of interest. No sampling will be used in this inquiry. However, it
should be noted that data obtained from some of the sources mentioned above may be obtained
from samples as indicated by the data owner. Analyses will be performed using the data
provided by the sources above.
Study Variables
The following variables will be used in this inquiry; in some instances a few of these
variables have been utilized in previous studies that have used the population ecology theoretical
framework to examine environmental factors impacting the supply of health professionals. A
description of the variables can be found in Table 4.
Dependent Variable.
The dependent variable for this inquiry is the pharmacist supply in the United States. For
the purposes of this inquiry the pharmacist supply will be the total number of pharmacists in the
United States in a given year. The total number of pharmacists for each state is based on data
reported by the NABP. To prevent duplication and over counting, only those pharmacists with
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addresses within their reported state of residence are counted in the state totals. The majority of
the studies that have looked at pharmacist supply have used national data from the U.S. Census
Bureau. However, the data from the Pharmacy Census produced by the NABP is the most
accurate data to measure the number of pharmacists by state because the NABP data are derived
from the actual data submitted by each state pharmacy board; compared to the estimates from the
U.S. Census Bureau Survey.
Independent Variables.
Total population. is a variable obtained from the Census and will be all encompassing of the
population from babies to the elderly by state.
Elderly population. is a subset of the total population and is provided by the Census and will
be based upon the population that are 65 years and older and will be compiled by state.
Hospitals. is based upon facilities who are members of the AHA. The data utilized for this
study will be compiled on a state by state basis for all AHA hospitals and is located within
the ARF.
Pharmacies. Data will cover all pharmacy settings from retail pharmacies to institutional
pharmacies. This data is supplied by the NABP and provides the total number of pharmacies
for each state based upon all the licensures requested.
Prescriptions filled. The volume of prescriptions data are provided by the NACDS in
collaboration with Wolters Kluwer Health Source which is the primary source for filling
prescriptions throughout the United States. The data is compiled on a state by state basis
Physicians. The data for this variable is provided by the AMA and is subject to licensed
practitioners on a state by state basis, and is contained within the ARF.
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Median Household Income. The Median Household Income for each state will be measured
upon the median house hold income provided by the Census Bureau.
Hospital Beds Per 100,000 population. The data is measured on the number of hospital beds
per 100,000 population. The data utilized for this study will be retrieved from the AHA and
the Census Bureau located within the ARF.
Pharmacies per 100,000 population. The data is measured on the number of community
pharmacies per 100,000 population. The data utilized for this study will be retrieved from the
NACDS and the Census Bureau.
Office Based Physicians Per 100,000 population. The data is measured on the number of
licensed practitioners practicing in an office setting per 100,000 population. The data is
provided by the AMA contained within the ARF and the Census Bureau.
Employer Size. The data is provided by the United States Commerce. The data represents
the total number of employers that employ a certain number of people it is categorize by a
specified employee range.
Employer Volume The data is provided by the United States Commerce. The data represents
the total number of employers by state.
Insured Population. The data is based upon the total number of insured (public & private) by
state and is provided by the Census Bureau.
Analytic Methods
Univariate Analysis.
Descriptive statistics will be computed for each variable. The simple means of each
variable and the standard errors will be provided.
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Multivariate Analysis.
A Repeated Measures Regression Analysis will be used to test the hypotheses presented
in this study. Repeated Measures Regression Analysis employs a mixed effects regression model
and is able to account for the impact of covariates on the dependent variable (Brown and
Prescott, 2006). In the present case, year is a covariate of the pharmacist supply. The presence
of missing data does not pose the major problems for analysis that can occur with traditional
regression analysis (Brown & Prescott, 2006). Another benefit of repeated measures regression
is its ability to reveal trends over time as opposed to single point estimates of changes in the
dependent variable. The variable descriptions are listed in Table 4.
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Table 4. Variable Definitions

Variables

Variables
Abbreviation Levels

# of Pharmacists

Pharm

Continuous

Employer Size

EmpS1,
EmpS2

Continuous

Dates
19942009

Continuous

19942009
19942009
19942008
19942009

Description
Source
Total # of Pharmacists
with in state addresses NABP
Total # of Employers by
Employee Size: 0-19,20
or more
Census
Total # of U.S.
Employers by State
Census
Total # of Pharmacies by
State
NABP
Total # of U.S. Hospitals
by State
ARF
Total # of Prescriptions Wolters
Filled By State in Chain Kluwer
Drug Stores
Health Source
Total # of U.S.
population Insured by
State
Census
Total U.S. Population
Over 65 years of age by
State
Census
Total U.S. Population by
State
Census
Total # of Physicians
with in State addresses ARF
Median Household
Income by State
Census

Continuous

19952007

Number of Hospitals Per ARF &
100,000 population
Census

Continuous

19942008

Number of Pharmacies NACDS &
Per 100,000 population Census

Continuous

19952008

Number of Physicians ARF &
Per 100,000 population Census

Employer Volume EmpV

Continuous

# of Pharmacies
Total # of U.S. of
Hospitals

PharmF

Continuous

Hosp

Continuous

19882008
19882008
19942009
19952007

# of Prescriptions Rx
Total # of U.S.
population Insured
by State
Ins
# of U.S. people
over 65 years old by
State
Pop 65+
Total U.S.
Population by State Pop

Continuous

19962009

Continuous

19942009

# of Physicians
Dr
Median Household
Income
MHI

Continuous

Hospital Beds Per
100,000 population HospC
Pharmacies Per
100,000 population PharmFC
Office Based
Physicians Per
100,000 population OBDR

Continuous
Continuous

All Figures are summed across all states unless noted otherwise.
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Chapter 5: Results

This chapter will present the results of the analysis on the environmental factors affecting
the pharmacist supply in the U.S. A descriptive summary of the data is provided in the first
section of the chapter. Table 5 provides the change in pharmacist supply from year to year; in
appendices D-F the changes in the independent variables from year to year are displayed. Table
6 displays the descriptive statistics of all the variables being utilized in this study including the
timeframe of the data available. The second section of the chapter presents the results of each
hypothesis in the context of its construct association. In addition, there is a summary of each
construct in relation to the results of all the variables. The last section of the chapter provides a
summary of the findings based upon the results of the hypothesis testing utilizing the repeated
measures regression analysis.
Descriptive Statistics
Changes in the Pharmacist Supply Between 1994 and 2009.
Between 1994 and 2009 the number of licensed pharmacists in the U.S. grew from
181,134 to 264, 527; an average 2.5% increase per year during this 16 year period (NACDS,
2011). The dependent variable for this inquiry is the total number of licensed pharmacists with
instate addresses., this provides more of an accurate count considering a pharmacist may have
several state licenses for practicing pharmacy.
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As Table 5 indicates, the supply was the greatest in 2008 and least in 1994. During the 16
year period of this inquiry, on average, there were 224,301 licensed pharmacists with instate
addresses in the U.S., i.e. approximately 79 per 100,000 population. Table 6 illustrates the
descriptive statistics of the independent and dependent variables.
Table 5. Percentage Change in Pharmacist Supply Per Year, 1994-2009

Year

# of Pharmacists

% of Change

1994

181134

1995

185818

3

1996

198053

6

1997

201084

2

1998

201590

0

1999

206002

2

2000

197678

-4

2001

216248

9

2002

218609

1

2003

236009

7

2004

246392

4

2005

247560

0

2006

254566

3

2007

264490

4

2008

269066

2

2009

264527

-2
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Table 6. Descriptive Statistics for Study Variables

Variables

Mean

Median

Minimum

Maximum

Standard Error

Timeframe

224,301.6

217,428.5

181,134.0

269,066.0

7513.38

1994-2009

Pop

284,153,822.8

286,582,792.5

260,348,536.0

307,006,550.0

3950694.7

1995-2008

Pop 65+

36,159,035.4

35,947,903.5

33,208,822.0

39,570,590.0

419026.9

1994-2009

Hosp

6,429.7

6,346.0

6,285.0

6,641.0

52.1

1995-2007

PharmF

77,667.6

74,918.0

68,130.0

87,246.0

1650.8

1994-2009

Rx 2,991,969,779.9 3,061,141,763.0

2,211,372,768.0

3,658,892,270.0

122064017.2

1996-2009

Dependent Variable
Pharm
Independent Variables
Munificence
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DR

757,028.9

765,474.0

623,403.0

848,933.0

18484.1

1994-2008

MHI

50,153.9

50,616.1

46,399.1

52,138.1

429.8

1994-2009

Concentration
HospC

377.1

367.8

356.1

446.8

9.4

1995-2007

PharmFC

30.1

29.6

27.8

33.2

0.4

1994-2008

OBDR

178.2

180.6

157.0

187.8

2.8

1995-2008

EmpV
EmpS1(Employers
with 19 or less
employees)
EmpS2 (Employers
with
20 or more employees)
Ins

7,129,851.2

7,095,302.0

6,509,065.0

7,705,018.0

97276.1

1988-2008

4,610,787.7

4,376,391.0

4,115,583.0

5,466,985.0

131812.4

1988-2008

2,519,063.5
239,895,687.5

2,588,372.0
242,307,500.0

2,090,551.0
222,418,000.0

2,882,961.0
255,141,000.0

64963.1
2898134.2

1988-2008
1994-2009

These descriptive statistics represent the mean for the totals of the years specified above.

Variable Overview
Population (Pop) The U.S. population grew by approximately 2-3 million people per
year during the period 1994 through 2009. In the last several years of the timeframe,
the population grew by 3 million people per year. On average, over 284 million people lived in
the U.S. between 1994 and 2009. In 2009 the U.S. population reached 307 million people.
Elderly Population (Pop65+) Persons 65 years old and older comprise one of the fastest
growing segments of the U.S. population. During the 16 year period for this inquiry, this
segment of the U.S. population grew by six million (16%). This segment of the population
accounts for a disproportionately higher share of prescription drug use and is expected to
continue to grow at a faster rate than the rest of the population as a result of the continual
development of new medications to treat chronic conditions
Hospitals (Hosp) The number of hospitals with pharmacies in the U.S. remained fairly
stable during the period of time covered by this inquiry. The number of these U.S. hospitals
increased by approximately 360 between 1995 and 2007. In 2005, there were 6,641 hospitals
with pharmacies in the U.S. The mean number of such hospitals during the period of time
covered by this inquiry was 6,429. The number of hospitals decreased from the mid 1990s to the
mid 2000s then the number of hospitals started climbing.
Pharmacies (Pharm) There was an average of 77,667 pharmacies in the U.S. between 1994 and
2009. During the early part of this period the number of pharmacies fluctuated and there was a
downward trend in the number of pharmacies. In the years following 2001, there was a
remarkable upward trend in the number of pharmacies and by 2009 there were 84,813
pharmacies, an increase of 16% between 2001 (when the number of pharmacies was the lowest
for the period) and 2009.
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Prescription Filled (Rx) The number of prescriptions filled has consistently increased every year
from 1996 through 2009. There were over 2.2 billion prescriptions filled in 1996 with this
number increasing to over 3.6 billion by 2009. The mean number of prescriptions filled for the
timeframe for this inquiry was 2.9 billion. It is likely that the volume of prescriptions written
and dispensed will continue to rise as a result of many factors. Perhaps the most noteworthy of
these factors is the rapid growth of the 65 and over segment of the population and a rapid and
significant increase in the proportion of the population that is insured.
Physicians (Dr) Between 1994 and 2008 the number of physicians grew by 27%. The mean
number of physicians during this period was 757,028. There was a consistent upward trend in
the number of physicians during the period of time for this inquiry. The number of physicians
reached a peak of 848,933 in 2008. The size of the physician population is marked by such
demographic trends as the influx of international medical graduates and fluctuations in the
number of allopathic and osteopathic medical schools.
Median Household Income (MHI) The median household income fluctuated between 1994 and
2009 reaching a high of $52,138 in 2008 and a low of $46,399 in 1994. The mean median
household income for this 16--year time period was $50,153. There was a remarkable decline in
the median household income during the last two years of the 16 year period covered by this
inquiry.
Number of hospitals beds per 100,000 population (HospC) The number of hospital beds per
100,000 population decreased consistently over the 13 year time period beginning in 1995 and
ending in 2007. During this period, there was a mean of 377 hospital beds per 100,000
population. The maximum number of hospitals beds per 100,000 population during this 13 year
period peaked at 447 in 1995.
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The number of hospital beds per 100,000 population is expected to be marked by a perceptible
decrease in coming years due to a growing trend of shifting inpatient care to outpatient care.
Number of pharmacies per 100,000 population (PharmC) The number of pharmacies per
100,000 population remained stable over the period 1995 to 2008, with a mean of 30 pharmacies
per 100,000 population. The number of pharmacies per 100,000 population reached a peak of 33
in 2006 and a low of 28 in 1995.
Office Based Physicians per 100,000 population (OBDR) The number of office based physicians
per 100,000 population grew every year between 1995 and 2008. During this period there was a
mean of 178 office based physicians per 100,000 population, with a minimum of 157 and a
maximum of 180.
Employer Volume (EmpV) During the period of time covered by this inquiry there was a mean
of 7.1 million employers in the U.S. The number of employers reached a maximum of 7.7 in
2007. There was a downturn in the U.S. economy during the latter part of the decade ending in
2009. Consistent with a decline in the economy there was a decrease in the number of employers
during the last two years of the period of time covered by this inquiry.
Employer Size (EmpS1, EmpS2) For the purposes of this inquiry, employers size consists of
two categories: employers having 19 or fewer employees (EmpS1) and those with 20 or more
(EmpS2). There was a mean of 4.6 million employers with 19 or fewer employees during the
period for this inquiry. The corresponding mean for employers with 20 or more employees was
2.5. Employers with 20 or more employees reached a maximum of 2.8 million in 2004. The
maximum number of employers with 19 or fewer employees was 5.4 in 2007.
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Insured Population (Ins) The number of U.S. citizens with health insurance grew consistently
during the 16 year period for this inquiry. In fact, the number of insured increased in each year
of the period with a total increase of 13% between 1994 and 2009. On average, there were 240
million Americans with health insurance for the period 1994 to 2009. The insured population
grew from 222 million in 1994 to 253 million by 2009. The insured population accounted for
82% of the entire U.S. population in 2009.
Model Specification Interpretation
The model for this inquiry was presented in chapter 3. Within the context of the
population ecology theoretical framework are munificence (M) and concentration (C) which are
the overarching constructs posited to have an appreciable impact on the pharmacist supply. The
indicators of these two dimensions are the independent variables that were discussed in chapter 3
and summarized in the above section.

While munificence and concentration vary with time and

cannot be observed directly, they are useful for identifying and characterizing environmental
factors and interactions among them that affect the pharmacist supply.

The pharmacist supply

is represented by the following model.
Pjk = ß0 + ß1j* yearj+ ß2j +

k+

jk

Pjk represents the pharmacist supply as it interacts with the environment. ß 0 is the
intercept for the model and it is an estimate of the baseline of the pharmacist supply. The
parameter ß1j represents the relationship between year and the pharmacist supply. ß2j represents
the relationship between the pharmacist supply and the independent variable being measured.
The pharmacist supply in this inquiry, as previously stated it is the sum of the total number of
pharmacists in each state and the District of Columbia with instate addresses. It is believed that
there may be forces at work in each state that could affect the pharmacist supply when the data
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from the states are combined. It is believed that there is not sufficient data to account for these
forces in the states.

k represents

random effects in the model that may be the result of these

forces. E represents the error term within the model.
A mixed effects statistical model was used in this inquiry of the pharmacist supply. The
inclusion of a random effects term in the model makes it more robust and more methodologically
sound. It is believed that more of the variation in the pharmacist supply can be accounted for
using a statistical model with both fixed and random effects than with a fixed effects model
alone. Moreover, the inclusion of a random effects term is consistent with the LV model
discussed previously in the literature and in this inquiry.
It follows logically that if year is the covariate in the repeated measures regression that is
the principal statistical tool used in this inquiry, a random effects term is needed to account for
the fact that the total number of pharmacists from year to year are not orthogonal. As a result,
without the random effects term, our model may yield tenuous results that may confound our
findings in this inquiry.
It is assumed that the random effects follow a distribution across years and they inform
the model that the observations for the pharmacist supply are correlated. Consequently, a mixed
effects statistical model allows the ability to draw more tenable conclusions using repeated
measures regression to explain the variation in the total number of pharmacists from year to year
during the period covered by this inquiry.
Assumption Testing
Pharmacist supply was found to have a non-normal distribution over the 16 year
timeframe. A basic requirement of linear regression is that the dependent variable is normally
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distributed. In order to overcome this problem, a transformation of the dependent variable was
completed using its natural logarithm.
This is a common and frequently used statistical manipulation to achieve a normally distributed
dependent variable for the purposes of linear regression (Tabachnick & Fidell, 2001).
Hypothesis Testing
Munificence.
M refers to the level of resource supply within the environment. In this inquiry hypotheses H1H7 are tested to determine whether or not M is a significant environmental factor impacting the
pharmacist supply.
H1 There is a positive, linear relationship between a change in the size of the
population and a change in the pharmacist supply over time.
Equation1: Pjk = ß0 + ß1j*yearj+ ß2 Pop+

k+

jk

It is hypothesized that the size of the population is positively, linearly associated with the
pharmacist supply over time. This hypothesis was tested using repeated measures regression.
Population was found to have a significant, statistically discernible impact on the number of
licensed pharmacists with instate addresses during the 16--year period covered by this inquiry
(p=.04). The results of the repeated measures regression analysis are summarized in Tables 7
and 8.
Table 7. Summary of the Fixed Effect of Population on Pharmacist Supply, 1994-2009

Effect
Year
Pop

Type 3 Tests of Fixed Effects
Num Den DF F Value
DF
15
663
68.76
1
709
4.15
90

Pr > F
<.0001
0.042

Table 8. Parameter Estimates for Population, 1994-2009

Year
Intercept
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Pop

1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009

Estimate

Standard
Error

8.1026
-0.3293
-0.3069
-0.2611
-0.2505
-0.2542
-0.2163
-0.1856
-0.167
-0.1474
-0.1349
-0.13
-0.1201
-0.099
-0.0597
-0.0265

0.1497
0.01481
0.01473
0.01458
0.0145
0.01443
0.01436
0.01423
0.01401
0.01395
0.01383
0.01371
0.01368
0.01372
0.0137
0.01383

0 .
1.06E-08

DF

t Value

Pr > |t|

49.8
54.14
670
-22.24
669
-20.83
668
-17.91
668
-17.27
667
-17.62
667
-15.07
665
-13.04
664
-11.92
664
-10.57
663
-9.75
663
-9.48
663
-8.78
662
-7.22
662
-4.35
662
-1.91
.
.
0
0 .

<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
0.0561
.
.

The test results for H1 lead to acceptance and to conclude that the size of the resident
population is a significant environmental factor impacting the pharmacist supply. This finding is
consistent with other findings in the literature. Walton et al. (2004) corroborates these results.
In their inquiry it was found that population was a strong retro prospective predictor of
pharmacists. Year was found to be a significant covariate. Thus, the size of the population in one
year is a significant predictor of the pharmacist supply in a subsequent year.
H2 There is a positive, linear relationship between a change in the size of the elderly
population and a change in the pharmacist supply over time.
Equation2: Pjk = ß0 + ß1j*yearj+ ß2 Pop 65+ +

k+
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jk

Persons 65 years of age and older use a disproportionate share of prescription
medications because they are more likely to have one or more chronic conditions that are
controlled and treated with prescription medications. In H2 it is hypothesized that the size of the
elderly population would have a positive, significant impact on the pharmacist supply over time.
The 65+ segment of the population was not found to have a statistically significant impact on the
pharmacist supply over time (p=.06). The results of the repeated measures regression analysis for
H2 are presented and summarized in Table 9.
Table 9. Summary of the Fixed Effect of the 65+ Population on Pharmacist Supply 1994-2009

Effect
Year
Pop65+

Type 3 Tests of Fixed Effects
Num
Den
F
DF
DF
Value
15
664
95.56
1
679
3.4

Pr > F
<.0001
0.0657

The test results for H2 lead to rejection and to conclude that the size of the elderly
population is not a significant environmental factor impacting the pharmacist supply. The census
projections indicate that the elderly will make up at least 20% of the U.S. population by the year
2030, and the prediction is that the prescription drug use will continue to climb (Manasse &
Speedie, 2007).
In addition to this growth in the elderly population are all indicators of a rapid and
persistent rise in demand for pharmacists (Gershon, Cultice, & Knapp, 2000). While these two
studies display the elderly population having a strong impact on the pharmacist supply, the
empirical evidence in this study oppose this premise. The parameter estimates for the 65+
population based upon the repeated measures regression analysis for H2 are presented in Table
10.
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Table 10. Parameter Estimates for the 65+ Population 1994-2009

Effect

Year

Intercept
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Pop65+

1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009

Solution for Fixed Effects
Estimate
Standard
Error
8.1372
0.1511
-0.3343
0.01421
-0.3116
0.01418
-0.267
0.01396
-0.2563
0.01393
-0.2593
0.01394
-0.2211
0.01393
-0.1876
0.01408
-0.1686
0.01389
-0.1485
0.01388
-0.1357
0.01378
-0.1305
0.01368
-0.1204
0.01366
-0.099
0.0137
-0.0597
0.01369
-0.0267
0.01381
0
.
3.88E-08
0

DF

Pr > |t|

48.9
665
665
665
664
664
664
665
665
665
665
664
664
664
664
664
.
0

<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
0.0541
.
.

H3 There is a positive, linear relationship between the number of hospitals with pharmacies and
the pharmacist supply over time.
Equation 3: Pjk = ß0 + ß1j*yearj+ ß2 Hosp+

k+

jk

Hospitals are a primary location in which pharmacists utilize their unique skill set. In this
setting, pharmacists often work on teams alongside physicians and nurses to provide optimal
therapies leading to desirable patient outcomes. In light of this fact, it seems plausible that the
pharmacist supply would be positively impacted by growth in the number of hospitals with
pharmacies as more pharmacists would be required to staff these hospitals. The results of a
repeated measures regression analysis to test H3 revealed that there is a positive, linear
association between the number of hospitals with pharmacies and the pharmacist supply
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(p=.006), controlling for year. The results of the analysis are presented in Tables 11 and 12.
Table 11. Summary of the Fixed Effect of Hospitals with Pharmacies on Pharmacist Supply
1995-2007.
Type 3 Tests of Fixed Effects
Num
Den
F
DF
DF
Value
8
360
64.69
1
368
7.51

Effect
Year
Hosp

Pr > F
<.0001
0.0064

Table 12. Parameter Estimates for Hospitals with Pharmacies 1995-2007 Results.

Effect
Intercept
Year
Year
Year
Year
Year
Year
Year
Year
Year
Hosp

Year

1995
2000
2001
2002
2003
2004
2005
2006
2007

Solution for Fixed Effects
Estimate
Standard
Error
8.0901
-0.2541
-0.1294
-0.1102
-0.09
-0.0755
-0.0706
-0.0628
-0.0402
0
0.00043

0.1472
0.01243
0.01244
0.01229
0.01229
0.01222
0.01212
0.01209
0.01215
.
0.00016

DF

Pr > |t|

48.8
360
360
360
360
360
360
360
360
.
368

<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
0.001
.
0.0064

The test results for H3 lead to acceptance and to conclude that the number of hospitals
with pharmacies is a significant environmental factor impacting the pharmacist supply. The
DHHS (2000) supported the premise that hospitals need for pharmacists are due to an ever
expanding role to care for a growth in the number of complex diseases and conditions treatable
by medication. The sharp increase in the utilization of prescription drugs, among additional
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factors, has been a driving force in the need for pharmacists in the hospital setting (Wisconsin
Hospital Association, 2006).
The findings in this inquiry are consistent with these assessments made by DHHS and the
Wisconsin Hospital Association. Year was found to be a significant covariate. Thus, the number
of hospitals in one year is a significant predictor of the pharmacist supply in a subsequent year.
H4 There is a positive, linear relationship between the number of pharmacies and the
pharmacist supply over time.
Equation 4: Pjk = ß0 + ß1j*yearj+ ß2 PharmF+

k+

jk

Although the number of hospitals with pharmacies employing pharmacists increased
between 1995 and 2007, the primary venue in which pharmacists practice continues to be retail
pharmacies, super market pharmacies, and chain drugstores. Ostensibly, it would appear that the
number of community-based pharmacies might have a significant impact on the pharmacist
supply over time. Hypothesis 4 was tested with this in mind. It was hypothesized that the
number of pharmacies is positively, linearly associated with the pharmacist supply over time.
An analysis to test this hypothesis revealed that, for the period 1995-2007 the number of
pharmacies does not have a statistically discernible impact (p=.13) on the pharmacist supply
from year to year. The results of the analysis are presented in Table 13.
Table 13. Summary of the Fixed Effect of Number of Pharmacies on Pharmacist Supply,
1995-2007

Effect
Year
# of Pharmacies

Type 3 Tests of Fixed Effects
Num
Den
F
DF
DF
Value
14
619
89.83
1
621
2.23
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Pr > F
<.0001
0.1362

The test results for H4 lead to the rejection and to conclude that the number of
pharmacies is not a significant environmental factor impacting the pharmacist supply. The need
for pharmacists has been a constant area of concern as pharmacies have cut their hours of service
and in some instances retired pharmacists reentering the work force (Manasse & Speedie 2007).
The need for pharmacists may be greater in certain community/retail settings than in hospital or
institutional settings (Mott et al., 2006). The results in this inquiry are in direct contrast with the
literature. The parameter estimates for the number of pharmacies based upon the repeated
measures regression analysis for H4 are presented in Table 14. It bears watching how the number
of pharmacies changes over time as an increasing number of pharmacists enter the healthcare
arena.
Table 14. Parameter Estimates for Number of Pharmacies, 1995-2007

Effect
Intercept
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
# of pharmacies

Year
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009

Solution for Fixed Effects
Estimate Standard Error
8.1566
0.1525
-0.3139
0.01359
-0.2681
0.01359
-0.2572
0.01346
-0.2605
0.01345
-0.2219
0.01347
-0.1897
0.01353
-0.1701
0.01344
-0.1492
0.01342
-0.1375
0.01327
-0.1324
0.01318
-0.1228
0.01317
-0.1009
0.01323
-0.061
0.01323
-0.02728
0.01337
0
.
6.72E-06 4.51E-06
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DF

Pr > |t|

48.5
619
619
619
619
619
619
619
619
619
619
619
619
619
619
.
621

<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
0.0418
.
0.1362

H5 There is a positive, linear relationship between the number of prescriptions filled and
the pharmacist supply over time
Equation 5: Pjk = ß0 + ß1j*yearj+ ß2 Rx+

k+

jk

Hypothesis 5 addresses the number of prescriptions filled over time and its impact on the
pharmacist supply. The number of prescriptions filled is another indicator of M.
It is hypothesized that there is a positive, linear relationship between the number of
prescriptions filled and the pharmacist supply over time. This hypothesis was tested using
Equation 5 above. Results from a repeated measures regression reveal that the number of
prescriptions filled does not have a statistically discernible impact (p=.12) on the pharmacist
supply over time. Based on this finding H5 was rejected. Results of the test of H5 are presented
in Table 15.
Table 15. Summary of Fixed Effects of Prescriptions Filled on Pharmacist Supply, 1996-2009

Effect
Year
Rx

Type 3 Tests of Fixed Effects
Num
Den
F
DF
DF
Value
13
579
50.87
1
589
2.34

Pr > F
<.0001
0.1263

The test results for H5 lead to rejection and to conclude that the number of prescriptions
is not a significant environmental factor impacting the pharmacist supply. This outcome is rather
surprising considering the current volume of prescriptions being filled. Based upon current
trends and annual growth rates, it is estimated that approximately 7.2 billion prescriptions will be
written to be filled in 2020, with an estimated 80,000 to 100,000 additional FTE pharmacists
needed to meet such a great prescription demand (Pal, 2002). According to the Kaiser Family
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Foundation (2011), this projection appears to be probable in light of the fact that approximately 4
billion prescriptions were dispensed in 2010.
At this juncture, the prescription volume appears not to be a good predictor of the
pharmacist supply, possibly due to the current pharmacist supply’s ability to handle the
workload. Nevertheless, this trend seems to be in jeopardy based upon projections of
prescriptions to be filled and may cause a serious ramification for the future. The parameter
estimate results for the number of prescriptions filled H5 are presented in Table 16.
Table 16. Parameter Estimate for Number of Prescriptions filled, 1996-2009

Effect
Intercept
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Rx

Year
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009

Solution for Fixed Effects
Estimate Standard Error
8.1976
0.1574
-0.2817
0.01508
-0.2699
0.01487
-0.2719
0.01451
-0.2316
0.01398
-0.198
0.01374
-0.1779
0.0134
-0.1569
0.01329
-0.1432
0.01318
-0.1374
0.01307
-0.1263
0.01298
-0.1036
0.01291
-0.06223
0.0128
-0.02818
0.01291
0
.
-4.00E-10
0

DF
49.1
581
581
581
580
579
579
579
579
579
579
579
578
578
.
0

Pr > |t|
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
0.0295
.
.

H6 There is a positive, linear relationship between the size of the physician population and
the pharmacist supply over time.
Equation 6: Pjk = ß0 + ß1j*yearj+ ß2 Dr +

k+

jk
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Physicians are key players in the U.S. healthcare system. They diagnose and treat
diseases. Among the treatment options used by physicians are pharmaceutical interventions that
require prescriptions. It seems logical that the size of the physician population might be related
to the pharmacist supply.
In previous studies it has been shown that there is a consistent increase in both the
physician and pharmacist workforce populations in recent years (Shih, 1999; DHHS, 2006;
DHHS, 2008). In light of previous studies, it is hypothesized that there is a positive, linear
relationship between the number of physicians and the pharmacist supply.
Hypothesis H6 was tested using a repeated measures regression analysis. Results indicated that,
controlling for year, there is no statistically significant relationship (p=.48) between the
physician population and the pharmacist supply for the 16 year period covered by this inquiry. A
summary of the tests of H6 is found in Table 17.
Table 17. Summary of the Fixed Effects of Number of Physicians on Pharmacist Supply,
1994- 2008

Type 3 Tests of Fixed Effects
Den DF
F Value

Effect Num DF
Year

14

623

51.46

DR

1

656

0.49

Pr > F
<.0001
0.4832

The relationship between physicians and pharmacists seems to be one of possible
commensalism. Commensalism refers to a relationship where one subject or organism benefits
but the other is neutral (there is no harm or benefit). This will continue to be a relationship of
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interest as the number of physicians continues to increase. The yearly results of the repeated
measures regression analysis for H6 are presented in Table 18.
Table 18. Parameter Estimates for Number of Physicians, 1994-2008
Solution for Fixed Effects
Effect

Year

Intercept

Estimate Standard Error

DF

Pr > |t|

8.161

0.1582

49.7

<.0001

Year

1994

-0.3173

0.01578

631

<.0001

Year
Year

1995
1996

-0.2936
-0.2469

0.01532
0.01499

629
628

<.0001
<.0001

Year

1997

-0.2352

0.0147

626

<.0001

Year

1998

-0.2379

0.01445

625

<.0001

Year

1999

-0.1991

0.01431

624

<.0001

Year

2000

-0.1664

0.01425

624

<.0001

Year

2001

-0.1471

0.014

623

<.0001

Year

2002

-0.1264

0.01389

623

<.0001

Year

2003

-0.1125

0.01371

622

<.0001

Year

2004

-0.1069

0.0136

622

<.0001

Year

2005

-0.09621

0.01357

622

<.0001

Year

2006

-0.07419

0.01361

622

<.0001

Year

2007

-0.03395

0.01359

621

0.0128

Year

2008

0

.

.

.

656

0.4832

DR

-1.16E-06

1.65E-06

H7 There is a positive, linear relationship between the median household income and
the pharmacist supply over time.
Equation 7: Pjk = ß0 + ß1j*yearj+ ß2 MHI +

k+

jk

In H7 it was hypothesized that there is a positive, linear relationship between median
household income and pharmacist supply over time.
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Median household income is the final indicator of M used in this inquiry. Hypothesis H7 was
tested utilizing a repeated measures regression and found that median household income did not
have a statistically discernible impact (p=.89) on pharmacist supply for the time period covered
by this inquiry. These results are presented in Table 19.
Table 19. Summary of Fixed Effects of Median Household Income on Pharmacist Supply,
1994-2009

Effect

Type 3 Tests of Fixed Effects
Num
Den
F
DF
DF
Value

Pr > F

Year

15

665

90.88

<.0001

MHI

1

668

0.02

0.8976

Hypothesis 7 was rejected when it was tested to determine if the median household
income supports the premise that income level affected pharmacist supply. The yearly results of
the repeated measures regression analysis for H7 are presented in Table 20 this is illustrated by
the parameter estimates. Previous research provided empirical evidence that a community’s
wealth does impact their ability to afford healthcare.
To support this premise there are findings that have determined that people with higher
levels of income tend to purchase more healthcare, all other factors being equal (Sing, Miller, &
Banthin, 2008). This study provides some indication that income can affect one’s ability to
attain healthcare which affects the supply needed to meet a perceived demand for certain services
and supplies.
So, while median household income was not a predictor of the pharmacist supply,
however it seems there is the ability for it to have an indirect impact on the pharmacist supply.
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The median household income was found not to be statistically significant; however it may be
possible that health insurance safeguards compensate for income for some families.
Table 20. Parameter Estimates for Median Household Income, 1994-2009

Effect
Intercept
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
MHI

Year
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009

Solution for Fixed Effects
Estimate Standard Error
8.175
0.1622
-0.3399
0.01442
-0.3168
0.01422
-0.2705
0.01402
-0.2592
0.01391
-0.2622
0.01389
-0.2237
0.01401
-0.191
0.01412
-0.1719
0.01386
-0.1517
0.01379
-0.1386
0.01371
-0.1331
0.01363
-0.1226
0.01363
-0.1007
0.01376
-0.06076
0.01387
-0.0271
0.01383
0
.
-1.34E-07
0

DF
60.2
665
665
665
665
665
665
665
665
665
665
665
665
665
665
665
.
0

Pr > |t|
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
0.0505
.
.

Pharmacist Supply Munificence Summary
The goal of utilizing munificence in this inquiry was to measure the environmental
resources on the pharmacist supply. This will help to facilitate strategic decisions on the
pharmacist supply. The greater the level of munificence, the more opportunities the environment
provides which tremendously increases organization’s ability to survive and flourish.
It has been noted through multiple studies that there is a plethora of factors that has the
potential to influence the pharmacist supply. The Walton et al. (2004) study determined that
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population and the number of community pharmacy prescriptions were very accurate predictors
of the number of pharmacists.
There have been studies such as Reissman (2004) that look at the elderly and insured
population with certain instances in the study alluding to its impact on the pharmacist supply. In
the majority of the studies reviewed the pharmacists are directly tested against environmental
factors such as facilities, prescriptions filled, or the population. While this is important, it is
imperative to expand the scope of research and examine the pharmacist supply against
environmental factors such as the number of physicians and median household Income.
The ability for physicians to influence the pharmacist supply is not relegated to just
prescriptions written, there are other aspects such as consulting calls, and placement of both on
multidisciplinary teams. The ability to afford one’s healthcare is also vital to this research in
that it has not been addressed whether income levels are predictors of the pharmacist supply.
The evidence in this inquiry will help to determine if the number of prescriptions affects the
pharmacist supply. This inquiry will not only address previous environmental factors but
additional ones as well which will provide empirical evidence for future investigational studies.
Concentration
Concentration describes the level to which resources are evenly distributed. It will be measured
by H8-H12.
H8 There is a positive, linear relationship between hospital beds per 100,000 population
and the pharmacist supply over time.
Equation 8: Pjk = ß0 + ß1j*yearj+ ß2 HospC+

k+

jk

Hospitals provide treatment and care at varying levels, with the level of specialization
having an association with the number of occupied beds and length of stay. The provision of
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tertiary care leads to an increase in occupied beds in a facility. This, in turn, can amplify the
demand for pharmacists who are integral in drug therapy for patients.
In H8 it was hypothesized that the number of hospital beds per 100,000 population would
have a positive, significant impact on the pharmacist supply over time. The analysis conducted
determined that the number of hospital beds per 100,000 population did not have a statistically
tangible impact on the pharmacist supply for the period of time in this study (p=.09). Tables 21
and 22 presented below display the results for H8.
Table 21. Summary of Fixed Effects of Hospital Beds Per 100,000 Population on Pharmacist
Supply, 1995-2007

Effect
Year
Beds

Type 3 Tests of Fixed Effects
Num
Den
F
DF
DF
Value
8
362
21.19
1
377
2.86

Pr > F
<.0001
0.0919

Table 22. Parameter Estimates for Hospital Beds Per 100,000 Population, 1995-2007

Effect

Year

Intercept
Year
Year
Year
Year
Year
Year
Year
Year
Year
Beds

1995
2000
2001
2002
2003
2004
2005
2006
2007

Solution for Fixed Effects
Estimate
Standard Error

DF

t Value

Pr > |t|

8.0145
-0.2893
-0.1429
-0.1236
-0.1001
-0.08353
-0.07624
-0.06405
-0.04063
0
0.000385

74.8
372
364
364
362
361
360
360
360
.
377

46.87
-12.46
-10.2
-8.98
-7.69
-6.65
-6.22
-5.27
-3.34
.
1.69

<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
0.0009
.
0.0919

0.171
0.02322
0.01401
0.01376
0.01301
0.01256
0.01226
0.01214
0.01217
.
0.000228
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The test results for H8 lead to rejection and to conclude that the number of hospital beds
per 100,000 population is not a significant environmental factor impacting the pharmacist
supply. Hospitals with tertiary care services are subject to longer occupied beds days compared
to facilities with less specialized services.
This, in turn, increases the demand for pharmacists whose role has increased with
emphasis on collaborative care and patient interaction (Kaboli, Hoth McClimon, & Schnipper,
2006). The number of pharmacists involved in monitoring patients increased to 84% of hospitals
in the 2008 survey compared to 75% in 2000 with larger bedded hospitals employing a greater
number of pharmacists (Pederson, Schneider & Sheckelhoff, 2009). While these two studies
exhibit hospital beds having a strong impact on the pharmacist supply, the empirical evidence in
this study oppose this premise.
H9 There is a positive linear relationship between the number of pharmacies per 100,000
people and the pharmacist supply over time.
Equation 9: Pjk = ß0 + ß1j*yearj+ ß2 PharmFC+

k+

jk

As noted earlier there are approximately 55,400 community pharmacies in the U.S., More than
50 percent are members of chains and the remainders are independently owned. Chain
pharmacies fall into the following categories: traditional chains (e.g., CVS), mass merchandisers
(e.g., Walmart), and supermarket pharmacies (e.g., Safeway) (Christensen & Farris, 2006).
Hypothesis 9 in the concentration dimension measures the number of pharmacies per 100,000.
population and the pharmacist supply over time. It is hypothesized that the number of
pharmacies per 100,000 population is positively linearly associated with the pharmacist supply
over time. The analysis conducted determined that the number of pharmacies per 100,000
population did not have a statistically significant impact on the pharmacist supply for the period
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of time in this study (p=73). Due to the statistical results, H9 was rejected as a predictor of
pharmacist supply. Chain pharmacies operate approximately 39,000 pharmacies and fill nearly
2.6 billion prescriptions annually, which account for more than 72% of annual prescriptions
filled in the United States (NACDS, 2011). Tables 23 and 24 illustrate the results for H9.
Table 23. Summary of Fixed Effects of Pharmacies Per 100,000 Population on Pharmacist
Supply, 1994-2008.
Type 3 Tests of Fixed Effects
Effect
Num DF
Den DF
F Value
Year
14 619
95.58
Pharmacies per 100,000 population
1
619
0.11

Pr > F
<.0001
0.7387

Table 24. Parameter Estimates for Pharmacies Per 100,000 Population, 1994-2008

Effect
Intercept
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Pharmacies per
100,000 population

Year
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009

Solution for Fixed Effects
Estimate Standard Error DF t Value
8.1675
0.1535 48.4
53.21
-0.3163
0.01351
619
-23.42
-0.2708
0.0135
619
-20.07
-0.2589
0.01342
619
-19.29
-0.2621
0.01342
619
-19.53
-0.2238
0.01342
619
-16.67
-0.1913
0.01351
619
-14.16
-0.1725
0.0136
619
-12.68
-0.1506
0.01341
619
-11.23
-0.1385
0.01327
619
-10.44
-0.133
0.01319
619
-10.09
-0.1227
0.01319
619
-9.3
-0.1009
0.01325
619
-7.62
-0.0611
0.01325
619
-4.61
-0.0276
0.01338
619
-2.06
0 .
.
.
2.1E-05
6.3E-05
619
0.33

Pr > |t|
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
0.0399
.
0.7387

The majority of currently employed pharmacists work for community pharmacies. While
these statistics from the literature point to the magnitude of prescriptions dispensed by chain
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pharmacies, it does not account for the over-the-counter consumers asking questions and needing
behind the counter nonprescription medication. While there are studies in the literature that lend
support to pharmacies as a predictor, the empirical evidence in this study opposes this assertion.
H10

There is a positive linear relationship between the number of office based
physicians per 100,000 population and the pharmacist supply over time.

Equation 10: Pjk = ß0 + ß1j*yearj+ ß2 PharmFC+

k+

jk

Physicians are primarily responsible for almost all of the prescriptions that are written in
the United States. Hypothesis 10 is focused on office-based physicians per 100,000 population,
a variable within the concentration dimension of the population ecology theory. The volume of
scripts being written can impact the workload of pharmacists. In an outpatient or office-based
setting, physicians write a significant amount of prescriptions, thereby leading to a specified
need for pharmacists to meet the demands. It is hypothesized that the number of office-based
physicians per 100,000 population has a positive linear association with the pharmacist supply
over time. The results of the analysis determined that when adjusting for year the number of
office based physicians per 100,000 population does not have an effect on the pharmacist supply
(p=.51). The results are displayed in Tables 25 and 26.
Table 25. Summary of Fixed Effects of Office Based Physicians Per 100,000 Population on
Pharmacist Supply, 1995-2008

Effect
Year
OBDR per
100,000 population

Type 3 Tests of Fixed Effects
Num DF Den DF
F Value

Pr > F

9

405

33.36

<.0001

1

419

0.42

0.5184
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Table 26. Parameter Estimates for Office Based Physicians Per 100,000 Population, 1995-2008

Effect
Intercept
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
OBDR per
100,000 population

Solution for Fixed Effects
Year Estimate Standard
DF
Error
8.2666
0.1989
132
1995 -0.301
0.02134
414
2000 -0.171
0.01449
408
2001 -0.1487 0.01256
405
2002 -0.1286 0.01262
405
2003 -0.1118 0.01227
404
2004 -0.1058 0.01226
404
2005 -0.0929 0.01314
406
2006 -0.0716 0.01261
405
2007 -0.032
0.01251
405
2008
0
.
.
-0.0005 0.00074
419

t Value

Pr > |t|

41.57
-14.11
-11.8
-11.83
-10.19
-9.11
-8.63
-7.07
-5.67
-2.56
.
-0.65

<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
0.011
.
0.5184

The empirical evidence provided by the analysis lead to the rejection of H10. According
to a study by Cherry et al. (2007), physicians wrote 2 billion prescriptions during office visits in
2005. To keep this in perspective, there were approximately 1.5 billion physician office visits in
2008, with approximately 20% of those visits resulting in patients leaving with at least one
prescription (Medical Expenditure Panel Survey, 2010).
These two studies provide support to the argument that office based physicians can be a
strong predictor on the pharmacist supply through the volume of prescriptions physicians
generate. Although the empirical evidence in this inquiry was rejected, there may to be a
potential commensalism relationship between office-based physicians and the pharmacist supply
or an indirect influence.
H11a There is a positive linear relationship between the number of employers and the
pharmacist supply over time.
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H11b1 There is a positive linear relationship between employer size (19 or less employees)
and the pharmacist supply over time.
H11b2 There is a positive linear relationship between employer size (20 or more employees)
and the pharmacist supply over time.
Equation 11a: Pjk = ß0 + ß1j*yearj+ ß2 EmpV +
Equation 11b1: Pjk = ß0 + ß1j*yearj+ ß2 EmpS1+
Equation 11b2: Pjk = ß0 + ß1j*yearj+ ß2 EmpS2+

k+

jk

k+

jk ,

k+

jk ,

Employers play a key role as purchasers and administrators of health insurance for the
working-age population in the United States, with the majority of Americans obtaining their health
insurance through an employer. The following two hypotheses address the employers and influence
on the pharmacist supply. Hypotheses 11a, 11b1 and 11b2 in the concentration dimension is
characterized by the total number of employers and the size of the employer (19 employees or
less, 20 or more employees) respectively. Specifically, it is hypothesized in 11a that the number
of employers is positively linearly associated with the pharmacist supply over time.
In H11a the total number of employers was not found to be significant predictor of the
pharmacist supply (p=.85), therefore H11a was rejected. The results of the statistical analysis on
H11a are illustrated in Tables 27 and 28.
Table 27. Summary of the Fixed Effect of Total Number of Employers on Pharmacist Supply,
1994-2008
Type 3 Tests of Fixed Effects
Effect Num DF Den DF
F Value

Pr > F

Year

14

621

61.83

<.0001

EmpV

1

668

0.03

0.8534
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Table 28. Parameter Estimates for Total Number of Employers, 1994-2008

DF
49.9
628

Pr > |t|
<.0001
<.0001

1994

Year

1995

-0.2882

0.01465

627

<.0001

Year
Year

1996
1997

-0.242
-0.231

0.01441
0.01422

625
624

<.0001
<.0001

Year
Year

1998
1999

-0.2342
-0.1959

0.01417
0.01411

623
623

<.0001
<.0001

Year

2000

-0.1636

0.01411

622

<.0001

Year

2001

-0.1446

0.01393

622

<.0001

Year

2002

-0.1244

0.01386

621

<.0001

Year

2003

-0.111

0.01375

621

<.0001

Year
Year

2004
2005

-0.1057
-0.09531

0.0136
0.01356

620
620

<.0001
<.0001

Year

2006

-0.07364

0.01361

620

<.0001

Year

2007

-0.03389

0.01362

620

0.0131

Year

2008

0

.

.

.

4.41E-08

0

0

.

EmpV

Year

Solution for Fixed Effects
Estimate
Standard Error
8.1343
0.1572
-0.311
0.0148

Effect
Intercept
Year

While the total number of employers was not significant, the measurement of employers
with varying employee sizes yielded mixed results.
In H11b1 and H11b2 it is hypothesized that the size of the employers is positively
linearly associated with the pharmacist supply over time. Employers with 19 or less employees
were found not to be significant (p=.35), and employers with 20 or more employees were found
to be significant predictor when adjusting for year (p=.02). Tables 29-32 display the results of
employer size.
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Table 29. Summary of the Fixed Effect of Employers with 19 or Less Employees on Pharmacist
Supply 1994-2008
Type 3 Tests of Fixed Effects
Effect
Num DF Den DF
Year
14
623
EmpS (19 or less employees)
1
640

F Value
69.09
0.84

Pr > F
<.0001
0.3586

Table 30. Parameter Estimates for Employers with 19 or Less Employees, 1994-2008

Effect

Solution for Fixed Effects
Year
Estimate
Standard
Error

Intercept
Year

1994

8.16
-0.3163

0.157
0.01463

49 <.0001
624 <.0001

Year

1995

-0.2931

0.01456

624 <.0001

Year

1996

-0.2466

0.01441

624 <.0001

Year
Year
Year
Year
Year

1997
1998
1999
2000
2001

-0.2353
-0.2385
-0.2
-0.1675
-0.1484

0.01436
0.01433
0.01431
0.01435
0.01417

624
624
624
623
623

Year

2002

-0.1282

0.01419

623 <.0001

Year

2003

-0.1147

0.01409

623 <.0001

Year

2004

-0.109

0.01394

623 <.0001

Year

2005

-0.0953

0.01352

622 <.0001

Year

2006

-0.0734

0.01359

622 <.0001

Year

2007

-0.03342

0.01359

622

Year

2008

EmpS1 (19 or less employees)

DF

0 .
-1.75E-07
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.
0

Pr > |t|

<.0001
<.0001
<.0001
<.0001
<.0001

0.0142
.

0 .

Table 31. Summary of the Fixed Effect of Employers with 20 or More Employees on
Pharmacist Supply 1994-2008

Effect
Year

Type 3 Tests of Fixed Effects
Num
Den
DF
DF
14
623

EmpS2 (20 or more employees)

1

645

F Value

Pr > F

87.37

<.0001

5.15

0.0236

Table 32. Parameter Estimates for Employers with 20 or More Employees, 1994-2008

Solution for Fixed Effects
Effect
Year
Estimate
Standard
Error
Intercept
8.0993
0.1492
Year
1994
-0.3148
0.01392
Year
1995
-0.2925
0.01395
Year
1996
-0.2472
0.01392
Year
1997
-0.238
0.01407
Year
1998
-0.2416
0.0141
Year
1999
-0.204
0.01418
Year
2000
-0.1724
0.01435
Year
2001
-0.1534
0.01418
Year
2002
-0.1351
0.01444
Year
2003
-0.1221
0.01442
Year
2004
-0.118
0.01454
Year
2005
-0.09254
0.01359
Year
2006
-0.07216
0.01361
Year
2007
-0.03358
0.01359
Year
2008
0
.
EmpS2 (20 or more employees)
9.25E-07
0

DF

Pr > |t|

48.6
622
622
622
623
623
623
623
624
624
625
625
622
622
622
.
0

<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
0.0137
.
.

The test results lead to the rejection of H11a, and 11b1, while accepting H11b2 and
concluding that the number of employers is not a significant environmental factor impacting the
pharmacist supply. However, the size of the employers can be a significant predictor in this
regard. Findings in the literature have determined that large employers have significantly more
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employees who obtain healthcare coverage through their employer compared to smaller
employers (SHADAC, 2011). Previous research provides credence to the empirical evidence
found in H11b1 and H11b2, which helps one to deduce that employers wield a considerable
amount of purchasing power in the healthcare arena, and consequently, may substantially impact
the pharmacist demand and supply. The increase in the number of large employers affects the
supply, by having the potential to offer more types of drug coverage which has the propensity to
increase medication demand, while the increase in the number of small employers does not
provide the same influence.
H12 There is a positive linear relationship between the number of insured and
pharmacist supply over time.
Equation 12: Pjk = ß0 + ß1j*yearj+ ß2 Ins+

k+

jk

The number of insured is significant in determining one’s ability to obtain prescriptions
which facilitates a pharmacist’s workload and pharmacist demand. Hypothesis 12 focuses on the
insured population and is the last variable in the concentration dimension being measured as part
of the population ecology theory. In H12 it is hypothesized that the number of insured would
have a positive, significant impact on the pharmacist supply over time. The number of insured
was found to have a significant, statistically discernible impact on the number of licensed
pharmacists with instate addresses during the 16--year period covered by this inquiry (p=.17).
Table 33 provides the summary of repeated measures analysis on the number of insured .
The parameter estimate results of the number of insured is presented in Table 34. The empirical
evidence provided in this inquisition leads to acceptance of H12.
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Table 33. Summary of the Fixed Effect of Number of Insured on Pharmacist Supply, 1994-2009

Effect

Type 3 Tests of Fixed Effects
Num
Den
F
DF
DF
Value

Pr > F

Year

15

663

72.21

<.0001

Insured

1

711

5.66

0.0176

Table 34. Parameter Estimates for Number of Insured, 1994-2009

Effect
Intercept
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Insured

Year
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009

Solution for Fixed Effects
Estimate Standard Error
8.0876
0.1483
-0.3294
0.01457
-0.307
0.01451
-0.2612
0.01438
-0.2502
0.01436
-0.2539
0.01431
-0.2184
0.01406
-0.1867
0.01408
-0.1677
0.0139
-0.1479
0.01388
-0.1353
0.01378
-0.1307
0.01366
-0.1209
0.01364
-0.0995
0.0137
-0.0608
0.01368
-0.0276
0.01383
0
.
1.6E-05
6.62E-06
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DF
49.9
668
667
667
667
666
664
663
663
663
662
662
662
662
662
662
.
711

Pr > |t|
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
0.046
.
0.0176

The results of the analysis corroborates with previous research findings that the insured
population has an impact on the pharmacist supply. One example of insurance coverage impact
on the pharmacist supply is the implementation of Medicare Part D which helps make 14 to 30
million prescriptions available monthly at a cost savings to persons who may not have been able
previously to afford their prescription drugs (Kostick, 2006).
In addition, the healthcare reform act would offer health insurance to an estimated 32
million previously uninsured people which would drive up the demand (Wechsler, 2010). These
two studies in the literature add credence to the empirical evidence found in this investigation.
Pharmacist Supply Concentration Summary
Concentration describes the level to which resources are distributed. As with the goals
specified in the munificence summary the primary interests in concentration revolve around
applicability to the pharmacist supply. Organizations and entities that impact the distribution of
resources include pharmacies, hospitals, physicians, and employers. The number of hospitals
beds per 100,000 Population is of interest as it has been noted in several studies that more
hospitals are making a concerted effort to increase the number of pharmacists they have to be
part of their healthcare teams for monitoring patients (Pederson et al., 2009).
Measurement of chain pharmacies per 100,000 population had the potential to add
considerable insight into the pharmacist supply. It was noted by NACDS (2011) that the chain
pharmacies which are a part of their organization, operate approximately 39,000 pharmacies, and
fill nearly 2.6 billion prescriptions annually, and account for more than 72% of annual
prescriptions in the United States. The majority of currently employed pharmacists work for
community pharmacies. While these statistics from the literature point to the magnitude of
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prescriptions dispensed by chain pharmacies, it does not account for the over-the-counter
consumers asking questions and needing behind the counter nonprescription medication.
Measurement of the pharmacies per 100,000 population helps to directly examine the part
of the pharmacy consumer and pharmacist workload not captured by the sheer number of
prescriptions filled.

Analysis of the office based physicians provides a more detailed

interpretation of physicians on the pharmacist supply.
This is an important measurement since according to a study by Cherry et al. (2007),
physicians wrote two billion prescriptions during office visits in 2005. The two hypotheses that
were statistically significant in the concentration dimension were the size of employers (20 or
more employees) and the number of insured.

Nearly 60% of people with employer-sponsored

health insurance coverage obtain it through large employers compared to slightly more than one
in four persons with smaller employers (SHADAC, 2011). The evidence provided by this study
corroborates the results in our inquiry. In addition another study was conducted on Medicare
beneficiaries reported that drug coverage was associated with a 9.6% Increase in the probability
of any prescription use (Huh, Rice, & Ettner, 2008).
The most prominent outcome of a larger percentage of persons having coverage for
prescription drugs is likely to lead to an increased volume of prescriptions being written, which
will increase demand for more pharmacists and pharmacy personnel (Vivian, 2010). These
several studies demonstrate that employer size and the numbers of insured have an impact on the
pharmacist supply which supports the empirical evidence in this study. The results from this
inquiry will factor in the determination of the need to recruit pharmacists based upon the number
of insured in your service area in conjunction with the type and size of employers that are in the
service area.
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Density.
Density explains the interactions between organizations in a community. It will be measured by
H13.
H13

Is there a change in the pharmacist supply overtime.
The last hypothesis measured density in the pharmacist supply. Testing H13 was to

determine if there is change in pharmacist population overtime. Some states had big spurts in
growth from one year to the next year. In order to attain the correct results, the bonferroni
correction, was utilized in order to account for the 14 differences that were tested. Based upon
the bonferroni correction the significance level was calculated as .0035.
Overall, the pharmacist supply continued to rise at a consistent pace throughout the years,
with their seeming to be no impact on its growth from the previous year supply levels. It is
important to point out that while the pharmacist supply continued to grow steadily over the
timeframe researched, there were only two years that were statistically significant 1995-1996
(p=.0008) and 2006-2007 (p=.0029). The results of the analysis are presented in Tables 35-38.
Table 35. Year Significance Test Results
Type 3 Tests of Fixed Effects

Effect
Year

Num
DF
15

Den
DF

F Value

666
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Pr > F
104.1 1995 –1996,
.0008
2006 – 2007,
.0029

Table 36. Year Parameter Estimate Results

Effect

Year

Estimate

Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year

1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009

7.8289
7.8518
7.8981
7.9092
7.906
7.9444
7.977
7.9962
8.0165
8.0296
8.0351
8.0456
8.0674
8.1072
8.1411
8.1683

Least Squares Means
Standard
DF
Error
0.1535
48.4
0.1535
48.4
0.1535
48.4
0.1535
48.4
0.1535
48.4
0.1535
48.4
0.1535
48.4
0.1535
48.4
0.1535
48.4
0.1535
48.4
0.1535
48.4
0.1535
48.4
0.1535
48.4
0.1535
48.4
0.1535
48.4
0.1535
48.4

Pr > |t|
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001
<.0001

Alpha Lower
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05

7.5203
7.5432
7.5895
7.6006
7.5974
7.6358
7.6684
7.6876
7.7079
7.721
7.7266
7.7371
7.7588
7.7987
7.8326
7.8597

Upper
8.1375
8.1604
8.2066
8.2178
8.2146
8.253
8.2856
8.3048
8.3251
8.3382
8.3437
8.3542
8.376
8.4158
8.4497
8.4769

Table 37. Yearly Change in Parameter Estimates

Effect
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year
Year

Year
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008

Year
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009

Differences of Least Squares Means
Estimate Standard Error DF Pr > |t|
-0.023
0.01379
666 0.0964
-0.0462
0.01372
666 0.0008
-0.0111
0.01363
666 0.4141
0.00322
0.01363
666 0.8133
-0.0384
0.01363
666 0.005
-0.0327
0.01372
666 0.0176
-0.0192
0.01365
666 0.1606
-0.0203
0.01348
666 0.1329
-0.0131
0.01342
666 0.3284
-0.0055
0.01328
666 0.6772
-0.0105
0.0132
666 0.427
-0.0218
0.01328
666 0.1015
-0.0398
0.01334
666 0.0029
-0.0339
0.0135
666 0.0123
-0.0272
0.01381
666 0.0494
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Alpha
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05

Lower
-0.05
-0.0732
-0.0379
-0.0236
-0.0652
-0.0596
-0.046
-0.0468
-0.0395
-0.0316
-0.0364
-0.0478
-0.066
-0.0604
-0.0543

Upper
0.00412
-0.0193
0.01563
0.02999
-0.0116
-0.0057
0.00763
0.00619
0.01322
0.02055
0.01543
0.0043
-0.0137
-0.0074
-7E-05

Table 38. Natural Log of Pharmacist Supply Growth Estimate Over Time

Pharmacist Supply (Natural Log)

Growth Estimate

8.2
8.1
8
7.9
7.8
7.7
7.6
1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Estimate 7.83 7.85 7.9 7.91 7.91 7.94 7.98

8

8.02 8.03 8.04 8.05 8.07 8.11 8.14 8.17

Summary of Findings
The pharmacist supply was measured over time to attain an understanding of the
environment’s impact on it. Of the 13 hypotheses posited in this inquiry, five were accepted as a
result of the empirical testing. The size of the population and the number of hospitals were the
two variables found to be statistically significant when measuring munificence. Previous
research has corroborated the empirical evidence found in this study that the population is a focal
point when determining predictors of pharmacists supply (Knapp, Shah, & Barnett, 2010;
Manolakis, & Skelton, 2010). The second hypothesis in munificence that was statistically
significant was the number of hospitals.
It seems that the consensus among hospitals to address concerns related to rising multidrug therapy regimens and medication safety is to employ additional pharmacists (Pederson,
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Schneider, & Scheckelhoff, 2009). This trend in one setting in which pharmacists work is
characterized by its positive, linear association with the total number of pharmacists.
Employers with 20 or more employees and the number of insured were the variables
found to be statistically significant when measuring concentration. Employers with 20 or more
employees were found to be statistically significant. This result is further supported by previous
empirical evidence that larger employers are more likely to offer health/medication coverage
than smaller employers.
This leads to a potential causal relationship where larger employers equate to more
coverage which translates to more prescription utilization and pharmacists. Empirical evidence
from this inquiry provided the basis for accepting the hypothesis regarding the relationship
between the number of insured and the total number of pharmacists. This finding is
consistent with empirical findings in the extant literature on the pharmacist supply reported
by previous investigators. Insurance coverage impact on the pharmacist supply is exemplified in
two studies which showed that Medicare Part D helped make 14 to 30 million prescriptions
available monthly at a cost savings to persons who may not have been able previously to afford
their prescription drugs and it increased the probability of any prescription use by 9.6% (Kostick,
2006; Huh, Rice, & Ettner, 2008). In addition, other studies have reported an increase in
prescription drug utilization and pharmacist workload when accounting for insurance coverage
(Huh, Rice, and Ettner, 2008; & Geib, 2007).
The last hypothesis pertained to pharmacist growth over time. The pharmacist supply
exemplified a change in supply over the timeframe analyzed with two segments of the timeframe
being significant based upon the threshold established by the bonferonni correction. The results
of the hypotheses are summarized in Table 39.
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Table 39. Summary of Hypotheses Tested

Hypotheses
H1
H2
H3
H4
H5
H6
H7
H8
H9
H10
H11a
H11b1
H11b2
H12

H13

Variable
Munificence
Pop
Pop65+
Hosp
PharmF
Rx
Phys
MHI
Concentration
HospC per 100,000 population
PharmFC per 100,000 population
OBDR per 100,000 population
EmpV
EmpS1 (19 or less employees)
EmpS2 (20 or more employees)
Ins
Density
Year

Status

F Value

Pr > F

Accepted
Rejected
Accepted
Rejected
Rejected
Rejected
Rejected

4.13
3.4
7.51
2.23
2.34
0.49
0.02

0.0426
0.0657
0.0064
0.1362
0.1263
0.4832
0.8976

Rejected
Rejected
Rejected
Rejected
Rejected
Accepted
Accepted

2.86
0.11
0.42
0.03
0.84
5.15
5.66

0.0919
0.7387
0.5184
0.8534
0.3586
0.0236
0.0176

104.1

1995 –1996, .0008
2006 – 2007, .0029

Accepted
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Chapter 6: Discussion

The purpose of this study was to assess the feasibility of using the population ecology
theoretical framework to examine the impact of environmental factors on the pharmacist
supply.
Munificence Results
The first environmental dimension, munificence, is addressed in hypotheses H1-H6.
Hypothesis 1 addressed the impact of population size on the pharmacist supply. A test of H1
revealed that there is a positive, linear relationship between size of the residential population and
the pharmacist supply; as a result H1 was accepted. This finding is consistent with other findings
in the literature. The primary source for a pharmacist supply to sustain itself is a viable patient
population. It is logical and reasonable to expect that as the size of the residential population
increases there is likely to be a corresponding increase in the patient population. A larger patient
population may lead to a greater demand for prescriptions to be dispensed and, thus, an increased
demand for the services of pharmacists.
H2 focused on a subset of the population. This hypothesis addressed the impact of the
elderly on the pharmacist’s supply. The results were not statistically significant and, therefore,
divergent from the expectations that the elderly (65+ years old) population could impact
pharmacist supply. This was a surprising result considering the volume of prescriptions utilized
by the elderly population, which has been referenced in previous studies (Kaiser Family
Foundation, 2011; Stagnitti, 2007).
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It is important to note that although this result was not significant, this population
continues to grow and may be of interest as healthcare insurance policies are adjusted over the
next several years. This surprising finding may be attributed to several environmental factors
such as the impact of Medicare Part D and the fact that the baby boomer generation is just
starting to comprise a substantial proportion of the elderly population. Future research focusing
on environmental factors affecting the pharmacist supply should include a closer examination of
these factors.
H3 addressed the impact of hospital facilities with pharmacies and was accepted. The
increased utilization of hospital-based pharmacists on treatment teams appears to be a significant
environmental factor that may impact the pharmacist supply. This finding points to the fact that
pharmacists have a wider range of responsibilities in the hospital setting and they are expected to
apply their extensive pharmaceutical expertise to ensure optimal drug therapy outcomes and to
minimize medication errors in the hospital setting.
The impact of clinical pharmacists in hospitals has been documented in the literature and
findings from this inquiry are consistent with previous empirical findings regarding the role of
clinical pharmacists in hospital settings. In direct contrast to hospital settings, the number of
retail pharmacies was not found to be a significant environmental factor affecting the pharmacist
supply. H4 was rejected. This result was unexpected and surprising. The reason for this finding
is not immediately clear. It will be imperative to include this variable in future research on
environmental factors affecting the pharmacist supply. One possible explanation may be that
retail pharmacies are utilizing alternative manpower solutions to meet growing demands for
pharmacist services.
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Retail pharmacies appear to be searching for and implementing innovative and creative solutions
that involve an increased reliance on pharmacy technicians and advanced technology
(automation, robotics, electronic transmission of prescriptions) to handle the growing volume of
prescriptions to be filled. Such strategies may satisfy the demands of growing prescription
volume while at the same time having a neutral or negligible economic impact on the bottom line
of retail pharmacies. Although the implementation of advanced technology may initially be
expensive, retail pharmacies may be able to realize greater profit margins in the long-term
because pharmacy technicians are substantially less expensive than pharmacists. Future research
will need to examine these strategic choices in greater detail so that there will be a clearer,
empirically based understanding of their impact on the pharmacist supply. Downsides of these
strategic decisions include an increased propensity for medication errors and reduced
opportunities for pharmacist-patient interactions.
The volume of prescriptions being filled was not found to be a significant environmental
factor impacting the pharmacist supply. Consequently, H5 was rejected. Previous findings in
the extant literature on the pharmacist supply suggested that there indeed is a statistically
significant, linear relationship between the number of prescriptions filled and the pharmacist
supply. In light of the results from this inquiry, more empirical studies will be needed to clarify
the impact of this variable on the pharmacist supply. One possible explanation for this finding is
that, although the volume of prescriptions to be filled is growing, it has not reached the threshold
at which its impact can be discerned in light of other environmental factors affecting the
pharmacist supply. More empirical evidence is needed in order to reach more conclusive
findings regarding prescription volume and the pharmacist supply.
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It appears that there may be a significant interaction between prescription volume and the
number of prescriptions that can be reasonably filled by a single pharmacist during a shift.
Future studies should explore this possibility by including an interaction term in statistical
models purporting to explain the impact of environmental factors on the pharmacist supply.
H6 explored the relationship between the physician supply and the pharmacist supply.
The test of H6 revealed no statistically significant relationship between the total number of
physicians and the pharmacist supply. Consequently, H6 was rejected. In light of the fact that
physicians write the overwhelming majority of prescriptions to be filled in the U.S., it seemed
logical that this environmental factor could have a statistically discernible impact on the
pharmacist supply. It seems plausible that as the physician population increases there will be an
increase in the number of prescriptions written and, in turn, an increased demand for pharmacists
to keep pace with the growing volume of prescriptions to be filled. Although this association
was not confirmed in this inquiry, future research should continue to explore this relationship.
The number of physicians, total number of pharmacists and the volume of prescriptions
being written are all expected to continue to increase in coming decades. One possible
explanation for the finding in this inquiry may be that, while physicians do write a large number
of prescriptions, a large portion of these prescriptions may never be filled. Thus, there may not
be a sufficient enough increase in prescription volume to increase the demand for pharmacists.
Paramount among the reasons a patient may choose not to have one or more of their
prescriptions filled is a lack of insurance or a means of paying to have a prescription filled.
Improved methodological approaches for exploring the relationship between the
physician supply and the pharmacist supply may shed more light on this relationship and enable
the ability to reach more tenable conclusions and consensus regarding the impact of the
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physician supply on the pharmacist supply. Such methodological approaches may include better
predictive models and a means of controlling for possible intervening variables that could
confound the presumptive relationship between the physician supply and the pharmacist supply
in a population ecology framework.
Wealth of the community was the final environmental factor that was believed to have
an impact on the pharmacist supply. It is hypothesized that there would be a positive, linear
relationship between wealth of the community and the pharmacist supply. A test of H7 caused
the rejection of this hypothesis. It was not a statistically significant relationship between wealth
of the community (indicated by median household income) and the pharmacist supply in this
inquiry. This finding contradicts our premise that increasing community wealth will lead to an
increased demand for pharmacists. It was our contention that wealthier communities could better
afford prescription medications and are more likely to get their prescriptions filled compared to
less wealthy communities. Future research into the environmental factors impacting the
pharmacist supply may need to test for an interaction effect involving number of prescriptions,
insurance status and wealth. Additionally, future models may need to also control for
community health status. It is well-known in the health services literature that health status and
income (one indicator of wealth) are inversely related.
Concentration Results
Concentration describes the level to which resources are evenly distributed. H8 was the
first hypothesis tested in the concentration dimension and it explored the relationship between
hospital beds per 100,000 population and the pharmacist supply. This variable was not found to
be statistically significant and lead to the rejection of H8. This finding is surprising in light of
the fact that the number of hospitals was found to be a significant environmental factor
126

impacting the pharmacist supply. Future research may need to explore the relationship between
hospital size and the pharmacist supply to shed more light on how this dimension affects the
pharmacist supply. One possible explanation for this finding may be that the number of hospital
beds per 100,000 may not be as pertinent a point in measuring pharmacist supply as are factors
within a hospital, such as the type of services they provide and their patient mix. These hospital
attributes may prove to be more important antecedents to the pharmacist supply than the size of
the hospital.
The number of pharmacies per 100,000 population was the next indicator of
concentration that was examined in this inquiry and it was the focus of H9. As was the case for
H8, a test of H9 did not yield statistically significant results and it was rejected. It seemed
logical that as the ratio of pharmacy facilities to the population increase there would be more
pharmacist positions to fill and, thus, the pharmacist supply would increase. The primary source
for a pharmacist to sustain himself or herself is a viable patient population and the setting in
which those services will be rendered. Community-based pharmacies would appear to meet that
need for practicing pharmacists. Although not significant in this inquiry, this variable should be
explored in future studies seeking to understand how environmental factors impact the
pharmacist supply. It may be helpful in such studies to control for type of pharmacy facility
(e.g., grocery stores, wholesale warehouses and mail-order).
The third indicator of concentration that was explored in this inquiry was the number of
office-based physicians per 100,000 population. It is hypothesized that there is a positive, linear
relationship between the number of office-based physicians per 100,000 population and the
pharmacist supply. This relationship was the focus of H10. Based on the results from testing
H10, it was rejected it and concluded that the number of office-based physician per 100,000
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population is not a significant environmental factor affecting the pharmacist supply. Although
the number of office-based physicians per 100,000 population continues to increase, it does not
impact the growth of the pharmacists supply. This may be due to the supply of pharmacists
being able to handle the increased volume of prescriptions at this juncture; possibly augmented
by medication dispensing technology and pharmacy technicians (Adams, Martin, & Stolpe,
2011). The specific types of physicians along with their patient mix may provide a better
barometer of how the number of office-based physicians per 100,000 population may impact the
pharmacist supply and should be explored in more detail in future studies.
Hypotheses 11a and 11b address employer concentration levels. Employers are the
primary source of health insurance coverage. H11a focused on employer volume (number of
employers) and was rejected. The number of employers does not have a significant impact on
the pharmacist supply. Although the numbers of employers was not found to be significant,
employer size does appear to have a significant environmental impact on the pharmacist supply.
H11b1 and H11b2 focused on employer size, with H11b1 being rejected, and H11b2
being accepted based upon test results. Large employers (20 or more employees) were found to
have a statistically significant effect on the pharmacist supply. Two separate repeated measures
regression equations were solved to reach this conclusion. Results were not statistically
significant for the equation that included employers with 19 or fewer employees. Large
employers have at least two advantages over their smaller counterparts: (1) they are more able to
offer health coverage and (2) they can offer better medication insurance coverage. Small
employers who may have predominantly lower-wage workers are much less likely to offer health
insurance since the greater cost of underwriting and administering coverage for each enrollee in a
small workforce adds to the cost of the premium.
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H12 addressed insurance coverage and was accepted based on test results. Insurance
coverage was found to be a statistically significant environmental factor affecting the pharmacist
supply. The impact of increased insurance coverage for prescription drugs has resulted in a
significant increase in prescription volume. Health insurance is usually the primary source for
paying for prescriptions. The ability to pay for prescriptions through insurance coverage plays a
vital role in the volume of prescriptions to be filled, which in turn plays a role in the need for
pharmacists. This result places emphasis on the importance of insurance as individuals decline
filling prescriptions due to lack of insurance. Increased access to prescription drugs through
insurance coverage appears to impact the pharmacist supply.
Density Results
Hypotheses H1-H12 explored the impact of munificence and concentration the
pharmacist supply. H13 was the final hypothesis tested in this inquiry. A test of H13 sought to
answer the question of whether there was a statistically significant change in the pharmacist
supply over the 16-year time period of this inquiry. This question addresses the dimension of
density in the population ecology theoretical framework.
In this inquiry the pharmacist supply was treated as an organization within the context of
the population ecology theoretical framework. It is important to note that, while the environment
plays a role in determining the ebb and flow of organizations, in this instance the pharmacist
supply, it is important to determine what type of impact changes in the organization has on the
organization over time. For instance, does the organization have different factions, and if so,
what types of interactions exist among these factions (e.g. symbiosis, commensalism,
competition). In the case of the pharmacists supply, it seems that if there are any factions they
may likely be work milieu and degree of specialization. Competition at some level is plausible
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given the primary functions all pharmacists are capable of performing. However, this is most
likely to occur when there is a scarcity of resources.
An examination of the possible factions mentioned above with regard to the pharmacist
supply is beyond the scope of this inquiry. The test of H13 was performed to answer the
question of whether there was a statistically significant change in the pharmacist supply between
the first year of the time period for this inquiry (1994) and the last year (2009). If that is the
case, there will be some indication of the extent to which the past pharmacist supply impacts
future supply.
Hypothesis 13 was accepted and it was concluded that the past pharmacist supply does
impact the future supply. Future studies will need to consider the roles of the factions mentioned
above in this relationship. Overall, the pharmacist supply continued to rise at a consistent pace
across the years in the period of time covered by this inquiry. Aside from the statistically
significant change in the pharmacist supply between 1994 and 2009, there was a significant
change for two other years within the time period for this inquiry when the bonferonni correction
was applied: 1995-1996 and 2006-2007.
Possible reasons for the continuous growth of the pharmacist supply between 1994 and
2009 include: (1) expansion of the scope of practice, (2) expanded practice settings, (3) an
increase in the number of pharmacy schools and increased class sizes within schools and (4) a
higher influx of international pharmacy graduates who meet licensure requirements and become
licensed to practice in the U.S.
Summary of Hypothesis Testing
H1-H7 addressed the munificence dimension of the population ecology framework. H8H12 addressed the concentration dimension. H1 and H3 were accepted and it was concluded that
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the size of the population and the number of hospitals are significant munificence factors
affecting the pharmacist supply.
H11b2, H12 and H13 were accepted. Employers with 20 or more employees and having
insurance were found to be significant concentration factors affecting the pharmacist supply
between 1994 and 2009. Previous pharmacist supply was found to significantly affect future
supply.
Implications
Theoretical Implications.
The theoretical framework utilized in this inquiry has been used by organization theorists
to determine how environmental factors impact organizations in the restaurant, newspaper and
health care industries in the past. The population ecology theory has both benefits and
limitations when it is applied to the study of the pharmacist supply. Among the benefits, the
population ecology theory enables the ability to explore the impact of environmental factors on
the pharmacist supply overall as well as specific subsets of it (e.g., mail order pharmacists, retail
pharmacists). The inclusion of carrying capacity helps to ensure that the role of the environment
on the pharmacist supply can be explored in terms of dimensions such as munificence (e.g., the
residential population) and concentration (e.g., pharmacies per 100,000 population).
The use of the population ecology framework in this inquiry provides an opportunity to
expand the use of this theory to shed more empirical light on the impact of environmental factors
on the healthcare workforce. The exploration of the density construct within the healthcare
industry is particularly promising. In density, all organizational members are assumed to be
equivalent in terms of measuring competition for resources. This, however can have the ability
to lead to some misinterpretation due to the fact not all members of an organization are equally
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competitive. A second area in which the population ecology theory may not be beneficial in the
measurement of the pharmacist supply is where a pharmacist may have two competing roles such
as a retail pharmacist at day and a mail order pharmacist at night serving the same population.
For instance how can the size of populations or resource space be determined if they work as
retail pharmacists during the day and mail order pharmacists at night servicing the same
geographical population?
Future studies should include an analysis of specialties within the profession of pharmacy
and additional healthcare providers that may impact the pharmacist supply.
Methodological Implications.
Treating the pharmacist supply as an organization and examining it within the population
ecology theoretical framework appears to have been a suitable methodological approach for
examining environmental factors affecting the pharmacist supply. The profession of pharmacy is
broad enough in scope so that it is amenable to being examined from the perspective of the
various dimensions of the population ecology theory.
Growing specialization within the profession has expanded the practice settings for
pharmacists and they can be found in a number of settings in which they are able to perform
basic and advanced functions. Although the population ecology framework has been used in
previous studies of various industries, its use in the healthcare industry has been limited. This
framework was particularly amenable to employing repeated measures as a means of testing
empirically based hypotheses to shed light on how various environmental dimensions affect the
pharmacist supply over time (e.g., munificence, concentration and density).
Understanding how the pharmacist supply is impacted individually and collectively by
environmental factors will yield fertile ground for more sophisticated statistical and
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methodological approaches to examine this topic in the future. The use of a 16-year time frame
for this inquiry was a noteworthy departure from previous studies that have used as few as two
years. Longer time periods allow the ability to obtain a more accurate picture of the impact of
environmental factors on the pharmacist supply.
Health Policy Implications.
The pharmacist workforce continues to grow and diversify into a myriad of disciplines as
demands for pharmaceutical services has entered specialty areas such as geriatrics, oncology, and
radioactive pharmaceuticals.
Numerous studies have reported that an increase in prescription drug utilization and
pharmacist workload occurs when the proportion of the resident population with insurance
coverage increases. The passage of the Affordable Care Act and its gradual implementation over
the next several years is expected to have a very significant and discernible impact on this well
established relationship. It is estimated that 32 million previously uninsured people will become
insured as a result of the Affordable Care Act. No doubt this fact will significantly change the
pharmacist workforce landscape. It is likely that with the growth in insurance coverage, the
pharmacist supply will grow as well and pharmacists will be presented with additional practice
opportunities in more practice settings. Another environmental factor that could potentially
impact the pharmacist supply in coming years is the increase in the elderly segment of the
residential population. Although this was not found to be a significant environmental factor in
this inquiry, it should be explored in future studies of the pharmacist supply as it has been found
to be significant in past studies. If it is a significant environmental factor, it will no doubt have a
profound impact on the pharmacist supply with important health care policy implications.
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The practice of defensive medicine is a third environmental factor that may warrant
exploration in futures studies of the pharmacist supply in the context of the population ecology
theory. Defensive medicine refers to situations in which physicians prescribe medications to
ensure that they have covered every possibility; even in circumstances wherein prescription
medications may not be indicated.
The implementation of Medicare Part D is projected to result in an increase of 14 to 30
million prescriptions to be filled monthly (Kostick, 2006). While the healthcare reform act will
not just provide healthcare services to the elderly, one must be cognizant of the potential increase
in the prescription volume and the demands that are accompany this influx of potentially new
patients.
Managerial/Administrative Implications.
Growth in the pharmacist supply as a result of the reasons mentioned above has
implications for healthcare executives, managers and personnel administrators. These
individuals will face various challenges as they strive to manage a larger, increasingly more
complex pharmacist workforce. They will need to keep abreast of changes in their environment
as they attempt to meet the needs of their professional workforce and dynamic patient/customer
population. An understanding of the demographic changes in their complex work environments
will enable executives and managers to respond more rapidly and appropriately to their practice
environments. A thorough knowledge of their work and practice environments will enable them
improve patient care and healthcare efficiency.
Pharmacy managers may need to develop more innovative strategies and pursue new
means of finding and hiring pharmacists to meet the needs of their practices (e.g., professional
recruitment agencies). Pharmacy schools have increased their class sizes in an attempt to meet
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the needs for pharmacist’s services in a growing resident population. Hospitals managers will
possibly need to award bonuses and other incentives to attract new hires, which may include
payment for relocation expenses and tuition assistance. It is imperative for pharmacy schools to
align their programs to meet the demands of hospitals as they try to curtail medication errors and
decrease mortality and morbidity rates.
The number of large employers and the number of insured both impact the pharmacist
supply. Large employers are more apt to provide insurance coverage, hence the potential to
increase prescriptions. Incentives directed toward retention and recruitment would be the staple
for managers where they may have to utilize salary increases, stay-on bonuses, and tuition
assistance for pharmacists. An additional bargaining tool may be the current or future influx of
large employers which will increase the hiring organization’s argument that they will have not
only a sufficient workload, but possibly the ability to give presentations at these facilities on
various medication topics. The questions that help determine and form their strategic goals/plans
are: how many pharmacists are needed at my hospital and will it improve the quality of care in
the community? Is the number of pharmacists in my community sufficient to address the number
of insured and physicians in the geographical area? Evaluating one’s environmental needs will
help to ensure that a practical plan is developed. This should help to guarantee that an
appropriate number of pharmacists are available to meet the current and changing demands of
their surrounding environment.
Limitations
The data used in this inquiry came from a number of sources. While the data were
sufficient to conduct the tests described in this inquiry, it should be noted that the two limitations
of the data. The first limitation relates to the prescription fill data obtained from NACDS.
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NACDS data come only from retail pharmacies that are members of the association. Future
studies should attempt to use as many sources as possible in order to get the most accurate,
comprehensive, unduplicated prescription fill data available.
Although the NACDS prescription fill data were sufficient for this inquiry, it should also
be noted that the conclusions are based on using these data may not be as generalizable as might
have been preferred. NACDS members represent a subset of prescription fill data sources in the
U.S. There is no single retail database of prescription fill data in the U. S. Should such a
database become available in the future, it will be very useful for inquiries such as this one. The
best source of data on prescriptions filled in institutional settings comes from medication orders
in hospitals. As is the case with retail prescription fills data, there is no single source of
prescription fill data for institutions. One problem with medication orders data is that a single
medication order may represent one to twenty separate prescriptions (DHHS, 2000). The
availability of more representative prescription fill data will greatly enhance studies of the
pharmacist supply in the future.
The second limitation of the data used in this inquiry was that there was no inclusion of
pharmacy technicians. Pharmacy technicians can perform a variety of tasks under the
supervision of a pharmacist. It is reasonable to assume that if a single pharmacist can supervise a
number of pharmacy technicians at a time, there may be less of a need for pharmacists and this
will impact the pharmacist supply.
Future studies of environmental factors impacting the pharmacist supply should include
data on pharmacy technicians. These health care workers have extensive training and provide
extensive support in the practice environment (Manasse & Speedie, 2007). There does not seem
to be an accurate source for tracking the technician workforce. The inclusion of more
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representative prescription fill data and data on pharmacy technicians should greatly enhance
future studies of the pharmacist supply and factors that impact it.
Future Research
The primary goal of this inquiry was to determine the feasibility of using the population
ecology theory to explore the impact of environmental factors on the pharmacist supply in the
U.S. Thirteen hypotheses were generated from a review of the literature and tested in this
inquiry. H1-H7 examined factors from the munificence construct of the population ecology
theory. As a result of testing these hypotheses H1 and H3 were accepted and it was concluded
that the size of the residential population and the number of hospital facilities are significant
munificence factors impacting the pharmacist supply.
H8-H12 examined the concentration construct of the theory. Tests of these hypotheses
resulted in acceptance of H11b2 and H12. It was concluded that employers with 20 or more
employees and having health insurance significantly impact the pharmacist supply. With regard
to density, H13 was accepted and it was concluded that past pharmacist supply significantly
impacts future pharmacist supply.While the findings from this inquiry are believed to be
contributions to the literature on environmental factors affecting the pharmacist supply, future
research should also take into account several additional variables. The first of these is physician
specialty (e.g. orthopedics, surgery, psychiatry etc.). The physician population was not found to
be a significant factor affecting the pharmacist supply in this inquiry. The inclusion of physician
specialty in future research may shed more light on the impact of this variable. Second, if the
data are available, it would be informative to have more data on pharmacist practice settings and
include such data in predictive models (e.g. retail pharmacists, mail-order pharmacists).
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Third, instead of using a dichotomous variable for insurance coverage, it might be
insightful to use type of coverage (e.g. HMO, PPO, etc). Fourth, if the data are available, it
would be advantageous to include information on pharmacy technicians in future studies.
Pharmacy technicians comprise an integral component of manpower in hospital and retail
pharmacy settings. The inclusion of pharmacy technician data in future studies is very important
because increasing number of states are introducing and enacting laws to expand the scope of
practice of pharmacy technicians. One example of this emerging trend is a tech-check-tech
(TCT) system, where a technician’s accuracy is reviewed by another technician as opposed to a
pharmacist (Adams et al., 2011; Reed, Thomley, Ludwig, & Rough 2011). This trend may have a
very significant impact on the pharmacist supply in the future and should be explored
empirically.
Technology used in various pharmacy settings continues to evolve. Future research must
examine the impact of evolving technology in order to more fully understand how it impacts the
pharmacist supply. One example of this technology is the use of dispensing machines. Centralfill pharmacies may be a viable option to handle an increasing demand for pharmacist services in
coming decades. This increase in demand for pharmacist services has been precipitated by a
growing volume of prescriptions to be filled, especially in retail settings in the community.
Future research into the environmental factors affecting the pharmacist supply
must include a close examination of the trend toward central fill pharmacies and the technologies
that they employ (e.g. increase use of dispensing machines) in order to fully understand how it
may impact the pharmacist supply. A mixed methods approach, involving both qualitative and
quantitative modalities, should be used in conjunction with the repeated measures regression
used in this inquiry to explore this variable.
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Within the context of the population ecology theoretical framework, central fill
pharmacies appear to be related to the density and concentration constructs. It will be
particularly interesting to examine this trend toward central fill pharmacies after 2009,
the last year in the period for this inquiry.
Finally, this inquiry examined the impact of environmental factors on the pharmacist
supply from a national perspective. It may be useful in future inquiries to examine these factors
by looking at regions or other sub national levels (e.g., metropolitan statistical areas, census
tracks, rural areas, etc.). By doing so it maybe plausible to provide a more detailed description
of environmental factors and their impact on pharmacist supply in the local practice
environment.
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Appendix A

Pharmacy Supply Model Results 1991-2020: Total Active Pharmacists

Year

Active as of
Jan 1

Graduates

IPGs

Workforce Losses Due to Estimated
Death and Retirement

Net Gain

Total Active
Dec 31

1991

NA

NA

NA

NA

NA

NA

1992
1993
1994

171611
173374
175577

7113
7380
7504

314
314
314

5664
5491
5347

1763
2203
2471

173374
175577
178048

1995
1996

178048
180959

7837
8003

314
314

5240
5168

2911
3149

180959
184108

1997
1998
1999
2000

184108
187067
189697
192793

7772
7400
7829
7945

314
314
314
314

5127
5084
5047
5040

2959
2630
3096
3219

187067
189697
192793
196012

2001
2002

196011
198718

7494
7485

314
314

5101
5157

2707
2642

198718
201360

2003
2004

201359
204194

7717
7965

314
314

5195
5230

2836
3049

204195
207243

2005
2006
2007
2008
2009

207243
210321
213289
216171
219041

8054
8054
8054
8133
8133

314
314
314
314
314

5289
5400
5486
5578
5657

3079
2968
2882
2869
2790

210322
213289
216171
219040
221831

2010
2011
2012
2013

221832
224524
227209
229807

8133
8213
8213
8213

314
314
314
314

5756
5842
5929
6004

2691
2685
2598
2523

224523
227209
229807
232330

2014

232330

8293

314

6058

2549

234879

2015

234879

8293

314

6128

2479

237358

2016

237358

8293

314

6203

2404

239762

2017

239762

8373

314

6266

2421

242183

2018

242182

8373

314

6325

2362

244544

2019

244543

8373

314

6385

2302

246845

2020

246844

8452

314

6524

2242

249086

Data Gershon et al., (2000) Study.
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Appendix B

NACDS Surveys, 1998 to 2006: Unfilled Positions

Employment Survey Vacancies Full-Time of
Time Series
Chain RPh
February 1998
2,163
August 1998
2,862
February 1999
3,453
August 1999
4,679
February 2000
5,971
August 2000
5,546
February 2001
5,723
August 2001
6,666
January 2002
5,619
July 2002
4,703
January 2003
4,886
July 2003
3,818
January 2004
3,538
July 2004
3,414
January 2005
4,542
July 2005
4,971
January 2006
3,941
July 2006
4,044

Vacancies Part-Time of
Chain RPh
505
648
1,024
1,263
949
879
841
1,078
883
772
613
845
470
610
1,420
1,000
3,558
389
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Total Vacancies
2,668
3,510
4,477
5,942
6,920
6,425
6,564
7,743
6,503
5,475
5,499
4,663
4,008
4,024
5,962
5,971
7,499
4,443

Appendix C

Mean U.S. ADI Values from September 1999 through September 2003

State
Alabama

Mean
ADI
4.06

State
Illinois

Mean
ADI
4.05

State
Montana

Mean
ADI
3.63

Alaska

4.05

Indiana

4.12

Nebraska

3.56

State
Rhode Island
South
Carolina

Mean
ADI
3.13
4.02
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Arizona

4.04

Iowa

3.94

Nevada

3.77

South Dakota

3.42

Arkansas
California

3.65
4.73

Kansas
Kentucky

3.84
4.42

New Hampshire
New Jersey

3.79
3.57

Tennessee
Texas

4.24
4.39

Colorado

3.89

Louisiana

3.75

New Mexico

3.93

Utah

3.86

Connecticut

4.03

Maine

4.09

New York

4.05

Vermont

3.58

Delaware
District of
Columbia
Florida

3.45

Maryland

4.35

North Carolina

4.05

Virginia

4.32

4.2
4.15

Massachusetts
Michigan

3.82
4.31

North Dakota
Ohio

3.45
4.15

Washington
West Virginia

3.98
4.22

Georgia
Hawaii
Idaho

4.05
3.1
3.61

Minnesota
Mississippi
Missouri

4.54
4
3.92

Oklahoma
Oregon
Pennsylvania

3.8
3.87
3.94

Wisconsin
Wyoming

4.6
3.73

Data provided by Knapp et al. (2005)
ADI = Aggregate Demand Index. Ratings are defined as follows: 5 = high demand for pharmacists, difficult to fill positions, 4 = moderate
demand, some difficulty filling positions, 3 = demand in balance with supply, 2 = demand is less than the pharmacist supply available and
1 = demand is much less than the pharmacist supply available.

Appendix D

Percentage Change in Number of Hospitals, Insured Population, Population 65+, Pharmacy Facilities, and Number of
Physicians Per Year, 1994-2009
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1

Year

Hosp1

% Change

Ins2

% Change

Pop 65+2

% Change

PharmF1

% Change

DR1

% Change

1994
1995
1996
1997
1998
1999

0
6.4
0
0
0
0

NA
NA
NA
NA
NA
NA

222.4
223.7
225.0
225.6
227.4
237.1

NA
1%
1%
0%
1%
4%

33.20
33.55
35.53
35.98
35.77
36.04

NA
1%
6%
1%
-1%
1%

0
68.13
70.77
72.87
73.31
72.03

NA
NA
4%
3%
1%
-2%

623.4
653.7
672.6
695.9
720.2
735.9

NA
5%
3%
3%
3%
2%

2000

6.3

-2%

240.3

1%

34.99

-3%

73.75

2%

752.2

2%

2001
2002
2003
2004
2005
2006
2007
2008

6.2
6.2
6.2
6.3
6.6
6.6
6.6
0

-1%
0%
0%
1%
4%
0%
0%
NA

241.4
243.1
244.0
246.8
249.0
249.8
253.4
255.1

0%
1%
0%
1%
1%
0%
1%
1%

35.28
35.59
35.91
36.29
36.78
37.25
37.88
38.86

1%
1%
1%
1%
1%
1%
2%
3%

72.93
74.91
78.47
80.85
87.24
85.26
85.67
83.94

-1%
3%
5%
3%
7%
-2%
0%
-2%

765.4
783.4
802.6
808.9
818.8
828.0
844.8
848.9

2%
2%
2%
1%
1%
1%
2%
0%

2009

0

NA

253.6

-1%

39.57

2%

84.81

1%

0

NA

Calculated in 1,000s, 2 Calculated in 1,000,000s

Appendix E

Percentage Change in Pop, Pharmacies Per 100,000, Employers by Size Per Year
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1

Year
1994
1995
1996
1997
1998
1999
2000
2001
2002

Pop2
260.34
262.76
265.28
267.60
270.24
272.65
281.42
284.79
288.36

%
Change
in Pop
Per
Year
NA
1%
1%
1%
1%
1%
3%
1%
1%

2003
2004
2005
2006
2007
2008
2009

290.80
293.65
296.41
299.39
301.62
304.05
307

1%
1%
1%
1%
1%
1%
1%

Rx2
0
0
2211
2290
2437
2682
2838
2974
3038

%
Change
in Rx
Per
Year
NA
NA
NA
3%
6%
9%
6%
5%
2%

Pharmacies
Per
100,000
population
(PharmFC)
0
27.81
28.40
28.98
28.90
29.62
29.52
29.64
29.11

% Change in
Pharmacies Per
100,000
population Per
Year (PharmFC)
NA
NA
2%
2%
0%
2%
0%
0%
-2%

Employers
with 19 or
Less
employees
(EmpS)1
4.11
4.18
4.25
4.30
4.33
4.24
4.36
4.38
4.37

% Change in
Employers with
19 or less
employees Per
Year (EmpS)
NA
2%
2%
1%
1%
-2%
3%
1%
0%

Employers
with 20 or
More
employees
(EmpS)2
2.39
2.42
2.48
2.59
2.60
2.58
2.70
2.70
2.82

% Change in
Employers
with 20 or
more
employees Per
Year (EmpS)
NA
1%
2%
4%
1%
-1%
4%
0%
4%

3083
3116
3192
3309
3496
3556
3658

1%
1%
2%
4%
5%
2%
3%

29.97
30.80
31.08
33.21
32.37
32.30
0

3%
3%
1%
6%
-3%
0%
NA

4.43
4.50
5.40
5.42
5.46
5.34
0

1%
2%
17%
0%
1%
-2%
NA

2.82
2.88
2.09
2.17
2.23
2.25
0

0%
2%
-38%
4%
3%
1%
NA

Calculated in 1,000s, 2 Calculated in 1,000,000s

Appendix F

Percentage Change in Employer Volume, Hospital Beds Per 100,000, Office based Physicians 100,000,
and Median Household Income Per Year
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1

% Change in
Hosp Beds Per
100,000
population Per
Year (HospC)

OBDR
Per
100,000
population

% Change
in OBDR
Per 100,000
population
Per Year

Median
household
income
(MHI)

% Change in
Median
household
income Per
Year (MHI)

Year

Total
Employers
(EmpV)2

% Change in
Employers Per
Year (EmpV)

Hosp beds Per
100,000
population
(HospC)

1994

6.50

NA

0

NA

0

NA

$46,399

1995

6.61

2%

446.8

NA

156.9

NA

$47,255

2%

1996

6.73

2%

0

NA

0

NA

$47,810

1%

1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009

6.89
6.94
6.83
7.07
7.09
7.20
7.25
7.38
7.49
7.60
7.70
7.60
0

2%
1%
-2%
3%
0%
1%
1%
2%
1%
1%
1%
-1%
NA

0
0
0
384.2
382.4
374.0
367.7
363.4
360.6
357.9
356.0
0
0

NA
NA
NA
-16%
0%
-2%
-2%
-1%
-1%
-1%
-1%
NA
NA

0
0
0
170.3
177.3
176.7
180.8
182.5
187.7
184.7
183.9
180.3
0

NA
NA
NA
8%
4%
0%
2%
1%
3%
-2%
0%
-2%
NA

$48,774
$50,661
$51,815
$52,017
$51,248
$50,511
$50,648
$50,529
$50,771
$51,439
$52,138
$50,583
$49,857

2%
4%
2%
0%
-2%
-1%
0%
0%
0%
1%
1%
-3%
-1%

Calculated in 1,000s, 2 Calculated in 1,000,000s
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